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A B S T R A C T
Background
Musculoskeletal conditions require particular management skills. Identification of interventions which are effective in equipping general
practitioners (GPs) with such necessary skills could translate to improved health outcomes for patients and reduced healthcare and
societal costs.
Objectives
To determine the effectiveness of professional interventions for GPs that aim to improve the management of musculoskeletal conditions
in primary care.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), 2010, Issue 2; MEDLINE, Ovid (1950 - October
2013); EMBASE, Ovid (1980 - Ocotber 2013); CINAHL, EbscoHost (1980 - November 2013), and the EPOC Specialised Register.
We conducted cited reference searches using ISI Web of Knowledge and Google Scholar; and handsearched selected issues of Arthritis
and Rheumatism and Primary Care-Clinics in Office Practice. The latest search was conducted in November 2013.
Selection criteria
We included randomised controlled trials (RCTs), non-randomised controlled trials (NRCTs), controlled before-and-after studies
(CBAs) and interrupted time series (ITS) studies of professional interventions for GPs, taking place in a community setting, aiming to
improve themanagement (including diagnosis and treatment) of musculoskeletal conditions and reporting any objective measure of GP
behaviour, patient or economic outcomes. We considered professional interventions of any length, duration, intensity and complexity
compared with active or inactive controls.
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Data collection and analysis
Two review authors independently abstracted all data. We calculated the risk difference (RD) and risk ratio (RR) of compliance with
desired practice for dichotomous outcomes, and the mean difference (MD) and standardised mean difference (SMD) for continuous
outcomes. We investigated whether the direction of the targeted behavioural change affects the effectiveness of interventions.
Main results
Thirty studies met our inclusion criteria.
From 11 studies on osteoporosis, meta-analysis of five studies (high-certainty evidence) showed that a combination of a GP alerting
system on a patient’s increased risk of osteoporosis and a patient-directed intervention (including patient education and a reminder
to see their GP) improves GP behaviour with regard to diagnostic bone mineral density (BMD) testing and osteoporosis medication
prescribing (RR 4.44; (95% confidence interval (CI) 3.54 to 5.55; 3 studies; 3,386 participants)) for BMD and RR 1.71 (95% CI 1.50
to 1.94; 5 studies; 4,223 participants) for osteoporosis medication. Meta-analysis of two studies showed that GP alerting on its own
also probably improves osteoporosis guideline-consistent GP behaviour (RR 4.75 (95% CI 3.62 to 6.24; 3,047 participants)) for BMD
and RR 1.52 (95% CI 1.26 to 1.84; 3.047 participants) for osteoporosis medication) and that adding the patient-directed component
probably does not lead to a greater effect (RR 0.94 (95% CI 0.81 to 1.09; 2,995 participants)) for BMD and RR 0.93 (95% CI 0.79
to 1.10; 2,995 participants) for osteoporosis medication.
Of the 10 studies on low back pain, seven showed that guideline dissemination and educational opportunities for GPs may lead to little
or no improvement with regard to guideline-consistent GP behaviour. Two studies showed that the combination of guidelines and GP
feedback on the total number of investigations requested may have an effect on GP behaviour and result in a slight reduction in the
number of tests, while one of these studies showed that the combination of guidelines and GP reminders attached to radiology reports
may result in a small but sustained reduction in the number of investigation requests.
Of the four studies on osteoarthritis, one study showed that using educationally influential physicians may result in improvement in
guideline-consistent GP behaviour. Another study showed slight improvements in patient outcomes (pain control) after training GPs
on pain management.
Of three studies on shoulder pain, one study reported that there may be little or no improvement in patient outcomes (functional
capacity) after GP education on shoulder pain and injection training.
Of two studies on other musculoskeletal conditions, one study on pain management showed that there may be worse patient outcomes
(pain control) after GP training on the use of validated assessment scales.
The 12 remaining studies across all musculoskeletal conditions showed little or no improvement in GP behaviour and patient outcomes.
The direction of the targeted behaviour (i.e. increasing or decreasing a behaviour) does not seem to affect the effectiveness of an
intervention. The majority of the studies did not investigate the potential adverse effects of the interventions and only three studies
included a cost-effectiveness analysis.
Overall, there were important methodological limitations in the body of evidence, with just a third of the studies reporting adequate
allocation concealment and blinded outcome assessments. While our confidence in the pooled effect estimate of interventions for
improving diagnostic testing and medication prescribing in osteoporosis is high, our confidence in the reported effect estimates in the
remaining studies is low.
Authors’ conclusions
There is good-quality evidence that aGP alerting systemwith or without patient-directed education on osteoporosis improves guideline-
consistent GP behaviour, resulting in better diagnosis and treatment rates.
Interventions such as GP reminder messages and GP feedback on performance combined with guideline dissemination may lead to
small improvements in guideline-consistent GP behaviour with regard to low back pain, while GP education on osteoarthritis pain and
the use of educationally influential physicians may lead to slight improvement in patient outcomes and guideline-consistent behaviour
respectively. However, further studies are needed to ascertain the effectiveness of such interventions in improving GP behaviour and
patient outcomes.
P L A I N L A N G U A G E S U M M A R Y
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Professional interventions for general practitioners (GPs) on the management of musculoskeletal conditions
Thirty studies met our inclusion criteria.
Eleven studies evaluated interventions aiming to improve the management of osteoporosis by GPs. Five of these studies were sufficiently
similar that we were able to combine their results. Our findings suggest that alerting the GP that a patient is at risk of osteoporosis
and educating the patient, reminding them to visit their GP, leads to improved GP behaviour (diagnostic testing and medication
prescribing). We determined that the quality or certainty of the evidence from these studies is high, so we are confident in these results.
GP alerting on its own is also probably effective according to two studies and adding the patient-directed component probably does
not lead to a greater effect.
Of the ten studies on low back pain, seven showed that GP education and distribution of guidelines may lead to little or no improvement
with regards to GPs’ clinical behaviour. Two studies showed that providing GPs with guidelines and information on the total number
of tests they request may have an effect on GP behaviour (resulting in a slight reduction in the number of tests). One study showed
that using a combination of guidelines and GP reminders attached to test reports may result in a small but sustained reduction in the
number of tests.
Of the four studies on osteoarthritis, one found that GP behaviour may improve when prominent GPs are recruited to educate their
colleagues. A second study showed slight improvements in patient outcomes (pain control) after training GPs on pain management.
Of the three studies on shoulder pain, one study showed that there may be little or no improvement in patient outcomes (functional
capacity) after GP education on shoulder pain and injection training.
Of the two studies on other musculoskeletal conditions, one study on pain management showed worse patient outcomes (pain control)
after GP training on the use of tools to measure pain.
The 12 remaining studies across all musculoskeletal conditions showed little or no improvement in GP behaviour and patient outcomes.
The majority of the studies did not investigate the potential adverse effects of the interventions and only three studies included a cost-
effectiveness analysis.
The direction of the targeted behaviour (i.e. increasing or decreasing a behaviour) does not seem to affect the effectiveness of an
intervention.
The certainty of the evidence was high from studies that examined the effectiveness of interventions to improve the management of
osteoporosis by GPs, so we are confident in these findings. There were important limitations in how most of the remaining studies were
conducted or reported, and we are less certain of the likely effects of these interventions to improve the management of musculoskeletal
conditions.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Primary care physician alerting system and a patient-directed intervention (education and reminder to see their primary care physician) compared to usual care for
osteoporosis management
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alert ing system and a patient-directed intervent ion (educat ion and reminder to see their primary care physician)
Comparison: Usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual care A physician alerting
system and a patient-
directed intervention
(education and re-
minder to see their pri-
mary care physician)
Bone M ineral Density 1
Follow-up: 6-12 months
Study population RR 4.44
(3.54 to 5.55)
3386
(3 studies)
⊕⊕⊕⊕
high3
49 per 1000 220 per 1000
(124 to 390)
M oderate
39 per 1000 176 per 1000
(99 to 311)
Osteoporosis medica-
tion 2
Follow-up: 6-12 months
Study population RR 1.71
(1.50 to 1.94)
4223
(5 studies)
⊕⊕⊕⊕
high3
131 per 1000 241 per 1000 3
(193 to 301)
M oderate4
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106 per 1000 195 per 1000 3
(156 to 244)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Bone mineral density (BMD) test ing is an important outcome for osteoporosis because it leads to the diagnosis of the
condit ion. This is one of the GP behaviour-related outcomes (primary outcome)
2 Osteoporosis medicat ion prescribing is an important outcome for osteoporosis management as it is the main aspect of
treatment. This is one of the GP behaviour-related outcomes (primary outcome)
3 One of the f ive studies (Roux 2013) had two intervent ion comparison groups which were combined to create a single pair-
wise comparison as recommended in chapter 16.5.4 of the Cochrane Handbook.
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B A C K G R O U N D
One in six adults (15.6%) suffers from a longstanding condition
of the musculoskeletal system (Arthritis Research UK 2011). Be-
tween 12 and 20% of general practitioner (GP) consultations are
for musculoskeletal problems (Jordan 2007; McCormick 1995;
RCGP 1995). Musculoskeletal impairments ranked number one
in chronic impairments in the USA (National Center for Health
Statistics 1995). Work-related musculoskeletal disorders were re-
sponsible for 11 million days lost fromwork in 1995 in the United
Kingdom (UK) and tended to involve higher percentages of long-
term work loss in the USA when compared with all non-fatal in-
juries and illnesses in 2001 (Jones 1998;WorkerHealthChartbook
2004). In the Ontario Health Survey musculoskeletal conditions
caused 40%of all chronic conditions, 54%of all long-termdisabil-
ity, and 24% of all restricted activity days (Badley 1994). However,
musculoskeletal training has not been part of traditional GP train-
ing and has only recently been introduced as part of the new Royal
College of General Practitioners curriculum (RCGP Curriculum
2006).
TheWorldHealthOrganization (WHO)dedicated the years 2000
to 2010 as Bone and Joint Decade. The importance of improv-
ing competency in the management of musculoskeletal problems
within primary care settings is highlighted by Akesson et al in the
Bulletin of the WHO (WHO 2003). Many GPs/family doctors
do not have adequate training and consequently lack the compe-
tency, skills and confidence to manage musculoskeletal disorders
in their daily practice; they may not recognise conditions or be
aware of what can be achieved by appropriate care (WHO 2003).
The majority of research on educational interventions for health-
care professionals focuses mainly on improving theoretical knowl-
edge and clinical decision making, with less emphasis on skill
acquisition. However, competency in examination and technical
skills, such as joint injections, is of paramount importance for
appropriate diagnosis and management of musculoskeletal condi-
tions. Technical skills require the use of targeted approaches for
effective teaching, learning, and assessment (Ajit 2004). Interven-
tions that may be successful at improving practice in other areas
of medicine may therefore not achieve the same results in muscu-
loskeletal medicine.
It is generally accepted that systematic development is needed for
quality-improvement interventions to be effective. Tailoring their
content and format to the specific features of a target group and set-
ting seems necessary to improve their effectiveness (Van Bokhoven
2003). Characteristics of the individual provider are important.
For example, a programme to increase specific knowledge is likely
to have a greater effect on providers with lower baseline knowledge,
but paradoxically practitioners are more likely to place greater em-
phasis on topics of continuing education in which they have tra-
ditionally received the greatest amount of training (Forrest 1989).
Efforts to tailor interventions to particular provider needs warrant
greater attention (Kroenke 2000). Competing demands inherent
in the primary care setting (such as limited time, frequent medical
comorbidity and somatisation) need to be considered. Failure to
recognise these constraints may sabotage interventions (Klinkman
1997). It cannot be assumed that interventions which are effective
in changing behaviour and improving management by hospital
specialists will also be effective in improving care provided by GPs
or family doctors.
The identification of successful professional interventions to im-
prove the management of musculoskeletal conditions by GPs
could potentially result in improved health outcomes for patients,
reduced healthcare costs and also reduced social costs related to
the loss of productivity and earnings. The aim of this systematic
review is to identify those professional interventions that improve
management, and to quantify their effects.
O B J E C T I V E S
To determine the effectiveness of professional interventions for
general practitioners/family doctors that aim to improve the man-
agement of musculoskeletal conditions in primary care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomised controlled trials (RCTs), non-ran-
domised controlled trials (NRCTs), controlled before-and-after
studies (CBAs) and interrupted time series (ITS) studies for this
review, in accord with the protocol (Tzortziou 2008). We used the
eligibility criteria for NRCTs published by the Effective Practice
and Organisation of Care (EPOC) Group (EPOC 2013a). Ac-
cording to this guidance, we excluded studies with only one inter-
vention or control site. We included CBA studies with at least two
intervention sites and two control sites. We excluded ITS studies
that did not have a clearly-defined point in time when the inter-
vention occurred and at least three data points before and three
after the intervention.
Types of participants
We included studies evaluating interventions within a primary
care setting, targeting the following types of participants:
• Individual general practitioners (GPs)/family doctors
• Groups of GPs/family doctors
• Multidisciplinary care teams (i.e. groups of healthcare
workers of different disciplines) where GPs/family doctors are a
substantial part of the team (50% or more)
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Types of interventions
Any professional interventions aimed at GPs/family doctors, de-
signed to improve the management of musculoskeletal conditions
in the community. Such conditions include neck pain, back pain
and other regional pain, possible or known arthritis (including
osteoarthritis, rheumatoid arthritis and spondylo-arthropathies),
osteoporosis, musculoskeletal injuries and trauma. We used the
term ’management’ in its broader definition within general prac-
tice, which includes diagnosis, investigations, explanation, advice,
prescribing, medical interventions/procedures, referral and pre-
vention.
We considered professional interventions of any length, duration,
intensity and complexity compared with active (i.e. different in-
terventions) or inactive (e.g. standard care) controls.
Eligible professional interventions include the following and their
combinations (based on the EPOC taxonomy, EPOC 2002):
• Distribution of educational materials including clinical
guidelines
• Educational meetings
• Educational outreach visits
• Patient-mediated interventions
• Audit and feedback
• Computer-aided decision support
• Marketing-focus groups
• E-learning/web-based educational programmes
• Educational courses with formal examination/assessment
(rather than attendance certificate only)
• Mentoring
• Training workshops
• Local consensus processes
• Local opinion leaders
• GP reminder
Types of outcome measures
Primary outcomes
Any objective measure (using validated tools wherever available)
of health professional behaviour related outcomes, patient or eco-
nomic outcomes such as:
a) Health professional (GP) behaviour-related outcomes
These outcomes measure GP behaviour, care provision and ad-
herence to recommended practice or guidelines across all aspects
of musculoskeletal management. As mentioned above, the term
’management’ is used in its broader definition within general prac-
tice, which includes diagnosis, investigations, explanation, advice,
prescribing, medical interventions/procedures, referral and pre-
vention. Examples of such outcomes include the following:
• Rates of diagnosis and diagnostic accuracy
• Rates of appropriate clinical assessment/examination
• Use of relevant clinical assessment and shared decision
support tools (e.g. pain assessment score tools)
• Ordering of tests/investigations to confirm a diagnosis or
exclude other conditions (e.g. x-rays, MRIs, bone scans,
ultrasound scans, bone mineral density (BMD) scans, blood
tests)
• Prescribing of medication (e.g. non-steroidal anti-
inflammatory medications for symptomatic pain relief,
osteoporosis medication for treatment)
• Provision of medical interventions/procedures (e.g. minor
surgery, joint injections, ultrasound treatment)
• Referral rates to other services (e.g. physiotherapy,
occupational therapy, secondary-care specialist clinics)
b) Patient outcomes
• Symptom burden and health status
◦ Markers of disease control (e.g. pain scores)
◦ Symptom days/scores
◦ Functional health status (e.g. disability scores)
◦ Quality of life, morbidity, mortality
◦ School/work days lost
• Patient behaviour and utilisation of health care
◦ Medication adherence
◦ Consultation length
◦ Patient repeat visits with same musculoskeletal
complaint
◦ Emergency Department visits
◦ Patient sickness certification
◦ Hospitalisations
c) Economic outcomes
• Health service and societal costs
• Cost effectiveness (for example, incremental cost-
effectiveness ratios (ICERs), incremental cost per quality-
adjusted life year (QALY) and cost-benefit ratios)
• Cost utility
Secondary outcomes
• Patient knowledge or satisfaction
• GP knowledge, attitude or satisfaction on the management
of musculoskeletal conditions
We included measures of GPs’ and patients’ knowledge, attitudes
or satisfaction in this review, as thesemay provide useful secondary
information. However, we excluded studies only reporting knowl-
edge, attitudes or satisfaction (i.e. secondary outcomes) with no
objective measure of professional performance, patient health or
economic outcomes (i.e. primary outcomes).
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Search methods for identification of studies
We searched the Cochrane Database of Systematic Reviews and
theDatabase of Abstracts of Reviews of Effects (DARE) for related
systematic reviews, and the electronic databases listed below for
primary studies. We designed a sensitive search strategy to retrieve
studies from these databases. We applied neither language nor date
restrictions.We conducted searches inAugust 2010 andNovember
2013; we include the exact search dates for each database with the
search strategies in Appendix 1
• Cochrane Central Register of Controlled Trials
(CENTRAL), via EBM Reviews OvidSP (2013)
• Cochrane Methodology Register, Health Technology
Assessment, NHS Economic Evaluation Database, via EBM
Reviews OvidSP (2013)
• MEDLINE via OVID (1946 - October 2013)
• EMBASE via OVID (1947 - October 2013)
• CINAHL via EbscoHost (1980 - November 2013)
We used the Cochrane 2013 sensitivity and precision-maximis-
ing filter for retrieving RCTs from MEDLINE (Lefebvre 2011).
To retrieve NRCT, CBA and ITS studies, we applied the EPOC
Methods Filter 2.6 (developed by the EPOC Trials Search Co-
ordinator (TSC), January 2013 version). The search strategy was
devised for the OVIDMedline interface and then adapted for the
other databases. For other databases, where no filter exists, study
designs can only be identified at the screening stage (see Types of
studies).
Searching other resources
We also:
1. screened individual journals, e.g. handsearched: Arthritis
and Rheumatism (ISSN 1529-0131) (November 1995 - August
2012), and Primary Care-Clinics in Office Practice (ISSN 0095-
4543) (March 1996 - June 2012);
2. reviewed reference lists of all included studies, relevant
systematic reviews, and primary studies;
3. conducted cited reference searches using ISI Web of
Knowledge and Google Scholar for all studies selected for
inclusion in this review.
Data collection and analysis
Selection of studies
Two review authors (VTB and NM) independently assessed all
titles and abstracts of articles identified by the searches. We ob-
tained the full-text articles of studies meeting the initial inclusion
criteria and for which we could not determine eligibility. Both au-
thors independently read the full text to confirm studies as accept-
able or not. A third review author (DM) was available to resolve
any disagreements. We list those that initially appeared to meet
the inclusion criteria but that we later deemed unsuitable for in-
clusion, in the Characteristics of excluded studies tables, together
with reasons for their exclusion. We documented the number of
articles screened, assessed for eligibility, and selected for inclusion
in a PRISMA flow diagram.
Data extraction and management
Two review authors (VTB and NM) independently extracted de-
tails of study design, population, intervention and control, and
outcome data from included articles using a data extraction form
based on the EPOCdata abstraction form (see EPOC2013b). For
economic outcomes, we designed data extraction forms according
to the Cochrane Handbook for Systematic Reviews of Interventions
(Cochrane Handbook: Shemilt 2011). We piloted the data extrac-
tion form on two included studies to minimise misinterpretation,
resolving any disagreement between the review authors regarding
study suitability or data extraction by discussion and consensus. If
necessary, we consulted a third review author (DM, MU or OW)
to resolve disagreements.
Assessment of risk of bias in included studies
We assessed the risk of bias of the included studies in accor-
dance with EPOC and Cochrane guidance (EPOC 2015; Higgins
2011b). We used the Cochrane tool for assessing risk of bias for
the included RCTs.The seven domains we addressed were: se-
quence generation, allocation concealment, blinding of partici-
pants, blinding of outcome assessment, incomplete outcome data,
selective outcome reporting and “other bias”. The seventh do-
main, “other bias”, included a baseline assessment (on whether the
groups differed in fundamental ways in terms of baseline charac-
teristics and outcomes) and an assessment of whether there was
any protection against contamination. By answering a prespecified
question about the adequacy of the study in relation to each of the
above domains, we made a judgement indicating low, high or un-
known risk of bias. Two review authors (VTB and NM) indepen-
dently assessed the overall risk of bias for each domain within each
study. Review authors were not blinded to study author, institu-
tion, or journal, as evidence indicates that little benefit is achieved
through blinding (Berlin 1997). We assessed the risk of bias for
NRCTs using the suggested risk of bias criteria for EPOC reviews
(EPOC 2015). We resolved any disagreement between review au-
thors (VTB and NM) by discussion and consensus.
Measures of treatment effect
We reported outcomes for each study in natural units.Where base-
line results were available from RCTs, NRCTs and CBAs, we re-
ported pre-intervention and post-intervention means or propor-
tions for both study and control groups.
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For studies reporting dichotomous outcomes, we reported the ab-
solute difference (risk difference, RD) calculated as the post-inter-
vention proportion of outcome in intervention group minus the
post-intervention proportion in the control group.We defined the
effect size as ’small’ if RD was less than or equal to 5%, ’mod-
est’ if greater than 5% but less than or equal to 10%, ’moderate’
if greater than 10% but less than or equal to 20%, and ’large’
if greater than 20%, according to Grimshaw 2004. We reported
the relative percentage difference (absolute difference divided by
post-intervention score in the control group).When baseline levels
were available, we calculated the absolute adjusted risk difference
(ARD), which adjusts for baseline differences between groups as
used by Flodgren 2011 and French 2010. An adjusted risk dif-
ference (ARD) is the difference between intervention and control
group proportions of compliance after (post) the intervention mi-
nus the difference between groups before (pre) the intervention
which may be expressed as: Adjusted risk difference (ARD) = (risk
of compliance (intervention− control) post-intervention)− (risk
of compliance (intervention− control) pre-intervention). We also
calculated the risk ratio (RR) for all outcomes and included the P
values as reported by the study authors. When summarising the
results of a study in a summary table, for studies reporting more
than one dichotomous outcome in which none was identified as
a primary outcome, we reported the effect sizes for all outcomes.
For studies reporting continuous data, we calculated the absolute
mean difference between intervention and control groups (MD)
and the relative percentage change i.e. the per cent improvement
relative to the post-intervention mean in the control group. We
calculated standardised mean differences (SMD) by dividing the
difference in mean scores between the intervention and compar-
ison group in each study, by an estimate of the pooled standard
deviation according to Smith 2016. We considered the SMD to
be small if < 0.40, moderate if 0.40 to 0.70 and large if > 0.70 ac-
cording to Chapter 12.6.of theCochrane Handbook (Schünemann
2011). Wherever possible, we also calculated the relative percent-
age change adjusted for baseline differences in the outcome mea-
sures (i.e. the absolute post-intervention difference between the
intervention and control groups minus the absolute pre-interven-
tion difference between the intervention and control groups, di-
vided by the post-intervention mean in the control group) accord-
ing to Analysis in EPOC reviews (EPOC 2013e).
The direction of effect differed between studies, with some studies
expecting an increase in outcome (such as an increase in BMD
testing for osteoporosis) and others expecting a decrease (such as
reduction of x-ray requests for low back pain) according to the
guidelines. In all cases we standardised the effect size, so that a pos-
itive RD, ARD, MD or SMD represents a beneficial intervention
outcome compared to control, according to Grimshaw 2004.
For the ITS study, we reported the pre- and post-intervention
means, their difference, the relative percentage change and the
mean change in level and slope.
We used ’Summary of findings’ tables for the main comparisons
in the review, to interpret the results and draw conclusions about
the effects of different interventions, including the size of effects
and certainty of the evidence.
Unit of analysis issues
For clustered randomised studies with potential unit of analysis
errors, we attempted to re-calculate the effect sizes using intraclus-
ter (or intraclass) correlation coefficient (ICC) wherever possible,
according to Chapter 16.3 of the Cochrane Handbook (Higgins
2011a). Where the relevant data was not available to allow the re-
calculation of effect sizes incorporating the effect of clustering, we
reported the relevant effect sizes without the confidence intervals
and P values and highlighted the potential unit of analysis errors
(French 2010, Ukoumunne 1999).
Assessment of heterogeneity
Given the wide scope of the review, we anticipated that many of
the included studies would be too heterogeneous in terms of inter-
vention types, musculoskeletal conditions targeted and outcomes
measured to undertake meta-analysis.
We assessed heterogeneity using the Chi² and I² tests, as described
by Higgins 2003 and the Cochrane Handbook (Deeks 2011). We
pooled results when aminimum of two studies were homogeneous
regarding the participants, interventions and outcomes.
Where poolingwas not possible, we presented anarrative summary
and attempted to organise the studies into groupings or clusters (by
musculoskeletal condition, intervention type, and study design)
so that it is easier to identify patterns in results, both within and
between the groups that were formed. We presented the studies
in tabular form, reporting the results descriptively, and made a
qualitative assessment of their effects.
Data synthesis
We pooled the results of studies which were homogeneous regard-
ing the interventions and outcomes as mentioned above, and used
a fixed-effect meta-analysis (Mantel-Haenszel method) to report
risk ratios (RRs) for dichotomous data, in accordance with the
Cochrane Handbook (Deeks 2011). We used risk ratios because
reporting relative effect measures is, on average, more consistent
than absolutemeasures, and this is in accordancewith theCochrane
Handbook (Deeks 2011).
If corrected data, taking into account the unit of analysis errors,
were reported for cluster-randomised trials, we planned to use
these data for meta-analysis. If corrected data were not reported,
we intended to estimate corrections if adequate datawere available;
however, these data were also not reported and were not available
after contacting the authors.
We assessed the overall confidence in estimate of effect (certainty
of evidence) for each outcome using the GRADE (Grading of
Recommendations Assessment, Development and Evaluation) ap-
proach which classifies the certainty or confidence of the evidence
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as high, moderate, low or very low in consideration of five factors:
risk of bias or study limitations, directness, consistency of results,
precision and publication bias (Guyatt 2008).
Two review authors independently assessed the certainty of evi-
dence; resolving disagreements by discussion. We did not exclude
studies on the basis of GRADE ratings; we took into account the
certainty of evidencewhen interpreting the results. For assessments
of the overall certainty of evidence for each outcome that included
pooled data from RCTs only, we downgraded the evidence from
’high certainty’ by one level for serious (or by two for very serious)
study limitations (risk of bias), indirectness of evidence, serious
inconsistency, imprecision of effect estimates or potential publi-
cation bias. Data from observational studies started at ’low cer-
tainty’.
Subgroup analysis and investigation of heterogeneity
We summarised the results meaningfully and organised the studies
into groupings or clusters to identify patterns in results. Clinically,
the main source of heterogeneity amongst studies is the muscu-
loskeletal condition studied, as this can often determine the type
of intervention andmeasured outcomes. For example, certain out-
comes (such as BMD scanning or steroid injections) are only ap-
plicable in specific musculoskeletal conditions. We therefore re-
ported the results of the included studies grouped by condition,
i.e. osteoporosis, osteoarthritis, low back pain, shoulder pain and
other musculoskeletal conditions. In each condition group, we
divided the evaluations of interventions against ’no intervention’
control groups and against a ’different intervention’ control group.
French 2010 followed the same approach in their review.
The vast majority of the included studies (26/30) focused on sin-
gle musculoskeletal conditions. Therefore, by grouping the stud-
ies by condition, we were able to establish whether within-study
relationships were replicated across similar studies. This boosted
our confidence in the findings, as differences in subgroups that are
observed within studies are more reliable than analyses of subsets
of studies (EPOC 2013c).
The osteoporosis studies which were sufficiently similar for their
results to be combined were further divided into those where the
intervention targeted just GPs versus those where both GPs and
patients were targeted. This allowed an assessment of the effect of
adding a patient directed component to interventions targeting a
GP in order to establish whether the combined intervention results
in improved outcomes.
We also did a subgroup analysis to assess the intended direction
of the intervention’s effect on the targeted behavioural change (i.e.
whether increasing or decreasing an existing behaviour resulted
in different effects). These additional aspects of analysis were not
part of the protocol and were added post hoc in order to further
explore heterogeneity.
Sensitivity analysis
We conducted a sensitivity analysis in order to ensure that the
findings of any meta-analysis are not dependent on arbitrary or
unclearmethodological decisions, in accordancewith theCochrane
Handbook (Deeks 2011). The sensitivity analysis was to reconsider
our analysis methods. In our meta-analysis we planned to use risk
ratios as recommended in the Cochrane Handbook (Deeks 2011).
However, it is often sensible to re-express the results using a more
easily interpretable statistic such as the risk differences (Higgins
2011a). We therefore decided to re-analyse the results using risk
difference in order to investigate whether the choice of summary
statistic could influence the conclusions of the meta-analysis.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies
Results of the search
Figure 1 outlines the process from searching to study inclu-
sion. We retrieved 9,665 potentially applicable citations from
searches of electronic databases (CENTRAL, MEDLINE, EM-
BASE, CINAHL, and the EPOC Register) and handsearches of
other resources.
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Figure 1. Prisma study flow diagram.
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Two review authors (VTB and NM) independently screened the
titles and abstracts of the studies and excluded 9614 records, leav-
ing 51 studies eligible for full-text review. Thirty of these studies
met our inclusion criteria and we describe their characteristics in
the Characteristics of included studies table. Studies initially ap-
pearing appropriate for inclusion, but then subsequently excluded
have their primary reason for exclusion listed in theCharacteristics
of excluded studies table.
Included studies
Characteristics of study design and setting:
Seventeen included studies were cluster-randomised trials, eleven
were individual randomised trials, one (Broadhurst 2007) was a
CBA and one (Hollingworth 2002) was an interrupted time series.
There were no NRCTs. Seventeen of the studies were two-arm
trials, eight compared three arms and five compared four arms.
All of the included studies were conducted in high-income coun-
tries, with eight based in Canada, eight in the USA, six in the
UK, two in Germany, two in France, two in Australia, one in the
Netherlands and one in Northern Ireland. All of the studies evalu-
ated professional interventions for GPs. We found no studies tar-
geting multidisciplinary care teams where GPs constituted 50%
or more of the participants.
All of the studies evaluated interventions delivered in a primary
care setting.
Characteristics of the professional interventions:
Eleven studies focused on the management of osteoporosis, ten
on low back pain of which two included knee pain, four on the
management of osteoarthritis, three on shoulder pain and the re-
maining two on other musculoskeletal pain.
Out of the thirty studies, twenty-four included interventions ad-
dressed solely to the GP (Becker 2008; Bishop 2006; Boyd 2002;
Broadhurst 2007; Chassany 2006; Dey 2004; Eccles 2001; Engers
2005; Feldstein 2006; French 2013;Gormley 2003;Hazard 1997;
Hollingworth 2002; Huas 2006; Kerry 2000; Leslie 2012; Rahme
2005; Robling 2002; Rosemann 2007; Rozental 2008; Schectman
2003; Solomon 2007a; Stross 1985; Watson 2008). Ten stud-
ies (Bessette 2011; Bishop 2006; Ciaschini 2010; Cranney 2008;
Feldstein 2006; Lafata 2007; Leslie 2012; Majumdar 2008; Roux
2013; Solomon 2007a) combined professional interventions with
patient-directed interventions such as patient-directed education
and reminders to see their GP. These patient-directed components
have been described as such whenever encountered.
Table 1 presents the classification of different educational inter-
ventions according to EPOC taxonomy (EPOC2002). The thirty
included studies provided an evaluation of a wide range of dif-
ferent professional interventions. Table 2 provides a summary of
these.
Studies comparing an intervention to a ‘no intervention’ con-
trol:
Twenty-three of the included studies assessed an intervention
against a ‘no intervention’ or ‘usual care’ control (Bessette 2011;
Bishop 2006; Broadhurst 2007; Chassany 2006; Ciaschini 2010;
Cranney 2008; Dey 2004; Engers 2005; Feldstein 2006; French
2013; Hazard 1997; Huas 2006; Kerry 2000; Lafata 2007; Leslie
2012; Majumdar 2008; Rahme 2005; Rosemann 2007; Roux
2013; Schectman 2003; Solomon 2007a; Stross 1985; Watson
2008) and Table 3 shows the different components of these in-
terventions. Distribution of educational material in combination
with an educational meeting/workshop was the most frequent
intervention assessed against a no-intervention control, and was
evaluated in six studies. Distribution of educational materials was
the intervention most frequently used as a component of a multi-
faceted intervention.
Studies comparing an intervention to a different intervention:
Fifteen studies (Becker 2008; Bessette 2011; Bishop 2006; Boyd
2002; Eccles 2001; Feldstein 2006; Gormley 2003; Lafata 2007;
Leslie 2012; Rahme 2005; Robling 2002; Rosemann 2007; Roux
2013; Rozental 2008; Solomon 2007a) evaluated single or multi-
faceted interventions against another intervention. The majority
of the studies evaluated different intervention combinations (see
Table 4).
Excluded studies
The main reasons for the studies’ exclusion were methodological
limitations; for example, absence of two control and two interven-
tion groups in CBAs, or observational studies with no compari-
son groups (Fabiani 2004; Feldstein 2007; Garala 1999; Gardner
2002; Ioannidis 2008; Ioannidis 2009;McDonald 2003;Nazareth
2002). We excluded five studies because fewer than 50% of the
participants were GPs (Gardner 2005; Glazier 2005; Goldberg
2001; Solomon 2007b; Vernacchio 2013).We excluded two stud-
ies because they did not evaluate professional interventions on
the management of musculoskeletal conditions (Corson 2011;
Rolfe 2001), and a further two because they did not report on
objectively-measured primary outcomes (Ashe 2004; Ruiz 2001).
The exact reasons for exclusion for each study are detailed in the
Characteristics of excluded studies table.
Risk of bias in included studies
We present the findings of ’Risk of bias’ assessments in Figure
2 and Figure 3 to demonstrate a graphical representation of the
judgements about each of the risk of bias items, and in Figure 4
and Figure 5 to present these as percentages across all included
studies.
12Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias summary for ITS study design: review authors’ judgements about each risk of bias
item for each included study.
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Figure 4. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Figure 5. Risk of bias graph for ITS study design: review authors’ judgements about each risk of bias item
presented as percentages across all included studies.
Overall, with the exception of the five studies included in themeta-
analysis, there was a high risk of bias across the included studies.
Despite the fact that twenty-eight out of the thirty studies
were randomised trials, in eight studies (Bessette 2011; Boyd
2002; Gormley 2003; Huas 2006; Rahme 2005; Rozental 2008;
Schectman 2003; Stross 1985) the method for random sequence
generation was unclear.
With regard to the study by Hollingworth 2002, which used an
ITS design, it was unclear whether the intervention took place in-
dependently of other changes and there was insufficient informa-
tion on the shape of the intervention effect and the completeness
of the outcome data.
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Allocation
We judged seven out of the twenty-nine controlled trials to have
a high risk of bias for allocation concealment, and twelve had an
unclear risk as they did not contain enough information for the
risk to be estimated.Ten studies had a low risk of selection bias
(Becker 2008; Cranney 2008; Dey 2004; Eccles 2001; Feldstein
2006; French 2013; Leslie 2012; Majumdar 2008; Roux 2013;
Schectman 2003).
Blinding
We rated six of the twenty-nine controlled trials as having a high
risk of detection bias, twelve studies as having an unclear risk,
and eleven studies with a low risk of such bias (Becker 2008;
Eccles 2001; Feldstein 2006; French 2013; Kerry 2000; Lafata
2007; Leslie 2012; Majumdar 2008; Rahme 2005; Robling 2002;
Solomon 2007a).
In half of the controlled studies, blinding of the participants
was either unclear or did not happen (Bishop 2006; Boyd 2002;
Feldstein 2006; French 2013; Hazard 1997; Lafata 2007; Rahme
2005;Robling 2002;Rosemann 2007;Roux 2013;Rozental 2008;
Schectman 2003; Solomon 2007a; Stross 1985; Watson 2008).
Incomplete outcome data
Three controlled studies had a high risk of bias for incomplete
outcome data (Bessette 2011; Boyd 2002; French 2013), five
had an unclear risk (Gormley 2003; Huas 2006; Robling 2002;
Schectman 2003; Stross 1985) and we judged the remaining
twenty-one controlled studies to have a low risk of such bias.
Selective reporting
Two controlled studies (French 2013; Kerry 2000) had a high risk
of selective reporting bias, twenty-two had an unclear risk, and we
judged five to be at low risk (Bessette 2011; Ciaschini 2010; Leslie
2012; Rosemann 2007; Solomon 2007a).
Other potential sources of bias
Other areas assessed for sources of bias included protection against
contamination (only eight out of the twenty-nine controlled stud-
ies were at low risk) and whether a baseline assessment of the in-
tervention groups had taken place with regard to group character-
istics (only eleven out of the twenty-nine controlled studies were
at low risk) and baseline outcomes (we judged sixteen of twenty-
nine controlled studies to be at low risk).
Effects of interventions
See: Summary of findings for the main comparison Primary
care physician alerting system and a patient-directed intervention
(education and reminder to see their primary care physician)
compared to standard care for osteoporosis management;
Summary of findings 2 Primary care physician alerting system
compared to usual care for osteoporosis management; Summary
of findings 3 Primary care physician alerting system compared
to primary care physician alerting system and a patient-directed
intervention (education and reminder to see their primary care
physician) for osteoporosis management; Summary of findings 4
Osteoporosis studies: Summary of findings; Summary of findings
5 Low back pain studies: Summary of findings; Summary of
findings 6Osteoarthritis studies: Summary of findings; Summary
of findings 7 Shoulder pain studies: Summary of findings;
Summary of findings 8 Studies on other musculoskeletal
conditions: Summary of findings
Wewere only able to include five out of the thirty studies in ameta-
analysis. These five studies evaluated interventions aiming to im-
prove the management of osteoporosis (Ciaschini 2010; Feldstein
2006; Leslie 2012; Majumdar 2008; Roux 2013) and were suf-
ficiently similar in terms of condition studied, intervention and
outcomes (GP behaviour-related outcomes: osteoporosis diagnos-
tic testing and medication prescribing), that we could pool the
results.
In many studies there was no reporting of baseline performance
and therefore for these studies we were unable to calculate an
adjusted risk difference (ARD) for dichotomous measures and
adjusted relative percentage change for continuous measures.
No study investigated the potential adverse effects of the interven-
tions on professionals’ health behaviours, coverage or access, qual-
ity of care or healthcare providers. Three studies on low back pain
(Becker 2008; Dey 2004; Hazard 1997) reported on sickness cer-
tification/work absence (social outcome). One study (Rosemann
2007) reported on service utilisation. Three studies (Majumdar
2008; Robling 2002; Watson 2008) investigated the potential ef-
fects on resources and included a cost-effectiveness analysis.
We explored the possibility of grouping the studies by intervention
type and pooling the results to assess their effect. However, this
was not always clinically appropriate, because not all intervention
outcomes were applicable to all musculoskeletal conditions (for
example, bone mineral density (BMD) scanning was only appli-
cable for osteoporosis).
We presented the included studies classified by condition (osteo-
porosis, osteoarthritis, low back pain, shoulder pain and other
musculoskeletal conditions). For each condition, we divided the
study results into two groups: evaluation of interventions against
a no-intervention control and evaluation of interventions against
’other intervention’ groups.
Osteoporosis studies:
Eleven studies included people with diagnosed osteoporosis or
at risk of its development (Bessette 2011; Boyd 2002; Ciaschini
2010; Cranney 2008; Feldstein 2006; Lafata 2007; Leslie 2012;
Majumdar 2008; Roux 2013; Rozental 2008; Solomon 2007a).
Eight of these studies (Bessette 2011; Cranney 2008; Feldstein
2006; Leslie 2012; Majumdar 2008; Roux 2013; Rozental 2008;
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Solomon 2007a) were for secondary prevention of osteoporosis,
and focused on people with a previous fracture and at an in-
creased risk of having osteoporosis. Six studies were conducted in
Canada, and five were set in the USA. Six studies were individual
RCTs (Bessette 2011;Ciaschini 2010; Feldstein 2006; Leslie 2012;
Majumdar 2008; Roux 2013), three were cluster-RCTs (Cranney
2008; Lafata 2007; Solomon 2007a) and two were randomised
trials without control groups (Boyd 2002; Rozental 2008). The
desired management outcome in all of the studies was diagnostic
testing for osteoporosis in the form of a BMD scan or prescribing
of osteoporosismedication, or both. These are clinically important
outcomes for osteoporosis management, as BMD testing leads to
the diagnosis and prescribing osteoporosis medication is one of
the main aspects of treatment.
Osteoporosis: evaluations of interventions compared to no-intervention
control groups
Nine studies (Bessette 2011; Ciaschini 2010; Cranney 2008;
Feldstein 2006; Lafata 2007; Leslie 2012; Majumdar 2008; Roux
2013; Solomon2007a) evaluated a single ormultifaceted interven-
tion compared to a no-intervention control. The results of these
studies are summarised in Table 5 and Table 6.
The majority of the studies used combinations of interventions.
All studies had a patient-directed component aiming to educate
the person on the condition and remind them to see their GP
to discuss its management. A GP-alerting system informing the
participant’s clinician on the increased risk of osteoporosis either
via a patient-specific letter or via an electronic reminder was also a
commonly-used component. Finally, seven out of the nine studies
used distribution of educational material on osteoporosis, such as
osteoporosis guidelines.
The majority of the studies reported improvements in GP be-
haviour and more specifically increases in BMD testing and os-
teoporosis medication prescribing rates.
The cluster-RCTs (Cranney 2008; Lafata 2007; Solomon 2007a)
did not provide sufficient data for the re-calculation of the ad-
justed for clustering effect sizes for this review. Cranney 2008
used patient-directed education, GP mailed reminders and dis-
semination of guidelines and showed that the intervention im-
provedBMDtesting (RD26%, rates 53.5% in intervention group
versus 25.5% in control, reported adjusted OR 3.38, 95% CI
1.83-6.26, P <0.001) and osteoporosis medication prescribing
rates (RD 17.7%, rates 28% in intervention group versus 10%
in control, reported adjusted OR 3.45, 95% CI 1.58-7.56, P =
0.002). This was a relatively small study (270 participants in to-
tal). Lafata 2007 evaluated the use a patient-directed interven-
tion (patient mailed reminders) alone and in combination with
GP prompts and showed that the intervention resulted in little
difference in outcomes (RD for BMD 10.6% and 18.1% respec-
tively and for osteoporosis medication prescribing rates 2.7% and
3.4% respectively). The authors reported generalised estimating
equation (GEE) adjusted treatment rates of 2.3% in the usual care
group, 4% in the patient mailed reminders group and 3.9% in
the mailed reminders with GP prompts group which were statis-
tically significant. Solomon 2007a evaluated the effect of a brief
programme of patient and/or GP education (academic detailing)
and showed that the intervention resulted in no difference in the
probability of the primary composite end-point (BMD testing or
osteoporosis medication prescribing) between the usual care and
intervention groups. The reported adjusted RR for the patient and
GP intervention was 1.04 (95% CI 0.85-1.26), for the GP only
intervention was 0.70 (95% CI 0.56-0.86) and for the patient
only intervention was 0.90 (95% CI 0.73-1.10). These results are
consistent with the small RDs (<5%) reported inTable 5 andTable
6.
From the remaining six RCT studies (Bessette 2011; Ciaschini
2010; Feldstein 2006; Leslie 2012; Majumdar 2008; Roux 2013)
three studies (Feldstein 2006; Leslie 2012; Majumdar 2008) eval-
uating interventions aimed at both GPs and patients resulted in
moderate to large effects in the investigation rates (BMD testing)
and four (Ciaschini 2010; Feldstein 2006; Majumdar 2008; Roux
2013) showed moderate to large effects in the prescribing rates for
osteoporosis medication. GP alerting on its own also resulted in
improved GP behaviour with regards to BMD testing and osteo-
porosis medication prescribing according to two studies (Feldstein
2006; Leslie 2012).
Majumdar 2007, assessed the cost-effectiveness of the study
Majumdar 2008, and concluded that the intervention led to a per
patient cost saving of CAD 13 (USD 9) and a gain of 0.012 qual-
ity-adjusted life years.
Meta-analysis of osteoporosis studies
Meta-analysis of studies evaluating professional and patient inter-
ventions versus usual care
Five osteoporosis studies (Ciaschini 2010; Feldstein 2006; Leslie
2012; Majumdar 2008; Roux 2013) used a similar intervention,
including a GP-alerting system (via a patient-specific letter or elec-
tronic reminder message) and a patient-directed intervention (in-
cluding patient education and a reminder to see their GP) and
provided adequate data to allowmeta-analysis of the results. Three
of these studies (Feldstein 2006; Leslie 2012; Majumdar 2008)
assessed BMD testing as one of the main outcomes, and five
(Ciaschini 2010; Feldstein 2006; Leslie 2012; Majumdar 2008;
Roux 2013) evaluated the effect on osteoporosis medication pre-
scribing rates. We pooled these studies (see Analysis 1.1; Analysis
1.2) and the results show that the combined intervention increases
BMD testing rates and osteoporosis medication prescribing rates:
RR 4.44 (95% CI 3.54 to 5.55; participants 3,386) for BMD and
RR 1.71 (95%CI 1.50 to 1.94; participants 4,223) formedication
prescribing, as shown in the Summary of findings for the main
comparison.The considerable statistical heterogeneity observed in
the meta-analysis for BMD testing,I2 = 75% (P=0.02), (Analysis
1.1) could be partly due to the low BMD testing in the usual
care group in the studies by Feldstein 2006 (2/1032, 0.2%) and
Leslie 2012 (58/1480, 4%) compared to the study by Majumdar
2008 where BMD testing in the usual care group was 18% (24/
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135). Additionally, the length of follow-up was different in the
three studies (six months in the studies by Feldstein 2006 and
Majumdar 2008, twelve months in the study by Leslie 2012).
TheCochrane Handbook recommends that “it is often sensible to use
one statistic for meta-analysis and re-express the results using a second,
more easily interpretable statistic. For example, meta-analysis may of-
ten be best performed using relative effect measures (risk ratios or odds
ratios) and the results re-expressed using absolute effect measures (risk
differences or numbers needed to treat)” (Deeks 2011). In view of
this recommendation and also the fact that we committed in our
protocol to reporting both risk ratios and risk differences when-
ever possible, we conducted a sensitivity analysis and reported the
results of the meta-analysis using risk differences. We calculated
the risk difference to be moderate for BMD testing at 17% (95%
CI 15% to 19%) and modest for osteoporosis medication pre-
scribing at 10% (95% CI 8% to 12%), confirming that the inter-
vention improves osteoporosis guideline-consistent GP behaviour
irrespective of the analysis method used to express the size of the
effect.
Meta-analysis of studies evaluating professional only interventions
versus usual care
Two osteoporosis studies (Feldstein 2006; Leslie 2012) evaluated
the effect of a GP-alerting system (via a patient-specific letter or
electronic reminder message) versus usual care on professional be-
haviour (BMD testing and osteoporosis medication prescribing).
The interventions were sufficiently similar and provided adequate
data to allow the pooling of the results (see Analysis 2.1; Analysis
2.2). The results show that the intervention probably leads to im-
proved BMD testing rates (RR 4.75 (95% CI 3.62 to 6.24); par-
ticipants 3,047) and a smaller effect with regards to osteoporosis
medication prescribing rates (RR 1.52 (95% CI 1.26 to 1.84; par-
ticipants 3,047), as shown in the Summary of findings 2. The cer-
tainty of evidence was downgraded due to the fact that only two
studies were included in the meta-analysis, due to the relatively
low number of patients and events in the study by Feldstein 2006
and also due to the considerable statistical heterogeneity observed.
The statistical heterogeneity in the meta-analysis for BMD testing
was I2 = 80% (P = 0.03), (Analysis 2.1) and the heterogeneity for
osteoporosis medication prescribing was I2 = 89% (P = 0.003),
(Analysis 2.2). These could not be explained by study design or
differences in populations but could be partly due to the different
length of follow-up (the follow up in the study by Feldstein 2006
was 6 months and in the study by Leslie 2012 was 12 months)
and the relatively larger effect size in the study by Feldstein 2006.
We calculated the risk difference for BMD testing to be moderate
at 14% (95% CI 12% to 16%) and for osteoporosis medication
prescribing small at 5% (95% CI 3% to 8%), confirming that the
intervention probably improves osteoporosis guideline-consistent
GP behaviour.
Osteoporosis: evaluations of interventions compared to another inter-
vention
Eight studies (Bessette 2011; Boyd 2002; Feldstein 2006; Lafata
2007; Leslie 2012; Roux 2013; Rozental 2008; Solomon 2007a)
evaluated single or multifaceted interventions compared to a dif-
ferent intervention control. The results of these studies are sum-
marised in Table 7 (outcome: BMD) and Table 8 (outcome: os-
teoporosis medication).
Bessette 2011 showed that the more intensive intervention of in-
cluding a video on osteoporosis as part of the educational material
distributed to participants probably results in little or no difference
in BMD testing and medication-prescribing rates (RD < 5%), and
in fact in the study it resulted in slightly lower BMD testing rates
in the intervention group (RD -1.1).
Boyd 2002 focused on the primary prevention of fractures and
showed that an extended letter (including guidelines on treatment)
to the GP may slightly improve professional behaviour (BMD
testing and osteoporosis medication prescribing) compared to a
standard letter (suggestion to investigate and treat); RD for BMD
testing modest at 7.1% and for medication prescribing small at
4.5%. The study had a potentially high risk of bias, as it did not
contain adequate information to ensure itsmethodological quality.
Feldstein 2006 showed that adding a patient-directed intervention
(education and reminders) to GP electronic reminder messages
does not increase the percentage of BMD testing or osteoporosis
medication prescribing; in fact, the results were slightly better (RD
6.9% and 7.7% respectively) for the professional-only interven-
tion.
Leslie 2012 showed that the addition of patient reminders and
educational material to an intervention aimed at GPs results in
little difference in professional behaviour-related outcomes (RD
1.7 and 1.8% for BMD and medication prescribing rates respec-
tively).
Roux 2013 compared a “minimal” intervention of patient edu-
cation and GP alerting with reminders (as mentioned above) to
the more “intensive” version which included patient blood and
BMD tests, the results of which were communicated to the pa-
tient’s GP andmore frequent reminders. Themore intensive inter-
vention may slightly increase osteoporosis medication prescribing
rates (62.2% versus 54.9%, RD modest at 7.2%).
Rozental 2008 showed that when an orthopaedic surgeon orders
a BMD test and forwards the results to the GP, there may be
an improvement in the rates of osteoporosis medication prescrib-
ing (74% compared with 26%, large RD of 48%). This was in
comparison with participants whose GP simply received a letter
from the orthopaedic surgeon outlining guidelines for osteoporo-
sis screening. However, this was a very small study (50 participants
randomised into two intervention groups).
Two cluster randomised studies (Lafata 2007 and Solomon 2007a)
did not provide sufficient data to allow data adjustment for clus-
tering. Lafata 2007 reported that a combination of GP alerts
and patient education and reminders does not result in signifi-
cant differences in BMD testing and osteoporosis medication pre-
scribing rates when compared to a patient-directed intervention
(RD -7.5% and -0.7% respectively, generalised estimated equa-
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tion (GEE) adjusted rates as reported by the authors for medica-
tion prescribing 3.9% versus 4%). Solomon 2007a reported that
there were no significant differences between the groups with re-
gard to the composite endpoint (BMD testing and/or osteoporosis
medication prescribing). The adjusted RR reported by the authors
were 0.70 (95% CI 0.56-0.86) for the GP only intervention ver-
sus 0.90 (95% CI 0.73-1.10) for the patient intervention group
versus 1.04 (95% CI 0.85-1.26) for the combined intervention,
which are consistent with the very small RDs (<5%) presented in
Table 7 and Table 8.
Meta-analysis of studies evaluating professional only interventions
versus professional and patient interventions
The studies by Feldstein 2006 and Leslie 2012 were sufficiently
similar and provided adequate data to allow a meta-analysis assess-
ing the effect of adding a patient-directed component to a pro-
fessional only intervention (see Analysis 3.1; Analysis 3.2). The
results show that the combined intervention probably does not
lead to an improved effect with regards to increasing BMD testing
rates (RR 0.94. (95% CI 0.81 to 1.09); participants 2995) and
osteoporosis medication prescribing rates (RR 0.93 (95% CI 0.79
to 1.10; participants 2,995), as shown in the Summary of findings
3. The certainty of evidence was downgraded because only two
studies were included in the meta-analysis, one of which had a
small number of participants and events.
We calculated the risk difference for BMD testing to be -1% (95%
CI -4% to 2%) and for osteoporosis medication prescribing -1%
(95% CI -4% to 2%), confirming that the combined intervention
probably does not improve osteoporosis guideline-consistent GP
behaviour when compared to a professional only intervention.
Osteoporosis studies: summary
Nine studies evaluated interventions versus no-intervention con-
trols to improve the management of people with or at high risk of
developing osteoporosis. All studies evaluated a combined inter-
vention addressed to both theGP and the patient. Three out of the
six RCT studies (Feldstein 2006; Leslie 2012; Majumdar 2008)
showed moderate to large effects in the investigation rates (BMD
testing) and four (Ciaschini 2010; Feldstein 2006; Majumdar
2008; Roux 2013) moderate to large effects in the osteoporosis
medication prescribing rates.
Meta-analysis of three studies on BMD testing (Feldstein 2006;
Leslie 2012; Majumdar 2008) and five studies on medication pre-
scribing (Ciaschini 2010; Feldstein 2006; Leslie 2012; Majumdar
2008; Roux 2013) showed that a combination of a GP-alerting
system (via a letter or educational reminder message (ERM)) and
a patient-directed intervention (including patient education and
a reminder to see their GP) improves guideline-consistent GP
behaviour (Analysis 1.1 and Analysis 1.2). Meta-analysis of two
studies (Feldstein 2006; Leslie 2012) showed that GP alerting on
its own also probably improves osteoporosis guideline-consistent
GP behaviour Analysis 2.1; Analysis 2.2) and that adding the pa-
tient-directed component probably does not lead to a greater ef-
fect (Analysis 3.1; Analysis 3.2).
The results of three studies (Bessette 2011; Boyd 2002; Roux
2013) suggest that more intensive interventions may result in little
or no improvement in GP behaviour-related outcomes. One study
(Solomon 2007a) showed that a brief educational intervention
addressed at GPs (academic detailing) and patients may not result
in improvements compared to usual care.
Low back pain studies:
We found 10 studies evaluating interventions on the management
of low back pain (Becker 2008; Bishop 2006; Dey 2004; Eccles
2001; Engers 2005; French 2013; Hazard 1997; Hollingworth
2002; Kerry 2000; Schectman 2003) of which five were clus-
ter-RCTs (Dey 2004; Engers 2005; French 2013; Kerry 2000;
Schectman 2003), two were individual RCTs (Bishop 2006;
Hazard 1997), twowere cluster randomised trials (without control
group) (Becker 2008; Eccles 2001) and one was an interrupted
time series (Hollingworth 2002). Four studies were conducted
in the UK (Dey 2004; Eccles 2001; Hollingworth 2002; Kerry
2000), two in the USA (Hazard 1997; Schectman 2003), one in
Germany (Becker 2008), one inCanada (Bishop 2006), one in the
Netherlands (Engers 2005) and one in Australia (French 2013).
Low back pain studies: evaluations of interventions compared to a no-
intervention control group
Seven studies (Bishop 2006; Dey 2004; Engers 2005; French
2013; Hazard 1997; Kerry 2000; Schectman 2003) used a control
group. The re-calculated effect sizes for those studies where the
data allowed us to re-calculate the effects are summarised in Table
9.
Different combinations of interventions were used in each study,
preventing us from pooling the results. All studies used dissemina-
tion of educational materials as a component of their intervention.
Five studies used some form of educational meeting/educational
outreach. The outcomes measured varied widely and included GP
behaviour-related outcomes, such as guideline-consistent advice
and x-ray requests, and patient-related outcomes, such as pain
scores.
Bishop 2006 compared GP education (guidelines) and three pa-
tient-specific reminder letters toGPs versus GP and patient educa-
tion and reminders versus a control group. Several outcomes were
measured assessing professional behaviour (clinician adherence to
the guidelines) and for the majority of these outcomes the study
showed that the interventions may lead to little or no improve-
ments (RD < 5%).
Dey 2004 showed that outreach visits to GP practices to promote
national guidelines on acute low back pain were unsuccessful in
changing GP behaviour with regard to ordering x-rays, issuing
sickness certificates and prescribing opioids. Access to fast-track
physiotherapy and a back-pain triage unit seemed to result in more
referrals (RD 12.6%).
Engers 2005 showed that a complex intervention including the
Dutch lowback painmanagement guideline dissemination, a two-
hour workshop, two scientific articles, additional guidance on low
back pain management for occupational physicians, a patient-ed-
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ucation tool and amanagement-decision tool may be unsuccessful
in improving GP behaviour with regard to prescribing and ad-
vising the patient, but may lead to reduced onward referrals to a
therapist at follow-up (RD 39.2%, 36% in the intervention group
versus 76% in the control group, clustered adjusted OR 0.2, 95%
CI (0.1 to 0.6)). These results were self-reported and there is there-
fore some risk of bias. The study did not provide adequate data
to allow the re-calculation of effect sizes taking into account the
effect of clustering.
French 2013 used interactive, educational workshops aiming to
facilitate GP behavioural change and the dissemination of educa-
tional materials in the form of aDVD. It showed that the interven-
tion may lead to little or no difference in the number of x-ray and
CT requests (RD -0.2% and 0.0% respectively).The study had
a potentially high risk of bias, as its primary outcomes (patient-
related outcomes) were not measured and GP behaviour-related
outcomes were reported instead.
Hazard 1997 used a risk stratification tool alerting GPs of patients
at high risk of disability, and disseminated guidance on low back
pain management. The study was very small (just 53 participants)
and showed that the intervention may result in no improvement
in patient-related outcomes (absence from work, RD -4.6%).
Kerry 2000 compared an intervention group (dissemination of
guidelines on the use of radiology and audit/feedback on num-
bers of radiological referrals) to a control group of practices, and
reported on GP behaviour-related outcomes (numbers of spinal
x-ray requests over a year). The study did not report the means
and standard deviations but showed a cluster-adjusted reduction
of spinal x-ray requests of 20% between the intervention and con-
trol groups (95% CI 4 to 36, P<0.05). There was no assessment of
the impact on the quality of these requests and their concordance
with the guidelines.
Schectman 2003 compared an intervention including guideline
dissemination on low back pain, a 90-minute educational session
delivered by local opinion leaders and two audit/feedback reports
summarising GP performance to a control group, part of which
had access to patient education materials (pamphlet and video).
The intervention may result in little or no improvement in guide-
line-consistent GP behaviour. There was no statistically significant
change in GP behaviour with regard to the utilisation of individ-
ual services, which were the main outcome measures used in the
study, and the RDs were small (RD < 5%) across all outcomes
including guideline-consistent behaviour. Additionally, the initial
four groups of the study were collapsed into two (GP intervention
versus no GP intervention), after analysis of the impact of the pa-
tient-education component of the intervention revealed no effect
on clinical service utilisation. This retrospective pooling of the re-
sults and the possibility of contamination between the groups may
have introduced bias.
In summary, the studies on back pain used interventions with
multiple components, mainly including dissemination of educa-
tional materials and educational meetings/outreach, and showed
that these interventions may result in little or no improvement in
GP behaviour and patient-related outcomes (Bishop 2006; Dey
2004; Engers 2005; French 2013;Hazard 1997; Schectman2003).
The combination of guidelines and audit/feedback may result in
a slight reduction in spinal radiology requests according to one
study (Kerry 2000).
Low back pain studies: evaluations of interventions compared to an-
other intervention
Three low back pain studies (Becker 2008; Bishop 2006; Eccles
2001) compared one intervention against a different intervention.
The results of these studies are summarised in Table 10 (dichoto-
mous data) and Table 11 (continuous data).
Becker 2008 assessed the effect of GP education using guideline
dissemination, three seminars and academic detailing (guideline
implementation, GI group) versus a ’control group’ which only
received guidelines by mail and versus GP education plus prac-
tice-nurse motivational counselling plus guidelines (motivational
counselling, MC group). The study showed that the intervention
resulted in little or no improvement with respect to the majority
of patient-related outcomes (functional capacity, overall activity,
days of sick leave and quality of life) compared to the guideline
dissemination only group. The main statistically and clinically sig-
nificant improvements were with regards to fewer days in pain at
6 months for both GI and MC intervention groups (SMD 0.2,
mean difference -16.4, 95% CI (-26.8 to -6), P = 0.002 for the
GI and SMD 0.2, mean difference -17.9, 95% CI (-28.2 to -7.6),
P = 0.001 for the MC group) and at 12 months for the GI group
(SMD 0.2, mean difference -12.8, 95% CI (-23.4 to -2.3), P =
0.018). There was only a small absolute and clinical difference be-
tween the GI and MC group means without consistent improve-
ment in one group over the other across outcomes (Table 11).
Bishop 2006 showed that the added intervention of providing
participants with lay-language versions of the guidelines may not
alter GP guideline-consistent behaviour, with the only moderate
improvement occurring with respect to the recommendations re-
garding aerobic exercise (RD 15%).
Eccles 2001 assessed the effect of audit/feedback and reminder
messages on primary care knee and spinal radiology referrals. The
study evaluated three intervention groups versus a ’control’ group
which only received guidelines. The first intervention group re-
ceived feedback on the number of radiographs requested in the six
months before and after the intervention. The second interven-
tion group received educational reminder messages (ERMs) on all
radiograph reports. The third intervention group received both
feedback and reminders. All groups, including the ’control’ group,
received referral guidelines. The study showed that there may be
some deterioration in the percentage of spinal radiographs which
are concordant with the guidelines in the intervention groups (RD
range -2.5% to -8.3%, Table 10) and a slight reduction in the
number of spinal radiograph requests across the groups (SMD
small for the feedback group at 0.2 and moderate for the reminder
group at 0.4) as seen in Table 11. The authors of this study recom-
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mended caution in the interpretation of the data, due to a base-
line imbalance between the study groups. Ramsey 2003 reported
on the effect of the educational reminder messages over the 12
months after the intervention by Eccles 2001. It showed that there
was a small but sustained reduction in the number of spinal ra-
diographs in the reminder group compared to the guideline-only
group (reported RR = 0.64, 95% CI (0.43 to 0.96), P=0.029).
Low back pain studies: evaluation of interventions using interrupted
time series
Hollingworth 2002 used interrupted times series to evaluate the
impact of guideline dissemination on the use of lumbar spine
radiography byGPs. The study did not report themean number of
radiographs at the different time periods (the trend was presented
in a graph form). The study showed that the intervention may
lead to no improvement in the referral patterns for radiography of
the lumbar spine.The outcomes of the study are summarised in
Table 12.
Low back pain studies: summary
In summary, the 10 studies on lowback pain showed that interven-
tions including guideline dissemination, educational reminders
and face-to-face educational opportunities for GPs may lead to
little or no improvement with regard to changing professional be-
haviour. Guidelines on their own may lead to little or no dif-
ference (Hollingworth 2002), while a combination of guidelines
and educational meetings/outreach may result in little or no im-
provement (Becker 2008; Bishop 2006; Dey 2004; Engers 2005;
French 2013; Hazard 1997; Schectman 2003). The combination
of guidelines and audit/feedback may result in a slight reduction
in radiology requests (Eccles 2001; Kerry 2000). The combination
of guidelines and GP reminders may result in a slight, sustained
reduction in the number of radiology requests but no improve-
ment in their quality, as shown in Eccles 2001.
Osteoarthritis studies:
Four studies included people with osteoarthritis (Chassany 2006;
Rahme 2005; Rosemann 2007; Stross 1985). All were cluster-
RCTs. One study was conducted in the USA (Stross 1985), one
in France (Chassany 2006), one in Germany (Rosemann 2007),
and one in Canada (Rahme 2005). The reported outcomes varied
amongst the studies and included patient-related outcomes (pain
control) and GP behaviour-related outcomes (prescribing of med-
ication and onward referrals for radiographs, physical therapy or
arthroplasty).
Osteoarthritis: evaluations of interventions compared to a no-inter-
vention control group
All four studies assessed a single or multifaceted intervention com-
pared to a no-intervention control group. The results of these stud-
ies are summarised in Table 13; and Table 14.
Chassany 2006 evaluated the effect of a four-hour interactive train-
ing session for GPs on relationships and communication, pain
evaluation, prescribing and negotiating a patient contract. Fol-
lowing the training, eight letters emphasising the recommenda-
tions were mailed to the participants. The intervention resulted in
small improvements with regard to patient-related outcomes such
as pain and disability scores (WOMAC index global score) (SMD
<0.40, P<0.05 across all outcomes, Table 13). The relative limita-
tion of the study was that results were assessed within two weeks
of the trial, so it is unclear whether the positive patient outcomes
persisted.
Rahme 2005 evaluated three intervention groups (a 90-minute
interactive workshop group on osteoarthritis management, a deci-
sion tree on osteoarthritis management, and a combination of the
two interventions) with a control (usual care) group. The results
showed a probable slight improvement in osteoarthritis guideline-
consistent GP behaviour (prescribing of medication) in all three
groups. The highest RD was 13% for the combined intervention
while the dissemination of educational material (decision tree) on
its own resulted in a 5% RD.
Rosemann 2007 evaluated two interactive eight-hour GP meet-
ings focusing on education and guideline dissemination with and
without nurse case management, and showed some improvements
with regard to GP behaviour-related outcomes (reduced referrals
to orthopaedic surgeons: SMD 0.8 for the educational interven-
tion and 0.2 for the combined intervention, reduced referrals for
radiographs: SMD0.2 and 0.4 respectively and increased prescrip-
tions for painkillers: RDs between -2.2 and 11.1%). There were
small or no improvements with regard to patient related outcomes
(quality of life: SMD <0.40).
Stross 1985 evaluated a complex intervention which was delivered
by educationally influential physicians (EIs) and targeted GPs. It
comprised a self-study programme including textbook, audiovi-
sual materials and recent articles on osteoarthritis. This was a small
study and showed that the intervention may improve guideline-
consistent GP behaviour by increasing the intra-articular corti-
costeroids (RD large at 29%) and reducing the use of systemic
corticosteroids (RD moderate at 19%) in osteoarthritis patients.
There were small reductions in the length of stay (MD 0.2 days
for osteoarthritis and 0.8 days for total hip arthroplasty, Table 13).
In those patients undergoing total hip arthroplasty, there may be
an increase in the utilisation of physical therapy pre-operatively
(RD large at 57%).
Osteoarthritis: evaluations of interventions compared to another in-
tervention
When comparing the three intervention groups (a 90-minute in-
teractive workshop group on osteoarthritis management, a deci-
sion tree on osteoarthritis management, and a combination of the
two interventions) in the study by Rahme 2005, the combined
intervention resulted in modest improvements in GP behaviour
(medication prescribing) compared to the single faceted interven-
tions (Table 15).
There was little or no difference with regard to the prescriptions
of painkillers (RD < 5.9%, Table 15), referrals to other services
(SMD <0.20 for the majority of outcomes, Table 16) and patient
related outcomes (quality of life) (SMD <0.20, Table 16) with the
addition of nurse case management in the study by Rosemann
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2007.
Osteoarthritis studies: summary
Educational sessions, workshops and guidelines on the manage-
ment of osteoarthritis were the main interventions evaluated, and
they may result in some positive changes in GP behaviour and pa-
tient-related outcomes. Chassany 2006 showed that the interven-
tion may result in little improvement in patient outcomes (pain
and disability) after training GPs in pain evaluation, management
and communication. Rahme 2005 and Stross 1985 showed mod-
est improvements in GP prescribing after clinician education, but
the results were not confirmed in Rosemann 2007. Stross 1985
delivered the educational intervention via local educationally in-
fluential physicians and showed that it may lead to an improve-
ment in guideline-consistent GP behaviour.
Shoulder pain studies:
Three studies evaluated interventions aiming to improve theman-
agement of shoulder pain by GPs (Broadhurst 2007; Gormley
2003;Watson 2008). The studies were set inAustralia (Broadhurst
2007), Northern Ireland (Gormley 2003), and the UK (Watson
2008). Broadhurst 2007 was a controlled before-and-after (CBA)
study with two intervention and two control groups, while
Gormley 2003 was a randomised controlled trial (RCT) and
Watson 2008 a cluster-RCT. All studies used educational inter-
ventions in the format of meetings or educational outreach.
Shoulder pain: evaluations of interventions compared to a no-inter-
vention control group
Broadhurst 2007 evaluated the effect of academic detailing on the
management of shoulder pain and recorded the number of shoul-
der x-rays and ultrasound scans before, during and after the in-
tervention. The time-adjusted rates of imaging requests were re-
ported, but not the absolute numbers, means or standard devia-
tions. There was no evidence to suggest a change in the rate of x-
ray requests over the different time periods between the interven-
tion and the control groups (P = 0.11). Requests for ultrasound
imaging were approximately 43.8% higher in the period two years
before academic detailing compared to six months after in the
academic detailing group, but an upward trend towards the base-
line was observed in the period six months to one year after the
intervention. The intervention may result in a temporary, slight
reduction in ultrasound requests, but little or no change in the x-
ray requests.
Watson 2008 reported on the SAPPHIRE randomised controlled
trial (Table 17). The intervention consisted of a 60-minute lec-
ture on shoulder disorders, summarised handouts and training in
injection techniques. The main outcomes reported were patient-
related (pain and disability assessed by the British Shoulder Dis-
ability questionnaire (BSDQ) and the Short-form 36 item (SF-
36) Health Survey). The intervention may result in little or no
improvement in pain and disability a year later (BSDQ SMD 0.2,
SF-36 for physical component SMD 0 and SF-36 mental com-
ponent SMD 0.1). McKenna 2009 assessed the cost-effectiveness
of providing practical training to GPs in the SAPPHIRE study. It
reported an incremental cost-effectiveness ratio of GBP 2813 per
QALY gained for trained GPs.
Shoulder pain: evaluations of interventions compared to another in-
tervention
Gormley 2003 evaluated the impact of two different types of
shoulder injection training (on mannequins versus mannequins
and real patients) for GPs, and reported the effects on professional
behaviour, i.e. the number of shoulder injections performed and
the number of referrals to injection or physiotherapy clinics. The
results are summarised in Table 18. Additional training with real
patients may result in an increase in the number of injections per-
formed byGPs (adjusted relative percentage change 44%, P=0.02)
and a reduction in the rates of onward referrals (adjusted relative
percentage change 38-100%, not statistically significant).
Shoulder studies: summary
The studies were heterogeneous in terms of design, type of inter-
vention and outcomes. Broadhurst 2007 showed that academic
detailing may result in a temporary, slight reduction of shoulder
ultrasound scans, but little or no change in the x-ray requests.
Watson 2008 showed there may be little or no improvement in pa-
tient-reported outcomes after education of GPs on shoulder pain
management and injection training. Gormley 2003 showed that
additional training with real patients may increase the number of
shoulder injections performed by GPs.
Other musculoskeletal conditions studies:
Four studies focused on musculoskeletal conditions other than
the ones mentioned above (Eccles 2001; Huas 2006; Kerry 2000;
Robling 2002). Eccles 2001 and Kerry 2000 have beenmentioned
above under the low back pain studies, as they also reported on low
back pain outcomes. All studies were cluster-randomised trials.
Three of the studies (Eccles 2001; Kerry 2000; Robling 2002)
were set in the UK and one (Huas 2006) was conducted in France.
The outcomes of these studies are summarised in Table 19; Table
20; Table 21.
Other musculoskeletal conditions: evaluations of interventions com-
pared to a no-intervention control group
Huas 2006 evaluated the impact of training GPs on the use of
two validated assessment scales (the VAS pain scale and the HAD
anxiety anddepression scale). The interventionmay result inworse
patient-related outcomes: pain relief scores (SMD 2, P=0.0004)
and increased level 3 (WHO classification) analgesic prescribing
(SMD 1.2, P=0.02).
Kerry 2000, as mentioned above, used dissemination of guidelines
on the use of radiology and GP audit/feedback on numbers of ra-
diological referrals. The study did not report the means and stan-
dard deviations. Overall a 1% reduction in the numbers of limb
and joint x-ray requests was observed in the intervention group
compared to a 9% increase in the control group (giving a total of
10% difference), but this did not achieve statistical significance
(95% CI -5 to 25). Overall, the intervention therefore may result
in a little or no reduction in GP radiology referrals.
Other musculoskeletal conditions: evaluations of interventions com-
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pared to another intervention
Eccles 2001 was discussed above as part of the low back pain stud-
ies. However, it also looked at knee radiographs. Educational re-
minder messages may result in a slight improvement in concor-
dance of the requests with guidelines (RD 5.3, Table 20). Audit/
feedback and educational reminder messages used separately and
in combination may show a slight reduction in the number of
knee radiograph requests per 1000 patients, as seen in Table 21
(SMD 0.2, 0.50, and 0.50 respectively). The authors of this study
recommended caution in the interpretation of the data, due to a
baseline imbalance between the study groups. Ramsey 2003 re-
ported on the effect of the educational reminder messages over
the 12 months after the intervention by Eccles 2001. It showed
that there was a small but sustained reduction in the number of
knee radiographs in the reminder group compared to the guide-
line-only group (reported RR = 0.65, 95% CI (0.46 to 0.91), P=
0.011).
Robling 2002 evaluated different combinations of guideline dis-
semination on knee and lumbar spinemagnetic resonance imaging
(MRI), practice-based seminar and audit/feedback on MRI use,
and comparative data on orthopaedic and neurosurgical referrals.
The results for both knee and spine MRIs were reported together
and therefore the study is not mentioned under the low back pain
studies. The results (summarised in Table 20) show that the in-
terventions may result in no difference in guideline-concordant
GPbehaviour (guideline-concordant requests forMRIs (RD -12.1
to 12.1)). A cost-effectiveness analysis showed that accessing the
MRI service in writing is probably more cost effective compared
to telephone access, and dissemination of guidelines is probably
more cost effective compared to the other types of intervention
used.
Other musculoskeletal conditions: summary
The four studies on other musculoskeletal conditions were het-
erogeneous in terms of intervention types and outcomes assessed.
Huas 2006 showed that GP training in the use of validated assess-
ment scales may result in worse pain control and increased pre-
scribing of strong (level 3) painkillers. Eccles 2001 showed that
educational reminder messages attached to radiographic reports
may result in a slight but sustained reduction in knee radiographs.
Kerry 2000 and Eccles 2001 showed that providing GP feedback
on the total number of investigations requested may result in a
slight reduction in the number of radiology requests.
Additional analysis
Does the effectiveness of interventions vary depending on the direction
of behaviour targeted?
Some of the interventions aimed to increase a clinical behaviour
(e.g. bone density testing) while others aimed to decrease certain
clinical actions (e.g. x-ray requests discordant with guidelines). We
examined whether the effectiveness of the interventions varied de-
pending on the direction of the targeted behaviour. The results are
presented in Table 22. The median absolute effect size for com-
parisons that aimed to increase a behaviour was 5 (interquartile
range (IQR) 0.6 to 12.6) compared to 1.1 (IQR -1.1 to 3) for
comparisons that aimed to decrease an existing behaviour (T-test
< 0.05).
The above seem to suggest that it may be more challenging for
an intervention to reduce an existing behaviour rather than to
increase a behaviour that is underused. However, as highlighted
in the review by French 2010, a difference in intervention effects
may be “due to factors inherent in the management of osteoporo-
sis and low back pain rather than due to increasing or decreasing
behaviours per se”. Therefore, in order to investigate the above
study characteristic further, we undertook a subgroup analysis by
condition. None of the osteoporosis studies included comparisons
aiming to decrease a clinical behaviour and they were therefore ex-
cluded from the condition-specific subgroup analysis. The results
for the low back pain and osteoarthritis studies are presented in
Table 23 and Table 24 respectively and show no significant dif-
ference between the median absolute effect sizes (T-test = 0.297
for low back pain and T-test=0.70 for osteoarthritis). The avail-
able data therefore do not support the notion that increasing a
behaviour is more or less challenging than reducing an existing
behaviour.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Primary care physician alerting system compared to usual care for osteoporosis management
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alert ing system
Comparison: Usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual care Primary care physician
alerting system
Bone mineral density1
Follow-up: 6-12 months
Study population RR 4.75
(3.62 to 6.24)
3047
(2 studies)
⊕⊕⊕
M oderate3
38 per 1000 302 per 1000
(64 to 1000)
M oderate
29 per 1000 231 per 1000
(49 to 1000)
Osteoporosis medica-
tion2
Follow-up: 6-12 months
Study population RR 1.52
(1.26 to 1.84)
3047
(2 studies)
⊕⊕⊕
M oderate3
102 per 1000 268 per 1000
(67 to 1000)
M oderate
77 per 1000 202 per 1000
(50 to 809)
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Bone mineral density (BMD) test ing is an important outcome for osteoporosis because it leads to the diagnosis of the
condit ion. This is one of the GP behaviour-related outcomes (primary outcome)
2 Osteoporosis medicat ion prescribing is an important outcome for osteoporosis management as it is the main aspect of
treatment. This is one of the GP behaviour-related outcomes (primary outcome)
3 The quality of evidence was downgraded because only two studies were included, one of which had a small number of
part icipants and events, and in view of the considerable stat ist ical heterogeneity observed.
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Primary care physician alerting system compared to Primary care physician alerting system and a patient-directed intervention (education and reminder to see their primary
care physician) for osteoporosis management
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with osteoporosis
Settings: Primary care
Intervention: Primary care physician alert ing system
Comparison: Primary care physician alert ing system and a patient-directed intervent ion (educat ion and reminder to see their primary care physician)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Primary care physician
alerting system and a
patient-directed inter-
vention (education and
reminder to see their
primary care physi-
cian)
Primary care physician
alerting system
Bone mineral density1
Follow-up: 6-12 months
Study population RR 0.94
(0.81 to 1.09)
2995
(2 studies)
⊕⊕⊕
moderate3
192 per 1000 194 per 1000
(123 to 261)
M oderate
254 per 1000 257 per 1000
(163 to 345)
M edication2
Follow-up: 6-12 months
Study population RR 0.93
(0.79 to 1.10)
2995
(2 studies)
⊕⊕⊕
moderate3
167 per 1000 176 per 1000
(115 to 264)
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182 per 1000 191 per 1000
(126 to 288)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Bone mineral density (BMD) test ing is an important outcome for osteoporosis because it leads to the diagnosis of the
condit ion. This is one of the GP behaviour-related outcomes (primary outcome)
2 Osteoporosis medicat ion prescribing is an important outcome for osteoporosis management as it is the main aspect of
treatment. This is one of the GP behaviour-related outcomes (primary outcome)
3 The quality of evidence was downgraded because only two studies were included, one of which had a small number of
part icipants and events.
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Professional interventions for GPs on the management of osteoporosis compared to usual care
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with osteoporosis
Settings: Primary care
Intervention: Professional intervent ions (target ing physician-only)
Comparison: Usual care
Outcomes Impact (including ef-
fect sizes wherever
available)
Number of Participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Health professional
(GP) behaviour- related
outcomes
• Bone Mineral
Density (BMD) test ing
• Osteoporosis
medicat ion
(appropriate
prescribing)
• BMD RR 4.75
(95% CI 3.62 to 6.24)
• Osteoporosis
medicat ion RR 1.52
(95% CI 1.26 to 1.84)
• BMD 3047 (2
studies)
• Osteoporosis
medicat ion 3047 (2
studies)
• BMD ⊕⊕⊕
moderate1
• Osteoporosis
⊕⊕⊕
moderate1
Patient outcomes
• Fragility f ractures
• Hospitalisat ion
None of the included
studies assessed these
outcomes
Economic outcomes
• Health service
costs (including
prescribing costs)
• Cost
ef fect iveness
Majumdar 2007, as-
sessed the cost ef fec-
t iveness of the study
Majumdar 2008, and
concluded that the in-
tervent ion led to a per
pat ient cost saving of
CAD 13 (USD 9) and a
gain of 0.012 quality-
adjusted lif e years
272 part icipants (1
study)
⊕⊕ low2
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: Conf idence Interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1The quality of evidence was downgraded because only two studies were included, one of which had a small number of
part icipants and events, and in view of the considerable stat ist ical heterogeneity observed.
2 The quality of evidence was downgraded because only one study was included which had some risk of bias.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Professional interventions for GPs on the management of low back pain compared to usual care
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with low back pain
Settings: Primary care
Intervention: Professional intervent ions (target ing physician-only)
Comparison: Usual care
Outcomes Impact (including ef-
fect sizes wherever
available)
No of studies Certainty of the evidence
(GRADE)
Comments
H ealth professional
(GP) behaviour- related
outcomes
Guideline-consistent
advice during consulta-
t ion
Bishop 2006 showed
that the intervent ion
may result in lit t le or
no improvements (RD
< 10%) with regard
to guideline-consistent
advice about exercise,
return to work and edu-
cat ion and reassurance
Dey 2004 showed that
the intervent ion proba-
bly results in a small re-
duct ion of sickness cer-
t if icat ion (RD 1.3)
Engers 2005 showed
that the intervent ion
may lead to no im-
provement of GP be-
haviour with regards to
pat ient educat ion and
advice during the con-
sultat ion (RD range (-1.
3 to 12.8), authors re-
ported OR ranging be-
tween 0.4 and 2.9)
3 ⊕⊕ low1
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Guideline-consistent
prescribing of medica-
t ion
Bishop 2006 showed
that the intervent ion
may lead to lit t le im-
provements (RD < 10%)
with regards to guide-
line-consistent medica-
t ion prescribing
Dey 2004 showed that
the intervent ion proba-
bly results in no dif -
ference on prescribing
rates of opioids (RD -1.
3)
Engers 2005 showed
that the intervent ion
may result in no im-
provement of GP be-
haviour with regard
to prescribing (RD=2.8,
OR=1, 95% CI (0.3 to 3)
, reported as not stat is-
t ically signif icant)
3 ⊕⊕ low1
Guideline-
consistent referrals for
invest igat ions (e.g.. x-
rays)
Schectman
2003 showed that the
intervent ion may result
in lit t le or no change in
GP behaviour with re-
gards to the number of
guideline-consistent re-
ferrals for lumbar spine
x-rays and CT scans (RD
<5%)
1 ⊕⊕ low2
Guideline-
consistent referrals to
other services
Bishop 2006 showed
that the intervent ion
may lead to lit t le or
no improvements (RD
< 5%) with regards to
guideline-consistent re-
ferral to other services
(such as physiother-
apy)
Schectman
2003 showed that the
intervent ion may result
in lit t le or no dif fer-
ence with regards to
the number of guide-
line-consistent special-
2 ⊕⊕ low3
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ist or physiotherapy re-
ferrals (RD <5%)
Number of invest iga-
t ions
Dey 2004 showed that
the intervent ion proba-
bly results in a small in-
crease in the ordering
of x-rays (RD 1.4)
French 2013 showed
that the intervent ion
may lead to lit t le or no
dif ference in the num-
ber of x-ray and CT re-
quests (RD -0.2% and 0.
0% respect ively)
Kerry 2000 showed that
the intervent ion proba-
bly results in a cluster-
adjusted reduct ion of
spinal x-ray requests of
20% between the in-
tervent ion and control
groups (95% CI 4 to 36,
P<0.05)
Schectman
2003 showed that the
intervent ion may result
in lit t le or no change in
GP behaviour with re-
gards to referrals for
lumbar spine x-rays and
CT scans (RD <5%)
4 ⊕⊕ low4
Number of referrals to
other services
Dey 2004 showed that
the intervent ion proba-
bly results in increased
referrals to fast-track
physiotherapy and a
back-pain triage ser-
vice (RD 12.6%)
Engers 2005 showed
that the intervent ion
may lead to lit t le reduc-
t ion of onward referrals
to a therapist (RD 4.6,
23% in the intervent ion
group versus 28% in
the control group, clus-
tered adjusted OR 0.8,
95% CI (0.5 to 1.4))
3 ⊕⊕ low4
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Schectman 2003
showed that the inter-
vent ion may result in lit -
t le or no dif ference with
regards to the number
of specialist or phys-
iotherapy referrals (RD
<5%)
Patient outcomes
Funct ional capacity/ ac-
t ivity scores
0 None of the included studies
assessed this outcome
Pain control 0 None of the included studies
assessed this outcome
Work absence Hazard 1997 showed
that the intervent ion
may result in no im-
provement with respect
to days of sick leave
compared to the con-
trol group (RD -4.6%)
1 ⊕⊕ low2 The study by Hazard 1997
was very small (just 53 par-
t icipants)
Quality of lif e 0 None of the included studies
assessed this outcome
Economic outcomes
• Health service
costs (including
prescribing costs)
• Cost
ef fect iveness
0 None of the included studies
assessed these outcomes
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
RD: Risk Dif ference SM D: Standardised Mean Dif ference CI: Conf idence Interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 The quality of evidence was downgraded because the studies have a high risk of bias and high heterogeneity in terms of the
types of intervent ions evaluated. Addit ionally the ef fect sizes are small.
2 The quality of evidence was downgraded because the results are based only on one study with high risk of bias.
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3 The quality of evidence was downgraded because the results are based on just two studies with high risk of bias.
4 The quality of evidence was downgraded because the studies have a high risk of bias and high heterogeneity in terms of the
types of intervent ions evaluated. Addit ionally there is high inconsistency in the direct ion of ef fects across the studies.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Professional interventions for GPs on the management of osteoarthritis compared to usual care
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with osteoarthrit is
Settings: Primary care
Intervention: Professional intervent ions (target ing physician-only)
Comparison: Usual care
Outcomes Impact (including ef-
fect sizes wherever
available)
No of studies Certainty of the evidence
(GRADE)
Comments
Health professional
(GP) behaviour- related
outcomes
Guideline-consistent
advice during consulta-
t ion
Stross 1985 showed
that the intervent ion
may increase the use
of intra-art icular cort i-
costeroids (RD large at
29%)
⊕⊕ low1
Guideline-consistent
prescribing of medica-
t ion
Rahme 2005 showed
that the intervent ion
may result in a slight
improvement in os-
teoarthrit is guideline-
consistent GP prescrib-
ing of medicat ion (ac-
etaminophen, NSAIDs
and COX-2 inhibitors) 5
months af terwards (RD
5% af ter disseminat ion
of educat ional material,
RD 7% af ter a work-
shop and RD 13% for
the combined interven-
t ion)
Rosemann 2007
showed that prescrip-
t ions for painkillers
may slight ly increase
following the interven-
t ion (RDs between -2.
⊕⊕ low1
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2% and 11.1%)
Stross 1985 showed
that the intervent ion
may reduce the use
of systemic cort icos-
teroids according to the
guidelines (RD moder-
ate at 19%)
Guideline-
consistent referrals for
invest igat ions (e.g.. x-
rays)
None of the included studies
assessed this outcome
Guideline-
consistent referrals to
other services
Stross 1985 showed
that the intervent ion
may increase the ut ili-
sat ion of physical ther-
apy pre-operat ively (RD
large at 57%)
⊕⊕ low1
Number of invest iga-
t ions
Rosemann
2007 showed that the
intervent ion may result
in some small reduct ion
in the number of GP re-
ferrals for radiographs
(SMD 0.2-0.4)
⊕⊕ low3
Number of referrals to
other services
Rosemann 2007
showed that the inter-
vent ion may result in a
reduct ion in the num-
ber of GP referrals to
orthopaedics (SMD 0.8
for the educat ional in-
tervent ion and 0.2 for
the combined interven-
t ion af ter adding nurse
case management)
⊕⊕ low4
Patient outcomes
Funct ional capacity/ ac-
t ivity scores
Chassany 2006 showed
that the intervent ion
may result in small
improvements with re-
gard to physical func-
t ion scores (WOMAC in-
dex physical funct ion
⊕⊕ low5 Results were assessed
within two weeks of the
Chassany 2006 trial, so it is
unclear whether the posit ive
pat ient outcomes persisted
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score) (SMD 0.3, P<0.
05)
Pain control Chassany 2006 showed
that the intervent ion
may result in small
improvements with re-
gard to pain scores
(VAS score, Pain relief
(SPID), WOMAC index
pain score) (SMD 0.2,
P<0.05 across all out-
comes)
⊕⊕ low5 Results were assessed
within two weeks of the
Chassany 2006 trial, so it is
unclear whether the posit ive
pat ient outcomes persisted
Work absence None of the included studies
assessed this outcome
Quality of lif e Rosemann
2007 showed that the
intervent ion may result
in small or no improve-
ment with regard to pa-
t ient related outcomes
(SMD <0.40)
⊕⊕ low3
Economic outcomes
• Health service costs
(including prescribing
costs)
• Cost effectiveness
None of the included studies
assessed these outcomes
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
RD: Risk Dif ference SM D: Standardised Mean Dif ference CI: Conf idence Interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 The quality of evidence was downgraded because the results are based on one study only with high risk of bias and a small
number of part icipants (114).
2 The quality of evidence was downgraded because the studies have high heterogeneity in terms of the types of intervent ions
and the types of medicat ions prescribed.
3 The quality of evidence was downgraded because the results are based on just one study and the ef fect size was small.
4 The quality of evidence was downgraded because the results are based on just one study and the ef fect size varies
considerably between the two intervent ion groups.
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5 The quality of evidence was downgraded because the results are based on just one study and were assessed just 2 weeks
following the intervent ion.
NSAIDs: Non steroidal ant i-inf lammatory drugs, COX-2 inhibitors: Cyclo-oxygenase 2 inhibitors, WOMAC: Western Ontario and
McMaster Universit ies Osteoarthrit is Index, VAS: Visual analogue scale, SPID: sum of pain intensity dif f erences.
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Professional interventions for GPs on the management of shoulder pain compared to usual care
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with shoulder pain
Settings: Primary care
Intervention: Professional intervent ions (target ing physician-only)
Comparison: Usual care
Outcomes Impact (including ef-
fect sizes wherever
available)
Number of studies Certainty of the evidence
(GRADE)
Comments
Health professional
(GP) behaviour- related
outcomes
Guideline-consistent
advice during consulta-
t ion
None of the included
studies assessed this
outcome
Guideline-consistent
prescribing of medica-
t ion
None of the included
studies assessed this
outcome
Guideline-
consistent referrals for
invest igat ions (e.g.. x-
rays)
None of the included
studies assessed this
outcome
Guideline-
consistent referrals to
other services
None of the included
studies assessed this
outcome
Number of invest iga-
t ions
Broadhurst
2007 showed that the
intervent ion may result
in a temporary, slight
reduct ion in ultrasound
requests, but lit t le or no
change in the x-ray re-
quests
⊕⊕ low1
Number of referrals to
other services
None of the included
studies assessed this
outcome
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Patient outcomes
Funct ional capacity/ ac-
t ivity scores
Watson 2008 showed
that the intervent ion
may result in lit t le
or no improvement in
funct ion a year later
(BSDQ SMD 0.2, SF-36
for physical component
SMD 0 and SF-36 men-
tal component SMD 0.
1)
⊕⊕ low2
Pain control None of the included
studies assessed this
outcome
Work absence None of the included
studies assessed this
outcome
Quality of lif e None of the included
studies assessed this
outcome
Economic outcomes
• Health service costs
(including prescribing
costs)
• Cost effectiveness
McKenna 2009 as-
sessed the cost ef -
fect iveness of provid-
ing pract ical training to
GPs in the SAPPHIRE
study by Watson 2008.
It reported an incre-
mental cost-ef fect ive-
ness rat io of GBP 2,
813 per QALY gained
for trained GPs
⊕⊕ low2
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
RD: Risk Dif ference SM D: Standardised Mean Dif ference CI: Conf idence Interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 The quality of evidence was downgraded because the results are based on just one study (CBA) with high risk of bias.
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2 The quality of evidence was downgraded because the results are based on just one study and the ef fect size was small.
BSDQ: Brit ish Shoulder Disability quest ionnaire, SF-36: Short-form 36 item Health Survey, GBP: Great Britain Pound
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Professional interventions for GPs on the management of shoulder pain compared to usual care
Patient or population: General pract it ioners/ family doctors involved in the management of pat ients with other muscu-
loskeletal condit ions
Settings: Primary care
Intervention: Professional intervent ions (target ing physician-only)
Comparison: Usual care
Outcomes Impact (including ef-
fect sizes wherever
available)
No of studies Certainty of the evidence
(GRADE)
Comments
Health professional
(GP) behaviour- related
outcomes
Guideline-consistent
advice during consulta-
t ion
None of the included studies
assessed this outcome
Guideline-consistent
prescribing of medica-
t ion
Huas 2006 showed that
the intervent ion may re-
sult in increased level
3 (WHO classif icat ion)
analgesic prescribing
(SMD 1.2, P=0.02)
⊕⊕ low1
Guideline-
consistent referrals for
invest igat ions (e.g.. x-
rays)
None of the included studies
assessed this outcome
Guideline-
consistent referrals to
other services
None of the included studies
assessed this outcome
Number of invest iga-
t ions
Kerry 2000 showed that
the intervent ion may re-
sult in lit t le or no re-
duct ion in GP knee radi-
ology requests (relat ive
change 10%, not stat is-
t ically signif icant)
⊕⊕ low2
Number of referrals to
other services
None of the included studies
assessed this outcome
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Patient outcomes
Funct ional capacity/ ac-
t ivity scores
None of the included studies
assessed this outcome
Pain control Huas 2006 showed that
the intervent ion may re-
sult in worse pat ient-
related outcomes: pain
relief scores (SMD 2, P=
0.0004)
⊕⊕ low1
Work absence None of the included studies
assessed this outcome
Quality of lif e None of the included studies
assessed this outcome
Economic outcomes
• Health service costs
(including prescribing
costs)
• Cost effectiveness
None of the included studies
assessed these outcomes
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
RD: Risk Dif ference SM D: Standardised Mean Dif ference CI: Conf idence Interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 The quality of evidence was downgraded because the results are based on just one study with high risk of bias.
2 The quality of evidence was downgraded because the results are based on just one study and the ef fect size was small.
D I S C U S S I O N
We included thirty studies assessing a range of professional inter-
ventions targeting GPs/family doctors and aiming to improve the
management of musculoskeletal conditions. Eleven studies evalu-
ated interventions on osteoporosis, ten on low back pain, four on
osteoarthritis, three on shoulder pain and four on other muscu-
loskeletal conditions (two of these studies looked at both low back
pain and other musculoskeletal conditions).
Summary of main results
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For improving the management of osteoporosis, a combination of
a GP-alerting system and patient education with reminders to see
their GP leads to improved professional behaviour. The combined
intervention increases both diagnostic testing rates for osteoporo-
sis and medication prescribing rates. GP-alerting on its own also
probably improves osteoporosis guideline-consistent professional
behaviour and adding the patient-directed component probably
does not lead to a greater effect.
Distribution of educational materials (including guideline dis-
semination) and participation in educational meetings/workshops
were common components of complex interventions. Seven stud-
ies on low back pain showed that guideline dissemination and ed-
ucational opportunities for GPs may lead to little or no improve-
ment with regard to guideline-consistent GP behaviour.
Two studies showed that the combination of guidelines and GP
feedback on the total number of investigations requested may re-
sult in a slight reduction in the number of tests requested, while
one of these studies showed that the combination of guidelines
and GP reminders attached to radiology reports may result in a
small but sustained reduction in the number of requests. One
study showed that using educationally influential physicians may
result in improvement in guideline-consistent GP behaviour.
The direction of the targeted behavioural change does not seem
to affect the effect size of interventions.
Overall completeness and applicability of
evidence
We are unable to draw firm conclusions on the effectiveness of the
tested professional interventions aimed at improving the manage-
ment of musculoskeletal conditions by GPs/family doctors. Only
five studies were sufficiently similar in terms of interventions and
outcomes studied and provided adequate data to allow a meta-
analysis of their results. These studies incorporated a patient-di-
rected component in addition to a professional intervention. This
additional component increases the complexity of the interven-
tions and limits their applicability as it introduces contextual and
cultural factors (e.g. linguistic and socioeconomic diversity of the
patient population) which may affect the success of the interven-
tion. Further meta-analysis of two of these studies showed that
probably the professional intervention on its own is effective and
that adding the patient component probably does not result in
improved professional behaviour. However, further studies are re-
quired to confirm this conclusion. Additionally, the included stud-
ies did not assess the effect of the above interventions on patient
related and economic outcomes.
Incomplete reporting of data and the relatively high risk of bias
in the remaining studies compromised our confidence in the re-
sults. Due to the complexity of the interventions and the often
inadequate intervention detail, we were unable to conduct robust
subgroup analysis of the different components of interventions, so
that we can confidently identify the ones associated with successful
outcomes.
The majority of the studies did not investigate the potential ad-
verse effects of the interventions. Thismay be becausemost studies
aimed to improve adherence to evidence-based clinical guidelines
which tend to promote clinical practice where the overall benefits
outweigh the risks. Only four studies reported on work absence
and service utilisation, and only three studies (Majumdar 2008;
Robling 2002; Watson 2008) included a cost-effectiveness analy-
sis.
No studies looked specifically at disadvantaged groups. The pri-
mary target of the interventions were the GPs/family doctors. The
patient-directed interventions did not focus specifically on any
disadvantaged groups. The applicability of such interventions to
patients with a low socioeconomic status may be different, espe-
cially in countries where the patients need to contribute financially
in order to access medical services.
Study locations may limit the external validity of the conclusions
drawn to high-income countries only.
Quality of the evidence
We judged the quality or certainty of the evidence of the five studies
included in the first meta-analysis to be high, because they were
all well designed and implemented RCTs which gave consistent
results with a low level of imprecision (Summary of findings for the
main comparison). Our confidence in the pooled effect estimate
of interventions directed to both GPs and patients for improving
diagnostic testing and medication prescribing in osteoporosis is
therefore high.
Our confidence in the pooled effect estimate reported in the two
additional meta-analyses (Summary of findings 2; Summary of
findings 3) is moderate because the analyses included only two
studies, one of which was relatively small. Therefore, the certainty
of the evidence was downgraded.
Our confidence in the reported effect estimates in the remaining
twenty-five studies is low. Most studies had limitations in design
or execution with an often unclear or high risk of associated bias
which affected the certainty of the evidence. We were unable to
judge the level of inconsistency for these studies, due to their wide
heterogeneity in terms of types of interventions and outcomes
which prevented us from comparing their effects. The heterogene-
ity of interventions and their combinations was also a source of
indirectness, as studies were reporting on the results of a variety
of intervention comparisons. Four of the studies (Gormley 2003;
Hazard 1997; Rozental 2008; Stross 1985) had high levels of im-
precision, including relatively few events in their analysis. For the
above reasons, we rated the certainty of the evidence as low or very
low for the comparisons and outcomes reported for these studies.
Overall, we found no indication of publication bias, and many of
the included studies reported uncertain results.
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Potential biases in the review process
The subject of this reviewwas very broad, including all professional
interventions on the management of musculoskeletal conditions
targeting GPs/family doctors. Although we made every effort to
create a broad search strategy that would identify all relevant stud-
ies, it is possible that we failed to locate important studies.
We used risk difference for dichotomous outcomes, because, ac-
cording to Higgins 2011a, paragraph 9.4.4.4, this summary statis-
tic is thought to be easier for clinicians to interpret. However, this
measure does not account for differences in baseline compliance
between intervention and control groups, and could produce bi-
ased effect estimates. We attempted to limit this risk by also calcu-
lating the adjusted risk difference (which does take into account
baseline differences between groups) wherever the data allowed.
The majority of the included studies were published before 2008.
Asmore studies are being conducted in this increasingly important
area, the review will need to be updated in order to identify and
incorporate the newest evidence.
Agreements and disagreements with other
studies or reviews
The findings of this review in the context of musculoskeletal con-
ditions are largely consistent with what was observed in a com-
prehensive systematic review (Grimshaw 2004) which reviewed all
guideline implementation strategies across all health conditions. It
showedGP reminders to havemoderate effects.We also found that
a GP-alerting system (via a patient-specific letter or electronic re-
minder), with or without a patient-directed intervention, leads to
improved professional behaviour (both diagnosis and treatment)
of osteoporosis. This is also in agreement with a more recent sys-
tematic review (French 2010). However, unlike Grimshaw 2004,
we found that distribution of educational material on its own may
result in no or minimal improvement, with only a small 5% RD
in the study by Rahme 2005 and no significant improvement in
the study by Hollingworth 2002.
A Cochrane systematic review by Giguere 2012 which evaluated
the effect of printed educational materials concluded that this in-
tervention, when used alone, may have a small beneficial effect on
GP behaviour and process-related outcomes but not necessarily on
patient outcomes. Our review suggests that educational materials
alone may not even improve process-related outcomes and guide-
line-concordant behaviour for low back pain, although our con-
clusion is based on only one study with ITS design (Hollingworth
2002).
We are unable to comment on the effect of feedback on perfor-
mance when used on its own, as this was only used as part of a
multifaceted intervention in the included studies. A systematic re-
view by Bywood 2008 showed that feedback is an effective strategy
which can facilitate professional behaviour change, and a more
recent Cochrane review (Ivers 2012) confirmed this finding.
The use of local opinion leaders was evaluated as part of a multi-
faceted intervention in three studies (Majumdar 2008; Schectman
2003; Stross 1985), two of which (Majumdar 2008; Stross 1985)
showed that it probably results in improved GP behaviour. This is
in accordance with the Cochrane review (Flodgren 2011) which
concluded that the use of local opinion leaders can successfully
promote evidence-based practice but that effectiveness varied both
within and between studies.
Guidelines and educational reminder messages attached to radi-
ology reports (Eccles 2001) may result in small but sustained re-
ductions in GP radiology requests. This is in accordance with the
findings by French 2010.
The use of educational meetings and workshops showed varied
results in our review. It seemed to work better for improving GP
behaviour in the management of osteoarthritis (Chassany 2006;
Rahme 2005; Rosemann 2007; Stross 1985) and not so well when
trying to improve themanagement of lowback pain (Bishop 2006;
Dey 2004; Engers 2005; French 2013; Hazard 1997; Schectman
2003). A systematic review (Smith 2009) concluded that educa-
tional meetings alone, or as a component of multifaceted inter-
ventions, can result in small to moderate increases in the adoption
of desired behaviours by healthcare professionals. Also, meetings
that combined interactive and didactic approaches seemed to be
more effective in changing the behaviour of healthcare profession-
als than meetings that were purely didactic or interactive. The
meetings and workshops in the studies included in our review had
both an interactive and a didactic component.
Our review investigated whether it is more challenging trying to
effect a reduction in established clinician behaviours than to gen-
erate new routines, as suggested by French 2010. Although an ini-
tial analysis of the effects of studies depending on the direction of
behavioural change seemed to agree with this notion, this obser-
vation may have been a consequence of the management specifics
of the conditions in the included studies, as demonstrated by the
results of the subgroup analysis which included only studies on
the same conditions. We could not find any systematic review that
looked in detail into this issue. Behaviour change is a complex pro-
cess and interventions are commonly designedwithout evidence of
having gone through a process of analysing the target behaviour or
the theoretically-predicted mechanisms of action as advocated by
Michie 2011. The theoretical framework behind the design of the
interventions in the studies included here was not always apparent.
Lally 2010 showed that repeating a behaviour in response to a cue
appeared to be enough for many people to develop automaticity
for that behaviour. It is not clear how applicable this observation
is when trying to develop new clinical habits. Additionally, there
seems to be a lack of evidence surrounding the complexities of
stopping an established clinical behaviour.
A U T H O R S ’ C O N C L U S I O N S
41Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Implications for practice
This review identified thirty studies that evaluated a variety of pro-
fessional interventions intended to improve the management of
musculoskeletal conditions by GPs. The most effective interven-
tion in terms of improvingGPbehaviour seems to be the use ofGP
alerting on a patient’s increased risk of osteoporosis, and patient
education and reminders to see their GP for their management.
Just alerting the GP also probably leads to improved clinician be-
haviour, and this intervention is relatively easy to implement. The
combination of guidelines and GP reminder messages attached to
radiology reports may result in a small but sustained reduction
in the number of radiology requests, which is another relatively
simple intervention to put into practice.
Implications for research
Future research is needed to identify professional interventions
which are successful at improving the management of muscu-
loskeletal conditions. Although GP alerting and patient education
seemed to increase concordance with osteoporosis guidelines, it is
unclear whether these methods would result in improved patient
related outcomes and whether they would be equally effective for
improving the management of other musculoskeletal pathology.
Multifaceted interventions were commonly used; however, it is
unclear what would be the most effective combination of com-
ponent interventions. Additionally, as the costs of an intervention
are likely to increase with the number of its components, a cost-
effectiveness analysis would add valuable information.
There were no studies evaluating the effectiveness of local consen-
sus processes. With the increasing focus on the importance of local
service integration and the development of local clinical pathways
of care, there is a need and an opportunity to evaluate the effect
of such local processes.
Given that the aim of the interventions is to change clinician
behaviour, it would be important that new studies consider and
clearly articulate the theoretical framework used when designing
new interventions. This informationwill help the categorisation of
interventions and the development of a more efficient method of
choosing the kinds of intervention that are likely to be appropriate
for a specific behavioural target in a particular context and adefined
population.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Becker 2008
Methods Study Design: Cluster-RCT
Participants Setting: Primary care
Country: Germany.
Participants: All 883 family physicians in 2 German regions were invited to participate
118 practices (126 GPs) agreed to participate and were randomised at practice level. 1
practice withdrew and 1 was excluded because it did not recruit any participants. Total
participants recruited: 1378
Condition: Low back pain
Inclusion criteria for patients were LBP as presenting symptomon the day of recruitment,
written consent to participate in the study, and age above 19 years. Exclusion
criteria were insufficient German language skills, pregnancy, and isolated thoracic pain
Interventions Practices were randomised into 2 intervention and 1 “control” group
1. Intervention: Distribution of guidelines on low back pain, 3 interactive seminars, 2
individual academic-detailing sessions, patient leaflets (educational material + outreach
visits +educational meetings)
2. Intervention: Distribution of guidelines on low back pain, 3 interactive seminars, 2
individual academic-detailing sessions, patient leaflets. Also, motivational counselling
session for GPs and 20-hour training for 2 nurses per practice. Patients recruited received
3 counselling sessions by the nurses (patient-directed component)
3.“Control”:Distributionof guidelines on lowback pain (educationalmaterial)
Outcomes GP outcomes: None
Patient outcomes: Functional capacity (measured byHannover Functional Ability Ques-
tionnaire), days in pain, days of sick leave physical activity, quality of life (measured with
EuroQol), and Fear Avoidance Beliefs questionnaire
Notes We were unable to confirm the results and calculate the standardised mean differences
(SMD) due to non-reported standard deviations
Sources of funding: The study was funded by the German Ministry for Education and
Research (BMBF, FKZ 01 EM 0113)
Conflicts of interest as declared by the authors: Federal funds were received in support
of this work. No benefits in any form have been or will be received from a commercial
party related
directly or indirectly to the subject of this manuscript.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Practices were assigned to the 3 study arms by central
permuted block randomisation with allocation conceal-
ment.”
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Becker 2008 (Continued)
Allocation concealment (selection bias) Low risk “Practices were assigned to the 3 study arms by central
permuted block randomisation with allocation conceal-
ment.”
Protection against contamination Unclear risk Allocation was by practice but it is unclear if communi-
cation between intervention and control practices could
have occurred
Baseline outcomes similar Low risk No important differences present across study groups.
Baseline characteristics similar Low risk Baseline characteristics were reported and were similar
between the 2 groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Outcome measure was objective and recorded by inter-
viewers and trained nurses.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes were reported
Selective reporting (reporting bias) Unclear risk No study protocol was published in order to be able to
verify this
Other bias Unclear risk Possibility of bias during participant recruitment butGPs
were asked to recruit consecutive patients
Bessette 2011
Methods Study design: RCT
Participants Country: Canada (Quebec)
Condition: osteoporosis
Participants: 1314 women without osteoporosis treatment were randomised
Inclusion Criteria:
Women, aged 50 years and over
Not residing in a long-term care hospital before the fracture
Able to understand the programme information and consent form
Must voluntarily accept to participate in this programme and sign the consent form
Participants must have a fragility or traumatic fracture of one of the following sites:
wrist, forearm, humerus, scapula, clavicle, sternum, thoracic or lumbar vertebrae, pelvis,
sacrum, hip, femur, proximal and distal tibia, fibula (including ankle), and foot
Participants must be able to answer the questionnaires via phone interviews
Exclusion Criteria:
Unable to understand the purpose of the programme
Participants with a traumatic fracture of one of the following sites: cervical, skull and
face, hand and finger, toe, metatarsus, and patella
Pathological fracture
Women currently participating in a clinical trial requiring them to take a medication for
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Bessette 2011 (Continued)
osteoporosis
Interventions Experimental group 1: Written educational material on osteoporosis for the physician
(distribution of educational material) plus education of patients with advice to see their
GP and give them written material (patient-directed component)
Experimental group 2: 15-minute educational video on osteoporosis as well as written
documentation on osteoporosis for the physician (distribution of educational material)
plus education of participants with written material and video and advice to see their
GP and give them written material (patient-directed component)
Control group: No intervention. However the control group completed a questionnaire
on osteoporosis which may have increased their awareness
Outcomes Treatment for osteoporosis (using bisphonates, raloxifene, nasal calcitonin or teri-
paratide)
Notes The analysis of the delivery of the reading material to physicians was completed as post
hoc observation
Conflicts of interest and funding sources as declared by the authors: Conflicts of interest
Dr. Bessette has received research grants from
Abbott, Amgen, Bristol-Myers-Squibb, Eli Lilly, Merck, Pfizer, and Roche, has received
consulting fees or other remuneration from Abbott,
Amgen, Merck, Novartis, Pfizer, and Roche and has participated on the speakers bureau
for Amgen, Novartis, Merck, Pfizer, Roche, andWarner
Chilcott. Dr. Brown has received research grants from Abbott, Amgen, Bristol-Myers-
Squibb, Eli Lilly, Pfizer, and Roche, has received consulting fees
or other remuneration from Abbott, Amgen, Eli Lilly, Novartis, Merck, and Warner
Chilcott and has participated on the speakers bureau for Eli
Lilly, Amgen,Novartis,Merck, andWarnerChilcott.Dr.Davisonhas received consulting
fees or other remuneration
fromAmgen and Servier and has participated on the Speakers’ Bureau for Amgen,Merck
Frosst Warner Chilcott and Servier.
Dr. Ste-Marie has received research grants from the Alliance for Better Bone Health and
Novartis, has received consulting fees or other
remuneration fromtheAlliance for Better Bone Health,Amgen,Novartis, Eli Lilly, and
Servier and has participated on the Speakers’ Bureau for the
Alliance for Better Bone Health, Amgen, Novartis, Eli Lilly, Servier, and Merck. No
other authors have a conflict or interest to disclose
TheROCQprogramwas funded byMerck Frosst Canada, Inc.,WarnerChilcott, Sanofi-
Aventis group, Amgen Canada Inc., Eli Lilly
Canada, Inc., and Novartis Pharmaceuticals Canada, Inc. None of the funding sources
had a role in the collection, analysis, or interpretation
of the data or in the decision to publish this article.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The manner of randomisation has not been reported
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Bessette 2011 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Low risk There were 4452 physicians available to treat 1174 included
patients and we therefore felt the risk of contamination to be
small
Baseline outcomes similar Low risk There were no statistically significant baseline differences among
the groups for any investigated variable
Baseline characteristics similar Low risk The distribution of baseline characteristics was similar among
the groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk There was no reported blinding of outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
High risk The main outcomes (treatment rates) were reported as percent-
ages. The analysis of the delivery of the readingmaterial to physi-
cians was completed as post hoc observation
Selective reporting (reporting bias) Low risk The main outcomes were treatment rates. The protocol of the
study was published
Other bias Unclear risk The analysis of the delivery of the reading material to physicians
was completed as post hoc observation
Bishop 2006
Methods Study design: RCT
Participants Setting: Primary care
Country: Canada
462 providers, 428 patients
Condition: Acute low back pain.
Inclusion criteria: The patients included in this study were all residents of British
Columbia, Canada, aged between 19 and 65 years.
They had as their chief complaint, acute low back pain and an accepted claim with the
Workers’ Compensation
Board of British Columbia relating to an injury that was thought to be causative. All
patients included in the study
satisfied the Quebec Task Force Classification of Spinal Disorders criteria for categories
1 or 2 and had symptoms
for more than 2 weeks and less than 4 weeks.
Interventions 1.Distribution of educational materials to GP only + 3 reminders at 0 - 4 weeks (via
letters), 5 - 12 weeks and after 12 weeks
2.Distribution of educational materials to participant and GP + 3 reminders (both to
participant and GP) at 0 - 4 weeks, 5 - 12 weeks and after 12 weeks (distribution of
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Bishop 2006 (Continued)
educational material, reminders and patient-directed component)
3. Control: no educational material, usual care
Outcomes GP outcomes: Concordance with specific clinical guideline-derived history-taking items,
physical examination procedures and treatment recommendations
Patient outcome: None
Conflicts of interest and sources of funding as declared by the authors: FDA device/drug
status: not applicable.
This research was supported by theWorkers’ Compensation Board of British Columbia,
Canada. No funds were received from a commercial
entity related to this manuscript.
Notes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random number generator” used
Allocation concealment (selection bias) High risk In group 2 GPs received “ a
letter from a study physician regarding a specific named patient.
”
Protection against contamination High risk Randomisation happened at participant level and it is not clear
if the same physician was part of both the intervention and the
control group
Also, there is a risk of contamination if communication occurred
between physicians allocated in different groups who worked in
the same practice
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Unclear risk Not specified
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Unclear risk No study protocol published and therefore this could not be
verified
Other bias Unclear risk It is unclear if either participants orGPswere blinded (possibility
of performance bias)
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Boyd 2002
Methods Study design: Randomised trial, no control
Participants Setting: Primary care
Country: USA
149 GPs were sent letters, 258 patients were recruited, 200 patients were contacted by
GPs
Condition: osteoporosis detected by heel ultrasound
Fifty-nine men (mean age 62.8) and 199 women (mean age 58.7) were involved in the
survey; thirty-seven men and 163 women were able to be questioned
Of Caucasian patients 169 of 223 were reached and of African American patients 30 of
35 were reached
Interventions 1. Patient-mediated: extended letter to physician about patient’s risk of osteoporosis after
USS screening result including advice on management (educational material)
2. Patient-mediated: short letter about patient’s risk of osteoporosis
Outcomes Number of participants contacted by GPs following distribution of reminders
Ordering BMD scan within 6 months
Prescription of osteoporosis medication
Notes There was no control group
Conflicts of interest and sources of funding as declared by the authors: Merck, Procter
and Gamble, and Aventis pharmaceuticals
for unrestricted grants for purchase of supplies and to support student activities related
to the health fairs
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly assigned” is the only informa-
tion provided
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Unclear risk Randomisationhappened at physician level
but it is not clear if physicians within the
same practice were allocated in different
groups
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Unclear risk Not specified
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
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Boyd 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes for only 63%of participants fol-
lowed up
Selective reporting (reporting bias) Unclear risk No published protocol and therefore un-
able to verify this
Other bias Unclear risk Potential bias when recruiting participants:
149GPswere sent letters, 258patientswere
recruited, 200 patients were contacted by
GPs
Also, not clear if participants were blinded
or if they were aware that they were taking
part in the study (potential performance
bias)
Broadhurst 2007
Methods Study design: CBA
2 intervention and 2 control sites (2 divisions of general practice in Adelaide)
Participants Setting: Primary care
Country: Australia
87 GPs were recruited in the intervention group. 90 in the control group. GPs were
eligible to participate if they were members in one of these
Divisions and were working ≥ 0.5 full time equivalent (FTE). All GPs in the two
Divisions who met the selection criteria were invited to participate.
Condition: Shoulder pain
Interventions 1. Two sessions of academic detailing (outreach session) on shoulder assessment + educa-
tional material (DVD) + guideline + follow-up session 3months afterwards (distribution
of educational material)
2. Control group: 90 randomly-selected GPs who received no extra training
Outcomes GP outcomes: Knowledge score before, immediately after and 3 months after academic
detailing + requests for ultrasound and Xray imaging
Notes Conflicts of interest and funding resources as declared by the authors: Funded by the
Diagnostic Imaging Reform Implementation Package, Diagnostic
Imaging Section, the Australian Department of Health and Ageing
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Not a randomised study
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Broadhurst 2007 (Continued)
Allocation concealment (selection bias) High risk Not done
Protection against contamination Unclear risk There is a possibility of contamination if
communication occurred between physi-
cians allocated in different groups but
working in the same practice
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Low risk Baseline characteristics of the intervention
and control providers are reported as simi-
lar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes reported
Selective reporting (reporting bias) Unclear risk No study protocol published and therefore
unable to verify this
Other bias High risk Possible recruitment (self selection) bias of
participants
Chassany 2006
Methods Study design: RCT
Participants Setting: Primary care
Country: France
180 GPs, randomisation at GP level.
842 patient participants were recruited by the GPs. Patients over 49 years of age could
enter the study if they had radiographic confirmation of OA
of the knee or hip for at least 6 months, had pain intensity on motion > or equal to 40
mm on a 100 mm visual analogue scale (VAS) the day before inclusion
; and were suitable for treatment with acetaminophen.
Condition: Osteoarthritis pain management
Interventions 1. Course on chronic pain management (3 x 4-hourly group sessions), 8 postal letters
emphasising recommendations, patient leaflet with 5 statements about pain relief (edu-
cational meeting/workshop plus distribution of educational material)
2. Control, unrelated presentation received
Outcomes Outcomes: Change in the intensity of pain on motion as measure on a 100 mm VAS +
Lequesne index score + Womac scores + Global perception of change + Acetaminophen
use
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Chassany 2006 (Continued)
Notes Conflicts of interest ad sources of funding as declared by the authors: Supported and
sponsored by Sanofi-Aventis OTC, Direction Medicale, Gentilly, France
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization stratified according to practice location and
date of qualification.”
Allocation concealment (selection bias) High risk Not done
Protection against contamination Unclear risk There is a possibility of contamination if communication oc-
curred between GPs allocated to different groups but working
in the same practice
Baseline outcomes similar Low risk No important differences present across study groups
Baseline characteristics similar Low risk Baseline characteristics are reported as similar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data balanced in numbers across groups. Similar reasons
for missing data across groups
Selective reporting (reporting bias) Unclear risk No evidence of published protocol
Other bias Unclear risk Possibility of bias during recruitment of patients byGPs.Unclear
if participants were blinded
Ciaschini 2010
Methods Study design: RCT
Participants Country: Canada, Ontario
Participants: patients over the age of 55, able to give consent and identified to be at risk
of future fracture
Patients were eligible for inclusion in the study if they were community-dwelling, aged
55 years or older, able
to give informed consent, and were identified to be at risk for future fracture according
to one of the following
criteria:
1. attended the hospital Fracture Clinic for a non-pathological fracture of the vertebrae,
hip or wrist or
had a BMD in the past year with a T-score of ≤-2.0
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Ciaschini 2010 (Continued)
2. attended the hospital Emergency Department with a fall and found to be at high risk
for falls as defined
by a Timed Up and Go [25] result of greater than 14 seconds; or,
3. were self-referred or referred by a health care provider because of perceived high risk
of fracture and
identified as a high risk for falls defined by a Timed Up and Go result of greater than 14
seconds.
Patients already receiving appropriate pharmacological therapy for osteoporosis as out-
lined in the Osteoporosis
Canada guidelines were excluded from the study.
Interventions Intervention group: The results of the patient’s recent BMD test (patient-mediated) and
patient-specific advice on prescribing according to the Osteoporosis Canada guidelines
(reminders and educational material) were sent to the participant’s physician. The partic-
ipant received personalised counselling on osteoporosis from a research nurse, a written
summary of the proposed management plan and educational material (patient-directed
component)
Control group: usual care
Outcomes Themain outcomewas prescribing of osteoporosis medication (alendronate, risedronate,
raloxifene) 6 months after the intervention
Notes The control participants received the intervention 6months after randomisation (delayed
protocol group)
Conflicts of interest and sources of funding as declared by the authors: Financial support
for completion of the study was given by Merck Frosst
Canada Ltd., Sanofi-Aventis Pharma Inc., Proctor & Gamble Pharmaceuticals Canada
Inc., Eli Lilly Canada Inc., and the Greenshield Foundation.
Equipment (e.g. office space, computers, telephones) was contributed in kind by the
Group Health Centre, Algoma Public Health, Sault Area Hospital,
Algoma Community Care Access Centre, and the Slips, Trips and Falls Committee of
Sault Ste. Marie Safe Communities Partnership, all located in
Sault Ste.Marie,Ontario. TheOntarioMinistry ofHealth and Long-termCare provided
additional support.
PMC is supported by the Algoma District Medical Group in Sault Ste. Marie, Ontario.
SES was supported by a salary award from the Alberta Heritage
Foundation for Medical Research (Health Scholar) when this study was completed and
holds a Canada Research Chair in Knowledge Translation
and Quality of Care. LRD is supported by a Canadian Institutes of Health Research
Rx&D Health Research Foundation Research Career Award. SRM is
supported by salary awards from the Alberta Heritage Foundation for Medical Research
(Health Scholar) and the Canadian Institutes for Health
Research (New Investigator).
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Ciaschini 2010 (Continued)
Random sequence generation (selection
bias)
Low risk A computer-generated randomisation scheme was used
Allocation concealment (selection bias) High risk Participants and treating physicians were not blinded
Protection against contamination Unclear risk Not reported
Baseline outcomes similar Low risk No statistically significant baseline differences were detected
among the groups
Baseline characteristics similar Low risk Baseline characteristics were similar among the groups
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessors could not be blinded; however the primary
source of data was obtained from the Group Health Centre
Electronic Medical record
Incomplete outcome data (attrition bias)
All outcomes
Low risk
Selective reporting (reporting bias) Low risk All outcomes were reported. The protocol of the study was pub-
lished
Other bias Low risk No other bias identified
Cranney 2008
Methods Study design: Cluster-RCT
56 cluster practices were in the intervention group and 63 in the control group
Participants Setting: Primary care
Country: Canada
119 GP practices (these were randomised), 270 patients (the unit of analysis)
Condition: Osteoporosis
Participants patients inclusion criteria: Participants included postmenopausal women
who had sustained a wrist fracture (confirmed by
x-ray). Women currently taking osteoporosis therapies (e.g., risedronate, raloxifene, al-
endronate, teriparatide) were
excluded, but we did not exclude women on hormone therapy (HT), since they may
have been taking HT for
menopausal symptoms.Womenwhohad a traumatic wrist fracture (based on description
of fracture), or were unable
to communicate in English or give consent were also excluded. Women who had a
previous BMD test were not
excluded, since a previous test could be a predictor of receiving osteoporosis therapy
Interventions 1. Personalised letter to GP from research co-ordinator 2 weeks and 2 months post-
fracture (patient-mediated and reminders) incorporating advice on management, rec-
ommended therapies and a treatment algorithm (distribution of educational material).
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Cranney 2008 (Continued)
Participants also received a letter 2 weeks and 2 months post-fracture with advice to see
their GP and an educational booklet (patient-directed component)
2. Control: no information, usual care
Outcomes Outcomes: Proportion of women who stated that their primary care physician had:
Discussed osteoporosis with them + started them on osteoporosis therapy within 6
months of fracture + BMD testing within 6 months + changes in the participant’s
knowledge of osteoporosis using the Osteoporosis Knowledge Questionnaire (OPQ).
Outcomes were assessed by telephone interviews
Notes Conflicts of interest and sources of funding as declared by the authors: This trial was
funded by a peer-reviewed grant from the
Canadian Institutes of Health Research (KTS 62358).
The study did not provide sufficient information to allow the re-calculation of adjusted
for clustering effect sizes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer generated list of random num-
bers in a blinded fashion”
Allocation concealment (selection bias) Low risk As above
Protection against contamination Unclear risk Although the practices were randomised
using a cluster design, it is still unclear if
communication between physicians or pa-
tients of different groups was possible
Baseline outcomes similar Low risk No important differences present between
the groups
Baseline characteristics similar Low risk Baseline characteristics were reported as
similar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not clear if telephone interviews were con-
ducted blindly
Incomplete outcome data (attrition bias)
All outcomes
Low risk Similar reasons and rates of dropouts be-
tween both groups
Selective reporting (reporting bias) Unclear risk No evidence of published protocol
Other bias Low risk No other bias identified
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Dey 2004
Methods Study design: cluster-RCT
Participants Setting: primary care
Country: UK
24 practices (practice was the unit of randomisation, stratified by primary care group; 3
primary care groups), 2187 patients
Condition: acute LBP
Patients were eligible for this study if they were aged between 18 and 64 years, registered
with a GP in
Birkenhead, Wallasey or West Wirral Primary Care Groups (PCGs), and had consulted
their GP about an episode of
acute low back pain for which they had not already sought advice during the preceding
6 months
Interventions 1. Educational outreach visit + guidelines (educational material)+ poster of guidelines +
referral formswith guidelines + access to fast-track physiotherapy and a back clinic
2. Control: standard practice
Outcomes Rate of referral for lumbar spine x-ray within 3 months
Number of sickness certificates issued
Number of prescribed opioids or muscle relaxants
Number referred to secondary care
Number referred to physio or educational programme
Notes Conflicts of interest and sources of funding as declared by the authors: None reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random allocation, each centre was given a unique iden-
tifier, stratification by primary care group
Allocation concealment (selection bias) Low risk Central allocation
Protection against contamination Unclear risk Although the practice was the unit of randomisation, it is
not clear if communication between practices could affect
the results
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Low risk Baseline characteristics are reported as similar
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “Only one research assistant was employed and blind out-
come assessment was not possible.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
60Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dey 2004 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information as no published protocol
Other bias Low risk No other bias identified
Eccles 2001
Methods Study design: cluster-RCT
Participants Setting: Primary care
Country: UK
247 practices randomised; practice was unit of randomisation and analysis-stratified
randomisation by radiology department (3 radiology departments) and practice size
The audit and
feedback intervention was delivered to all eligible GPs
according to study design.
Condition: acute LBP or knee pain
Interventions 2 x 2 factorial design
1.Distributionof educationalmaterials + audit and feedback (number of practice referrals
compared with peers)
2. Distribution of educational materials + reminders (messages on x-ray results)
3. Distribution of educational materials + audit and feedback + reminders
4. Distribution of educational materials (guideline) (control group)
Outcomes Number of lumbar or knee radiographs requested per 1000 patients for 2 years
Notes Intervention fidelity: Measured attachment rate of educational reminder messages to x-
ray reports
Conflicts of interest and sources of funding as reported by the authors: The study was
funded by the UK National Health Service Research and
Development Primary Secondary Interface Programme. The Health Service Research
Unit, University of Aberdeen, is funded by the Chief
Scientist Office of the Scottish Office Department of Health. The Centre for Health
Services Research, University of Newcastle upon Tyne, and the
Health Services Research Unit, University of Aberdeen are members of the Medical
Research Council Health Services Research Collaboration
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number tables.
Allocation concealment (selection bias) Low risk Performed centrally by statistician
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Eccles 2001 (Continued)
Protection against contamination Low risk The intervention was individualised messages and feed-
back to practices and therefore the risk of it being dissem-
inated to other practices is low
Baseline outcomes similar High risk There was baseline imbalance between the groups
Baseline characteristics similar Unclear risk Not specified
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes were measured objectively by radiology depart-
ments
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Unclear risk No published protocol
Other bias Unclear risk The intervention of attaching messages to radiology re-
ports was not consistently applied across sites. The site
where the messages were attached by an operator pressing
a key had an attachment rate of 40%while the other 2 sites
had a rate of close to 100%
Engers 2005
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: Netherlands
67 GPs eligible to participate, 41 of these completed outcome reports, 531 participants
Condition: Low back pain
The participating GPs were asked to recruit consecutive patients with a new episode of
low back pain as the main reason
for consultation. Low back pain was defined as pain, discomfort, stiffness, or fatigue
between the lower edge of the shoulder
blades and the gluteal fold either with or without radiation to the legs. Patients who were
pregnant, younger than 16 years of
age, or not familiar with the Dutch language were excluded. Only patients who were
diagnosed with “nonspecific low back
pain” and no “red flags” present were included in the analyses
Interventions 1. Two-hour workshop (negotiation skills) , guideline on low back pain and guidance
on low back pain for occupational physicians, 2 scientific articles, a patient education
tool and a management decision tool (distribution of educational materials)
2. Control: no intervention, usual care
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Engers 2005 (Continued)
Outcomes Number of referrals to a therapist (physical, exercise, or manual therapist)
Prescription of pain medication on a time-contingent basis
Prescription of paracetamol versusNSAIDs
Adequacy of patient education.
Notes Conflicts of interest and sources of funding as declared by the authors: The manuscript
submitted does not contain information about medical
device(s)/drug(s).
No funds were received in support of this work. No benefits in any form have been or
will be received from a commercial party related
directly or indirectly to the subject of this manuscript.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”Computer-generated random- list of numbers” used
Allocation concealment (selection bias) High risk “Research team knew which practices received which in-
tervention.“
Protection against contamination Unclear risk The unit of allocation was the GP so there is a risk of com-
munication betweenGPs allocated to different groups but
working in the same practice
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Unclear risk Baseline characteristics were reported as similar
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “Research team knew which practices received which in-
tervention.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis per-
formed
Selective reporting (reporting bias) Unclear risk No protocol was published (although the protocol is men-
tioned in the study)
Other bias High risk Possible bias as GPs recruited participants. Possible
recollection or report bias due to self-reported out-
comes
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Feldstein 2006
Methods Study design: RCT
Participants Setting: Primary care
Country: USA
15 practices, 159 providers, 327 participants (randomisation at patient level)
Condition: women aged 50 to 89 who had suffered a fracture (any type) and therefore
high likelihood of osteoporosis
The goal in participant selection was to identify older patients who had fractures indi-
cating an increased
risk of osteoporosis, had not received a BMD measurement or a medication for osteo-
porosis, and did not have
medical conditions or other factors that would contraindicate the interventions
Interventions 1. Reminders: electronic medical record message about participant’s risk of osteoporosis
+ distribution of education materials (with guidelines)
2. Reminders + distribution of education materials + patient-directed component (edu-
cational material and reminder to see the GP)
3. Control: standard practice
Outcomes GP outcomes: proportion of study population who receivedmedication for osteoporosis
or a BMD test within 6 months after the intervention
Participant outcomes: regular physical activity, total caloric expenditure, total calcium
intake and patient satisfaction
Notes Conflicts of interest and sources of funding as declared by the authors: This study was
supported by a research
contract through Merck & Co. Inc. The funding organization was not involved in the
design or conduct of the study;
the collection, management, analysis, or interpretation of the data; or in the preparation
or approval of this manuscript
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised random number generator
used
Allocation concealment (selection bias) Low risk “The study statistician randomised and assigned partici-
pants to the study groups”
Protection against contamination Unclear risk Possible contamination as the participant was the unit of
randomisation
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Low risk Baseline characteristics were reported as similar
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Feldstein 2006 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Study analyst “was blinded to the treatment groups.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Unclear risk Protocol mentioned in the study but not published
Other bias Unclear risk Unclear if participants were
blinded
French 2013
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: Australia
78 practices, 92 GPs were randomised and participated in the study (randomisation at
practice level)
Condition: Low back pain
Patient participant inclusion criteria were people presenting with acute (less than three
months duration) non-specific LBP and
aged 18 years or older.
Interventions Intervention group: 2 facilitated, interactive, educational workshops aiming to facilitate
behaviour change plus distribution of educational DVDs to all physicians
Control group: usual care
Outcomes Primary outcomes were patient outcomes but due to low numbers of patients recruited,
these were not measured
Secondary outcomes included self-reported behavioural change and number of x-ray and
CT requests
Notes Not all physicians participated in the full intervention. Only 36 (61%) attended the
workshops and an additional 6 watched the DVDs. However the analysis included all
physicians
Conflicts of interest and sources of funding as declared by the authors: The authors
have declared that no competing interests exist. The IMPLEMENT trial was funded by
the Australian National Health and Medical Research Council (NHMRC) by way of a
Primary Health Care Project
Grant (334060). SDF and DAO are supported by NHMRC Early Career Fellowships.
RB is supported in part by a NHMRC Practitioner Fellowship. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript
Risk of bias Risk of bias
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French 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent and blinded statistician implemented the
randomisation (computer-generated random numbers)
after stratifying practices based on the number of GPs and
whether the practice was rural or not
Allocation concealment (selection bias) Low risk Allocationwas concealed from the investigators until base-
line data had been collected from GPs
Protection against contamination Low risk The whole practice was randomised to reduce risk of con-
tamination
Baseline outcomes similar Unclear risk There is no information on baseline outcomes (on x-ray
and CT numbers)
Baseline characteristics similar High risk There was some baseline imbalance, with control GPs
more likely to identify themselves as having an interest
in low back pain (24% versus 9%) and more GPs in the
intervention group undertaking lowback pain continuing
education in the past year (16% versus 5%)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Investigators not involved in the interventionwho entered
the data and the statistician were blinded to group alloca-
tion until the statistical analysis was completed
Incomplete outcome data (attrition bias)
All outcomes
High risk The primary outcomes were not measured due to low
numbers of participants recruited
Selective reporting (reporting bias) High risk As above. Also, subgroup analysis to investigate the effect
on GPs who attended the workshop (as per protocol) was
not done
Other bias High risk Not all physicians participated in the full intervention.
Only 36 (61%) attended the workshops and an additional
6 watched the DVDs. However the analysis included all
physicians
Participants could not be blinded. Primary outcomes not
measured. Reported outcomes were self reported
Gormley 2003
Methods Study design: RCT
Participants Setting: Primary care
Country: Northern Ireland
40 GP principals randomised
Condition: Shoulder pain
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Gormley 2003 (Continued)
Interventions 1. Educational meeting/workshop on shoulder management and injection technique
training on mannequins
2. As above plus injection training on real patients
Outcomes Number of shoulder injections
Referrals to physiotherapy and injection clinics over last 6 months
Level of confidence (10 cm VAS)
Notes Conflicts of interest and sources of funding as declared by the authors: None reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported in the study
Allocation concealment (selection bias) Unclear risk Not reported in the study
Protection against contamination Low risk The randomisation was at physician level. The intervention re-
quired the physician to be present to practise their skills and
therefore contamination is unlikely
Baseline outcomes similar Low risk No important differences between the groups
Baseline characteristics similar Low risk No important differences between the groups
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not done, this was self reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “One GP’s assessment return after training was incomplete and
another failed to make a return. Both of these were in the ”man-
nequin only“ training group”. It is unclear what the exact pro-
portion of missing data was and if this could bias the results
Selective reporting (reporting bias) Unclear risk No published protocol of the study
Other bias High risk Results were based on self reporting by GPs. GPs were not
blinded
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Hazard 1997
Methods Study design: RCT
Participants Setting: Primary care
Country: USA
59 GPs
59 patients: workers 18-60 years old with VDPQ scores suggesting a high risk of pro-
longed work disability (i.e. VDPQ score of at least 0.37 (scale = 0-1))
Condition: Low back injury
Interventions 1.Distribution of educational materials + reminders to GPs (letters regarding the specific
patient with advice on how to limit work loss)
2. Control
Outcomes 3-month work absence rate
VDPQ (disability) score
Satisfaction with health care
Impact of health care on return to work
Days of work loss
Days until first return to work
Notes Conflicts of interest and sources of funding as reported by the authors: Supported, in
part, by The National Institute on Disability
and Rehabilitation Research, Washington, D.C. (grant H133E30014-95)
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”Each high risk worker was assigned to the physician interven-
tion group or to the control group, according to a predetermined
allotment list developed from a table of random digits balancing
the assignments with every six workers“
Allocation concealment (selection bias) High risk “Physician was sent a letter identifying the patient and the pa-
tient’s high risk for work absence 3 months after injury.”
“The workers themselves knew whether they were in the inter-
vention or control groups”
Protection against contamination Unclear risk Physicians could be working in the same practice.
Baseline outcomes similar Unclear risk Not specified
Baseline characteristics similar Unclear risk Not specified
Blinding of outcome assessment (detection
bias)
All outcomes
High risk “The follow up interviewer was not blinded to the VDPQ scores
or groups assignments”
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Hazard 1997 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Unclear risk No published protocol of the study
Was knowledge of the allocated inter-
ventions adequately prevented during the
study?
High risk
Other bias Unclear risk Participants were not blinded
Hollingworth 2002
Methods Study: ITS
Participants Setting: Primary care
Country: UK
Number of practices and GPs not reported. Analysed 2100 x-ray referrals
The mean age of the 2100 patients whose radiography reports were selected for review
was 53.6 years (range = 7 to 94 years), 57.9% were female
Interventions Distribution of guidelines (by Royal College of General Practitioners and Royal College
of Radiologists)
Outcomes Number of primary care referrals for radiography of the lumbar spine
Notes Conflicts of interest and sources of funding as declared by the authors: The lead author
is sponsored by a MRC training fellowship in Health
Services Research. This study was funded in part by task-linked NHS R&D support
funding.
The work was undertaken at University of Cambridge, which received funding from the
NHS Executive eastern region. The views expressed in
this publication are those of the authors and not necessarily those of the NHS Executive
eastern region
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Was the intervention independent of other
changes?
Unclear risk No other changes were reported at the time of the guideline
dissemination. However, such changes (such as waiting times,
funding arrangement changes or changes in the prevalence of
low back pain were possible)
Was the shape of the intervention effect
pre-specified?
Unclear risk This was not specified in the study
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Hollingworth 2002 (Continued)
Was the intervention unlikely to affect data
collection?
Low risk The interventionwas independent of the data collectionmethod
Was knowledge of the allocated inter-
ventions adequately prevented during the
study?
Low risk Participants were not aware of the study
Were incomplete outcome data adequately
addressed?
Unclear risk The study does not give sufficient information on this
Other bias Low risk No other risks identified
Huas 2006
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: France
155 GPs (randomisation was stratified by University; 20 different Universities), 772
participants
Condition: Chronic musculoskeletal pain
All included patients were over 18 years of age, had been suffering for at least 3 months
from sustained daily chronic pain, of musculoskeletal origin
affecting the locomotor system, and were regularly taking painkillers
Interventions 1.Training in the use of VAS and HAD scales for pain (educational meeting + patient-
mediated intervention)
2. Control: usual care
Outcomes GP outcomes: changes in prescription of painkilling modalities
Patient outcomes: Level of relief obtained (numerical relief scale) (self reported by par-
ticipant)
Notes Conflicts of interest and sources of funding as declared by the authors: The Fondation de
la Caisse Nationale de Prevoyance funded the study and the Nukleus company provided
material support
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomisation was stratified by University.” No further
information provided
Allocation concealment (selection bias) Unclear risk No information provided
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Huas 2006 (Continued)
Protection against contamination Low risk “In order to avoid contamination bias, physicians from
both groups never met during the course of the study”
Baseline outcomes similar Low risk “Painkilling treatment prescribed at inclusion was com-
parable in both groups - the main difference being that a
larger number of patients in the scale group were taking
level 3 analgesics, although the number of patients con-
cerned was very small”
Baseline characteristics similar Low risk “The characteristics of the physicians were comparable for
both groups”, “The patient groups in the treatment and
control groups were of similar nature”, “pain location was
comparable in the 2 groups except for back pain”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Participants probably unaware of GPs’ training. Not clear
how secondary outcomes were assessed and by whom
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No published protocol of the study
Other bias Low risk No other risks identified
Kerry 2000
Methods Study design: cluster-RCT
Participants Setting: Primary care
Country: UK
69practices (practice is the level of randomisation), 175GPs, 43,778 radiological requests
Condition: People potentially requiring an x-ray of chest, spine or limbs and joints
Interventions 1. Distribution of guidelines + individual feedback on referral rates + graph of the average
radiation dose for different examinations (educational material and audit/feedback)
2. Control: standard care
Outcomes Professional practice: number of x-rays requested (chest, limbs and joints, spine) within
12 months
Notes Conflict of interests and sources of funding as declared by the authors: This study was
funded by The South Thames Project
Grant Scheme.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Kerry 2000 (Continued)
Random sequence generation (selection
bias)
Low risk “Practices were randomly allocated to an intervention or a
control group using a stratified randomisation.”
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Unclear risk Randomisation was at practice level but unclear if practices
of different groups could communicate
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Unclear risk Not reported. Although randomisation happened using 10
strata depending on “numbers of partners, referral rates,
fund-holding status, and having received guidelines in a
previous study”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome objectively collected (routine data, collected
electronically)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes were reported
Selective reporting (reporting bias) High risk Results (referrals for x-rays) not reported per 1000 patients.
Protocol of the study not published
Other bias Low risk No other risks identified
Lafata 2007
Methods Study design: cluster-RCT
Participants Setting: Primary care
Country: USA
15practices randomised after stratification (randomisation at practice level), 123 primary
care physicians, 10,354 patients
Condition: women 65 to 89 years of age on 3/31/2003 and high likelihood of osteo-
porosis with a visit between 4/1/2001 and 3/31/2003 to
a primary care physician.
Interventions 1. Patient-directed component (educational material on osteoporosis)
2. Patient-directed (educational material on osteoporosis) + physician prompt/reminder
(reminder on electronic medical record and biweekly letter to physician listing patients
needing treatment)
3. Control: standard care
Outcomes Professional practice: proportion of patients receiving BMD testing within 12 months;
prescription of osteoporosis medication
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Lafata 2007 (Continued)
Notes Possible risk of contamination
Conflicts of interest and sources of funding as declared by the authors: Dr. Weiss and
Dr. Chen are employees of Merck & Co
The study did not provide sufficient information to allow the re-calculation of adjusted
for clustering effect sizes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Within stratum, clinics were allocated to the three arms
using a random numbers table”
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Unclear risk Randomisation was at practice level but unclear if practices
of different groups could communicate
Baseline outcomes similar Low risk Women with previous BMD screening or on osteoporosis
medication were excluded from the evaluation
Baseline characteristics similar Unclear risk “Although statistically significant baseline differences were
found for most of the patient characteristics assessed, only
a handful meaningful differences existed”
“Women in the patient mailed reminder arm were less
likely to be African American”,
“there was variation in health plan enrolment”.
There was no assessment of GP baseline characteristics
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Used “automated clinical and pharmacy data”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data balanced in numbers across inter-
vention groups
Selective reporting (reporting bias) Unclear risk Insufficient information provided. No published protocol
of the study
Other bias Low risk
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Leslie 2012
Methods Study design: RCT
Participants Setting: Primary care
Country: Canada
4264 patients were randomised; patients included men and women 50 years of age and
older who had suffered a previous fracture and had not received a BMD or osteoporosis
medication
Condition: osteoporosis
Interventions 1. Notification letter to primary care physician (reminder) about the patient’s fracture
accompanied by educational material
2. Notification letter to primary care physician accompanied by educational material as
above plus patient-directed intervention (educational material and reminder)
3. Control group: usual care
Outcomes BMD and osteoporosis medication
Notes Conflicts of interest and sources of funding as declared by the authors: Wiliam Leslie
has received speaker fees from Merck Frosst and Amgen;
he has unrestricted research grants fromMerck Frosst, Sanofi-Aventis, Procter and Gam-
ble, Novartis, Amgen and Genzyme; he is on the advisory boards
forGenzyme,Novartis, andAmgen. Patricia ACaetano has received unrestricted research
grant from Amgen. No other competing interests were declared
The article was funded by the Manitoba Patient Access Network whose mandate is to
identify, advocate, support and guide health system change and process improvement
initiatives. The network is financially supported by theWait Times Reduction Fund and
receives secretariat services from Manitoba Health‘s Wait Times Task Force
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation was done using a centralised computer-
based algorithm”
Allocation concealment (selection bias) Low risk “The computer-based algorithm concealed the allocation pro-
cess from the clinical investigators”
Protection against contamination Unclear risk It is not clear if primary care physicians in the control group
were also physicians of patients under the intervention groups
Baseline outcomes similar Low risk “The groups were well balanced in terms of age, sex and site of
fracture”
Baseline characteristics similar Low risk As above. The patients included had not received previous BMD
test or osteoporosis medication
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Leslie 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The outcomes were taken from a centralised database
Incomplete outcome data (attrition bias)
All outcomes
Low risk The analysis followed an intention-to-treat methodology and all
participants were included
Selective reporting (reporting bias) Low risk All outcomes as per study protocol were reported
Other bias Low risk No other risks identified
Majumdar 2008
Methods Study design: RCT
Participants Setting: Primary care
Country: Canada
266 GPs, 272 patients (unit of randomisation the patients)
Condition: 50 years or older and distal forearm fracture (high likelihood of osteoporosis)
Patients were excluded if they were already receiving treatment for osteoporosis with a
bisphosphonate,
were unable or unwilling to provide informed consent, had no fixed address, were residing
outside the Capital Health region
or were residing in a long-term care facility.
Interventions 1. Distribution of guidelines endorsed by five local leaders (educational material) + physi-
cian reminder (patient-specific letter to GP) + patient-directed component (education
and counselling via telephone)
2. Control group, usual care
Outcomes Proportion of participants who had received BMD test
Prescription of osteoporosis medication
Composite measure of quality of guideline-concordant or “appropriate” care
Patient Outcomes: Health status (SF-12)
Osteoporosis-related quality of life
Wrist-related functional outcomes
Osteoporosis-related knowledge
Satisfaction with care
Costs: intervention cost per patient (this outcome was reported in a different publication,
Majumdar 2007)
Notes Conflicts of interest and sources of funding as declared by the authors: None declared
for Sumit Majumdar, Jeffrey Johnson,
Finlay McAlister, Debbie Bellerose, Anthony Russell, Don Morrish, Walter Maksy-
mowych or Brian Rowe. David Hanley has been a clinical investigator
in phase III clinical trials of bisphosphonatesmanufactured by Proctor&Gamble,Merck
and Novartis; in addition, he has received speaker fees from
and has been a paid consultant on advisory boards of these companies.Sumit Majumdar,
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Majumdar 2008 (Continued)
Jeffrey Johnson, Finlay McAlister and
Walter Maksymowych receive salary support awards from the Alberta Heritage Founda-
tion for Medical Research; Sumit Majumdar and Finlay McAlister
receive salary support awards from the Canadian Institutes of Health Research; Jeffrey
Johnson and Brian Rowe hold Canada Research Chairs; and
Finley McAlister holds the Aventis/Merck-Frosst Chair in Patient Health Management.
The study was supported by peer-reviewed grants from the Canadian
Institutes of Health Research.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Allocation was concealed by application of various block sizes
and by use of a secure,centralised, Internet based computer-
generated randomisation system.”
Allocation concealment (selection bias) Low risk As above
Protection against contamination High risk The randomisation unit was the patient and therefore there
could be contamination at physician level
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Unclear risk “Intervention and control patients were comparable” and “all
multivariable analysis adjusted” for any differences. There was
no assessment of physician characteristics
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Research nurses collected outcome data without knowledge of
allocation status”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were accounted for
Selective reporting (reporting bias) Unclear risk All outcomes listed in Methods were reported. However, there
was no published study protocol
Was knowledge of the allocated inter-
ventions adequately prevented during the
study?
Low risk
Other bias Low risk “Neither physicians nor patients were aware of the study out-
comes”
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Rahme 2005
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: Canada
249 providers, patients; before intervention = 3280, and post intervention = 2883
Condition: Osteoarthritis
All NSAID, COX-2 inhibitor, or acetaminophen prescriptions dispensed to patients
with osteoarthritis were identified.
Patients with osteoarthritis were those who had at least one diagnosis for osteoarthritis
(ICD-9 code 715) in the
previous 1215 days.
Interventions 1. Distribution of educational material (decision-tree laminated sheet) without face-to-
face discussion
2. 90-minute workshops on osteoarthritis without distribution of the decision-tree lam-
inated sheet
3. 90-minute workshop on osteoarthritis + distribution of the decision-tree laminated
sheet
4. Controls: standard care, no educational intervention
Outcomes Professional practice: prescription of medications for elderly patients suffering from
osteoarthritis
Notes Conflicts of interest and sources of funding as declared by the authors: Drs. LeLorier,
Choquette, Bessette and Rahme have served as consultants
and paid speakers for Merck & Co. Inc. and for Pfizer Inc. Ms. Beaulieu is an employee
at Merck Frosst Canada Ltd. Dr. Rahme is a
research scholar funded by The Arthritis Society.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Each town was randomly allocated 1 of 4 intervention
options”. No further details of the randomisation method
are given
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Low risk “The townswere geographically distant tominimise cross-
contamination”
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Low risk “Patient andphysician characteristicswere on average sim-
ilar among the four groups”
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Rahme 2005 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes data were obtained from electronic databases
(Provincial Health Care Fund database)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis performed.
Selective reporting (reporting bias) Unclear risk No study protocol was published
Other bias Unclear risk Not clear if participants were blinded with regards to the
study outcomes
Robling 2002
Methods Study design: cluster-RCT
Participants Setting: Primary care
Country: UK
30 practices, 182 MRI requests
Condition: people who potentially require MRI for knee or lumbar problems
Interventions 1. Distribution of local guidelines + practice-based seminar during which a 15-minute
video was shown (outreach visit)
2. Distribution of local guidelines + feedback on practice-specific MRI use and compar-
ative data on orthopaedic and neurosurgical referrals (audit and feedback)
3. (1 + 2)Distribution of educationalmaterial plus outreach visits plus audit and feedback
4. Control group: distribution of local guidelines by post
Outcomes Professional practice: proportion of MRI requests that are in concordance with guideline
(length of follow-up not clear)
Cost outcome: intervention cost
Notes Conflicts of interest and sources of funding: The study was funded by the NHS Research
and Development Programme on the
Primary Secondary Care Interface.
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomisation was performed using a random numbers
table.”
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Unclear risk Randomisation was at practice level but it is unclear if
practices of different groups could communicate
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Robling 2002 (Continued)
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Unclear risk Not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Anonymised interview data were assessed by a study
panel”
“Panel members were blinded to study randomisation”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk Insufficient information, no study protocol was published.
Other bias Unclear risk It is unclear if participants were blinded on the outcome
measures
Rosemann 2007
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: Germany
75 practices, 75 GPs, 1021 patients. The GPs were the unit of randomisation
Condition: Osteoarthritis
To be eligible for inclusion, patients had to be age 18 years and diagnosed with OA in
the knee or the hip according to the American College of Rheumatology criteria
Interventions 1. Educationalmeeting/workshop (2 interactive quality circlemeetings of 8hours each on
management of osteoarthritis and motivational skills) plus educational material (written
educational material + patient educational material including leaflets, booklets and audio
CDs)
2. 1 + practice nurse training to call participants and complete questionnaire on os-
teoarthritis management
3. Control
Outcomes Patient outcomes:Change in quality of life, assessed by theGerman version of the Arthritis
Impact Measurement Scales Short Form (AIMS2-SF),
Health service utilisation
Prescriptions
Physical activity.
Notes Conflicts of interest and sources of funding as declared by the authors: None reported
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
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Rosemann 2007 (Continued)
Random sequence generation (selection
bias)
Low risk GPs randomised by SPSS
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination High risk As the randomisation was at GP level, it may have been
possible that communication between intervention and
control professionals could have occurred
Baseline outcomes similar Low risk No significant differences between participant groups
were identified
Baseline characteristics similar Low risk “No statistically significant differences in the outcome
measures” at baseline were found
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Participant answers were cross-checked by a research as-
sistant but it is not clear if the assistants were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data.“No practice dropped out dur-
ing the study”
Selective reporting (reporting bias) Low risk Published study protocol
Other bias Unclear risk The participants were not blinded and this may have af-
fected the results
Roux 2013
Methods Study design: RCT
Participants Setting: Primary care
Country: Canada (Quebec, Sherbrooke)
Women and men aged 50 years or older with a fracture confirmed on radiograph were
screened by the study co-ordinators for circumstances suggestive of a fragility fracture
when they attended the orthopedic outpatient clinics
Patients unable to speak French or English fluently, as well as those with known severe
psychiatric problems, delirium, or dementia were not approached because of their in-
ability to provide valid informed consent. 881 patients were randomised
Interventions Group 1: Verbal and written information on osteoporosis to patient (patient-directed
component) and letter with specific management plan sent to their treating physician
(GP reminder). Patient reminders at 6 and 12 months. Reminder to physician if patient
untreated at 6 months
Group 2: Verbal and written information on osteoporosis to patient (patient-directed
component) and letter with specific management plan sent to their treating physician
(GP reminder). Blood tests and BMD test ordered for patient and results sent to the
physician (patient-mediated intervention). Patient reminders at 4,8 and 12 months and
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Roux 2013 (Continued)
physician reminders at 4 and 8 months if patient remained untreated
Control group: Telephone interviews at 6 and 12 months to assess treatment scores
Outcomes Osteoporosis-related drug treatment at 12 months was the main outcome
Notes Conflicts of interest and sources of funding as reported by the authors: Supported by
unrestricted research grants from Merck Canada, The
Alliance for Better Bone Health at Procter&Gamble (nowWarner Chilcott) and Sanofi-
Aventis, Amgen Canada, Novartis Pharmaceuticals
Canada Inc., and Servier Canada; and by the Centre de Recherche Clinique Étienne-
LeBel (CRC), Centre Hospitalier Universitaire de
Sherbrooke (CHUS), which received a team grant from the Fonds de la Recherche en
Santé du Québec
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were recruited concurrently by a research co-ordinate
from consecutive fracture clinics. Attending surgeons did not
play an active role in recruitment
Recruitment to the control group was random but not ran-
domised relative to recruitment to the intervention groups in
order to avoid contamination between participants
Allocation concealment (selection bias) Low risk The consent formoutlined all 3 interventions but did not suggest
that any of the 3 was more effective. Primary care physicians
were blinded to which group their patients were assigned to
Protection against contamination Unclear risk Participants were protected from contamination by separating
the control and intervention groups but the possibility of physi-
cian contamination was not explored
Baseline outcomes similar Low risk There were no significant differences between groups
Baseline characteristics similar High risk The participants in the first intervention group were older (me-
dian age 67 while for the control group this was 64 and for the
second intervention group was 63)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk The assessors were not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk The data were analysed by intention-to-treat methodology
Selective reporting (reporting bias) Unclear risk The main outcome was reported but we could not find a pub-
lished study protocol
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Roux 2013 (Continued)
Other bias Unclear risk Unclear if the participants were blinded
Rozental 2008
Methods Study design: RT (no control group)
Participants Setting: Primary care
Country: USA
Aim 1: 240/298 patients: retrospective review
Aim 2: RT 50 patients were randomised to 1 of 2 interventions
Condition: Osteoporosis
The inclusion criteria included an age of over fifty years (for women) or over sixty-five
years (for men), a fragility fracture
of the distal part of the radius, no evaluation with a bone mineral density examination
within two years before the fracture,
and no current treatment with antiresorptive medication or hormone replacement ther-
apy
Interventions 1. Orthopaedic surgeon orders BMD and BMD results are forwarded to primary care
physician (patient-mediated)
2. Letter from orthopaedic surgeon to primary care physician outlining guidelines for
osteoporosis screening (educational material and reminder)
No control group
Outcomes Professional practice: the rates of evaluation (BMD testing) within 6 months and treat-
ment (discussion and initiation) for osteoporosis
Notes Conflicts of interest and sources of funding as declared by the authors: In support of
their research for or preparation of this work, one or more of the authors received, in
any one year, outside funding or grants of
less than $10,000 (a Procter and Gamble Development Grant). Neither they nor a
member of their immediate families received payments or other
benefits or a commitment or agreement to provide such benefits from a commercial
entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center, clinical practice,
or other charitable or nonprofit organization with which the
authors, or a member of their immediate families, are affiliated or associated
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information on how the randomisation took
place
Allocation concealment (selection bias) Unclear risk No information is provided on allocation con-
cealment
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Rozental 2008 (Continued)
Protection against contamination High risk Randomisation happened at patient level
Baseline outcomes similar Unclear risk These were not assessed at baseline
Baseline characteristics similar Low risk Baseline characteristics between participant
groups seemed similar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified in the paper.Not clear if the asses-
sor was blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were accounted for
Selective reporting (reporting bias) Unclear risk No study protocol was published
Other bias Unclear risk It is unclear if participants were blinded with
regards to the outcomes
Schectman 2003
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: USA
85 physicians, 2020 patients, 14 group practice sites, randomisation at practice level
Condition: Acute low back pain
Patients were eligible for study inclusion if they met all three of the following criteria:
(1) presence of low back pain; (2) duration
of current symptoms less than 6 weeks; and (3) no episodes of pain reported or office
visits for low back pain in the preceding year
Interventions 1. Distribution of guideline on the management of acute low back pain + educational
meeting + feedback on back pain encounters + individual follow-up visit by investigator
6 months afterwards and another feedback on back encounters + educational material
for patients including a videotape (educational material + meeting + audit + outreach)
2. Education materials for patients: pamphlet and video and 2 reminders within the first
3 months to clinicians to use these materials (educational material)
3. 1 + 2
4. Control group
Outcomes Professional practice:
Proportion of lumbar plain x-rays
CT or MRI consistent with guideline within 12 months
Subspecialty referral
Physiotherapy referral
Patient outcomes:
Beliefs about care
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Schectman 2003 (Continued)
Satisfaction with care
Clinical outcome measures using validated instruments
Notes Conflicts of interest and sources of funding as reported by the authors: Agency forHealth
Care Policy and Research,
Public Health Service, Department of Health and Human Services, Grant #: RO1
HS07069
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Clinician practices were stratified by affiliation and then,
using sealed envelopes, randomised by an investigator to
4 groups in a 2 × 2 factorial design.”
Allocation concealment (selection bias) Low risk Sealed envelopes used
Protection against contamination Unclear risk Randomisation was at practice level and also stratification
by affiliation was used which can reduce the risk of con-
tamination. However, there may have been contamina-
tion at patient level
Baseline outcomes similar High risk “The intervention group had substantially higher utiliza-
tion of radiologic and specialty services during the base-
line period”
“Similar baseline differences were found for utilization of
services inconsistent with the guideline”
“These differences remained, though were diminished,
after adjustment for patient characteristics that were
strongly associated with utilisation”
Baseline characteristics similar High risk Patient and clinician characteristics between the groups
were not similar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported if assessors were blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not recorded if all charts audited
Selective reporting (reporting bias) Unclear risk Insufficient information provided; no study protocol was
published
Was knowledge of the allocated inter-
ventions adequately prevented during the
study?
Unclear risk It is unclear if the participants were blinded with regards
to the outcomes
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Schectman 2003 (Continued)
Other bias High risk “The four intervention groups were collapsed into two
for analysis and reporting purposes” after the patient
education intervention revealed no effect. This was
not in accordance with the study protocol. Potential
unit of analysis error, potential contamination between
groups.
Solomon 2007a
Methods Study design: cluster-RCT
Participants Setting: Primary care
Country: USA
828 providers, 13,455 patients
Condition: people with high likelihood of osteoporosis and high risk of future fracture
The at-risk patients were women 65 years of age, men and women 65 years of age with
a prior fracture, and men and women 65 yr of age who
used oral glucocorticoids.
Interventions 1. Physician education by trained pharmacists or nurses (academic-detailing approach
via outreach visits) + educational material and handouts for patients
2. Patient-directed component: 3 mailed letters with educational material and questions
to ask the physician
3. 1 + 2
4. Control: standard care
Outcomes Professional practice (primary outcome): number of patients who began osteoporosis
medication or had BMD test within 12 months
Patient outcomes (secondary outcomes): fracture of wrist, humerus or hip
Notes Conflicts of interest and sources of funding: Dr Solomon possessed research grants in
the past fromMerck and Proctor &Gamble. Dr Gauthier is an employee of the Arthritis
Foundation, which partially funded this study. All other authors state that they have no
conflicts of interest.This study was supported by NIH Grant AR48616 and
the Arthritis Foundation.
The study did not provide sufficient information to allow the re-calculation of adjusted
for clustering effect sizes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random-number generator. The randomisation was at
doctor level
Allocation concealment (selection bias) Unclear risk Not reported
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Solomon 2007a (Continued)
Protection against contamination Low risk “All patients in a given physician’s practice were ran-
domised as a group (cluster randomisation) to avoid con-
tamination within a given physician’s practice”
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Low risk The baseline characteristics of patients and physicians were
similar across the groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk
Data used were electronic from outside sources (from
Medicare, PACE, inpatient and outpatient coding)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data; intention-to-treat analysis
Selective reporting (reporting bias) Low risk Primary and secondary outcomes reported. There is pub-
lished study protocol
Other bias Unclear risk Unclear if the participants were blinded
Stross 1985
Methods Study: Cluster-RCT
Participants Setting: Primary care
Country: USA
Participants: 6 communities in the state of Michigan: 3 were randomly selected to be
controls and 3 were designated as intervention communities. 6 educationally influential
physicians (EIs) recruited (1 in each community)
Interventions 1. Local opinion leaders’ education: self-study programme including textbook, audiovi-
sual materials and recent articles on osteoarthritis (distribution of educational material
and local opinion leaders)
The aim was to improve the management of patients with OA by focusing on the role
of intra-articular corticosteroids, physical therapy and joint replacement
2. Standard care: no educational package
Outcomes Total hip arthroplasties, use of intra-articular corticosteroids, use of physical therapy
Notes Conflicts of interest and sources of funding as declared by the authors: Supported by
Multipurpose Arthritis Center grant 2P 60
AM20557 from the National Institute of Arthritis, Diabetes, Digestive and Kidney
Diseases
Risk of bias Risk of bias
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Stross 1985 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear how the randomisation took place
Allocation concealment (selection bias) Unclear risk Not reported
Protection against contamination Low risk Contamination is less likely due to the randomisation at large
cluster level
Baseline outcomes similar Low risk There were no significant baseline differences between the
groups
Baseline characteristics similar Unclear risk Not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported, although datawere obtained fromhospital records
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) Unclear risk No published protocol of the study
Other bias Unclear risk It is not clear if the participants were blinded with regards to the
outcomes
Watson 2008
Methods Study design: Cluster-RCT
Participants Setting: Primary care
Country: UK
160 providers, 91 practices were randomised to training or not training, 155 patients
participated in the first part of the trial
Condition: Acute shoulder pain
Patients were eligible if:
1. they were presenting to GPs with pain in one or both shoulders for ≤12 months who
would otherwise have received a steroid injection from primary care.
2. had a clinical diagnosis of rotator cuff tendonitis based on both history of pain in the
deltoid area and pain during resisted active movement. Some mild restriction of passive
movement was acceptable.
3. were ≥ 16 yrs.
4. were able and willing to give informed consent.
Interventions 1. 60-minute lecture on shoulder disorders, handouts, training in injection techniques
(educational material + meeting)
2. Control (no educational intervention)
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Watson 2008 (Continued)
Outcomes Patient Outcomes: Shoulder pain assessed by 4 instruments: score on the British Shoulder
Disability Questionnaire (BSDQ), SF-36, EuroQol and three VAS (night, rest, move-
ment)
Notes The study had a second part testing whether cortisone injections were better than anaes-
thetic injections for rotator cuff problems (patients were randomised into 2 groups)
The study included a cost-effectiveness analysis
Conflicts of interest and sources of funding as declared by the authors: V.M. and J.W.
received salary from the
MRC research grant. J.D. has received travel grants from Pfizer, Wyeth, Novartis and
Napp and honoraria for tutorials from
Pfizer and Novartis. He has served on advisory boards for pharmaceutical companies
including GlaxoSmithKline, Wyeth,
Novartis and IDEA. All other authors have declared no conflicts of interest.This trial
was funded by the Medical Research Council
(grant number G0001147) and received support for the education seminars and training
events from Merck, Sharp and Dohme. The
MRC established a trial steering committee to advise the grant holders and trial team on
trial design, the collection, analysis,
interpretation and writing up of data and publication policy
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer generated sequence” used. Practices “were
stratified by area”
Allocation concealment (selection bias) High risk “Patients were not informed of the allocation.” But the
researchers were not blinded.
Protection against contamination Unclear risk Randomisation was at practice level but it is not clear if
practices of different groups could communicate between
themselves
Baseline outcomes similar Unclear risk Not reported
Baseline characteristics similar Low risk The participant baseline characteristics were reported and
were similar
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported; participants completed the pain-assessment
questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis was performed
Selective reporting (reporting bias) Unclear risk Not enough information is provided. The study protocol
has not been published
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Watson 2008 (Continued)
Other bias Unclear risk Unclear if participants were blinded with regards to the
outcomes.
CBA: controlled before-and-after
BMD: bone mineral density
HAD: Hamilton anxiety and depression
ITS: interrupted time series
LBP: low back pain
RCT: randomised controlled trial
USS: ultrasound scan
VAS: visual analogue scale
VDPQ: Vermont Disability Prediction Questionnaire
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ashe 2004 This was a small controlled trial; not all outcomes were reported and the measurement of the main outcome
(investigations for osteoporosis) was not well defined and not objectively measured or reported
Corson 2011 This was an organisational intervention and not a professional one according to the EPOC taxonomy
Fabiani 2004 Before-and-after study. 3 groups. There were no 2-intervention and 2-control groups
Feldstein 2007 Retrospective cohort study. No 2-intervention and 2-control groups
Garala 1999 CBA with no 2-intervention and 2-control groups
Gardner 2002 Retrospective cohort study in a hospital setting
Gardner 2005 The intervention was directed at patients and not their physicians
Glazier 2005 GPs not more than 50% of participants
Goldberg 2001 GPs not more than 50% of participants
Ioannidis 2008 Before-and-after study with no controls
Ioannidis 2009 2-year cohort study with no controls
McDonald 2003 Quasi-experimental with no controls
Nazareth 2002 Observational study, no control group
89Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Rolfe 2001 Pilot study, irrelevant topic (leg ulcer, persistent wheeze and stable angina)
Ruiz 2001 No objective measurement of primary outcomes
Solomon 2007b Only 1/3 of participants trained in family medicine
Vernacchio 2013 This was an ITS study addressed to paediatric physicians as opposed to general primary care physicians
CBA: controlled before-and-after
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D A T A A N D A N A L Y S E S
Comparison 1. Meta-analysis of osteoporosis studies evaluating physician and patient interventions versus usual
care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Bone Mineral Density 3 3386 Risk Ratio (M-H, Fixed, 95% CI) 4.44 [3.54, 5.55]
2 Osteoporosis medication 5 4223 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [1.50, 1.94]
Comparison 2. Meta-analysis of osteoporosis studies evaluating physician-only interventions versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Bone mineral density 2 3047 Risk Ratio (M-H, Fixed, 95% CI) 4.75 [3.62, 6.24]
2 Osteoporosis medication 2 3047 Risk Ratio (M-H, Fixed, 95% CI) 1.52 [1.26, 1.84]
Comparison 3. Meta-analysis of osteoporosis studies evaluating physician only interventions versus physician
and patient interventions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Bone mineral density 2 2995 Odds Ratio (M-H, Fixed, 95% CI) 0.93 [0.77, 1.12]
2 Medication 2 2995 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.79, 1.10]
91Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.1. Comparison 1 Meta-analysis of osteoporosis studies evaluating physician and patient
interventions versus usual care, Outcome 1 Bone Mineral Density.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 1 Meta-analysis of osteoporosis studies evaluating physician and patient interventions versus usual care
Outcome: 1 Bone Mineral Density
Study or subgroup Intervention Usual care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldstein 2006 36/110 2/103 2.5 % 16.85 [ 4.16, 68.23 ]
Leslie 2012 258/1421 58/1480 68.4 % 4.63 [ 3.52, 6.10 ]
Majumdar 2008 71/137 24/135 29.1 % 2.92 [ 1.96, 4.34 ]
Total (95% CI) 1668 1718 100.0 % 4.44 [ 3.54, 5.55 ]
Total events: 365 (Intervention), 84 (Usual care)
Heterogeneity: Chi2 = 7.89, df = 2 (P = 0.02); I2 =75%
Test for overall effect: Z = 13.01 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours usual care Favours intervention
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Analysis 1.2. Comparison 1 Meta-analysis of osteoporosis studies evaluating physician and patient
interventions versus usual care, Outcome 2 Osteoporosis medication.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 1 Meta-analysis of osteoporosis studies evaluating physician and patient interventions versus usual care
Outcome: 2 Osteoporosis medication
Study or subgroup Intervention Usual care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ciaschini 2010 29/52 16/60 5.2 % 2.09 [ 1.29, 3.39 ]
Feldstein 2006 22/110 5/103 1.8 % 4.12 [ 1.62, 10.47 ]
Leslie 2012 234/1421 157/1480 53.6 % 1.55 [ 1.29, 1.87 ]
Majumdar 2008 30/137 10/135 3.5 % 2.96 [ 1.51, 5.81 ]
Roux 2013 307/526 71/199 35.9 % 1.64 [ 1.34, 2.00 ]
Total (95% CI) 2246 1977 100.0 % 1.71 [ 1.50, 1.94 ]
Total events: 622 (Intervention), 259 (Usual care)
Heterogeneity: Chi2 = 7.79, df = 4 (P = 0.10); I2 =49%
Test for overall effect: Z = 8.10 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours usual care Favours intervention
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Analysis 2.1. Comparison 2 Meta-analysis of osteoporosis studies evaluating physician-only interventions
versus usual care, Outcome 1 Bone mineral density.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 2 Meta-analysis of osteoporosis studies evaluating physician-only interventions versus usual care
Outcome: 1 Bone mineral density
Study or subgroup Intervention Usual care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldstein 2006 40/101 2/103 3.4 % 20.40 [ 5.06, 82.16 ]
Leslie 2012 224/1363 58/1480 96.6 % 4.19 [ 3.17, 5.54 ]
Total (95% CI) 1464 1583 100.0 % 4.75 [ 3.62, 6.24 ]
Total events: 264 (Intervention), 60 (Usual care)
Heterogeneity: Chi2 = 4.97, df = 1 (P = 0.03); I2 =80%
Test for overall effect: Z = 11.23 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours usual care Favours intervention
Analysis 2.2. Comparison 2 Meta-analysis of osteoporosis studies evaluating physician-only interventions
versus usual care, Outcome 2 Osteoporosis medication.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 2 Meta-analysis of osteoporosis studies evaluating physician-only interventions versus usual care
Outcome: 2 Osteoporosis medication
Study or subgroup Intervention Usual care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldstein 2006 28/101 5/103 3.2 % 5.71 [ 2.30, 14.20 ]
Leslie 2012 200/1363 157/1480 96.8 % 1.38 [ 1.14, 1.68 ]
Total (95% CI) 1464 1583 100.0 % 1.52 [ 1.26, 1.84 ]
Total events: 228 (Intervention), 162 (Usual care)
Heterogeneity: Chi2 = 9.00, df = 1 (P = 0.003); I2 =89%
Test for overall effect: Z = 4.35 (P = 0.000014)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours usual care Favours intervention
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Analysis 3.1. Comparison 3 Meta-analysis of osteoporosis studies evaluating physician only interventions
versus physician and patient interventions, Outcome 1 Bone mineral density.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 3 Meta-analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions
Outcome: 1 Bone mineral density
Study or subgroup Physician only Physician and patient Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldstein 2006 40/101 36/110 9.0 % 1.35 [ 0.77, 2.37 ]
Leslie 2012 224/1363 258/1421 91.0 % 0.89 [ 0.73, 1.08 ]
Total (95% CI) 1464 1531 100.0 % 0.93 [ 0.77, 1.12 ]
Total events: 264 (Physician only), 294 (Physician and patient)
Heterogeneity: Chi2 = 1.89, df = 1 (P = 0.17); I2 =47%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours physician+patient Favours physician only
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Analysis 3.2. Comparison 3 Meta-analysis of osteoporosis studies evaluating physician only interventions
versus physician and patient interventions, Outcome 2 Medication.
Review: Professional interventions for general practitioners on the management of musculoskeletal conditions
Comparison: 3 Meta-analysis of osteoporosis studies evaluating physician only interventions versus physician and patient interventions
Outcome: 2 Medication
Study or subgroup Physician only Physician and patient Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldstein 2006 28/101 22/110 8.4 % 1.39 [ 0.85, 2.26 ]
Leslie 2012 200/1363 234/1421 91.6 % 0.89 [ 0.75, 1.06 ]
Total (95% CI) 1464 1531 100.0 % 0.93 [ 0.79, 1.10 ]
Total events: 228 (Physician only), 256 (Physician and patient)
Heterogeneity: Chi2 = 2.79, df = 1 (P = 0.09); I2 =64%
Test for overall effect: Z = 0.84 (P = 0.40)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours physician+patient Favours physician only
A D D I T I O N A L T A B L E S
Table 1. Classification of relevant interventions from EPOC taxonomy
Table 1: Classification of relevant interventions from EPOC taxonomy Table 1: Classification
Intervention Description
Distribution of educational materials Distribution of published or printed recommendations for clin-
ical care, including clinical practice guidelines, audio-visual ma-
terials and electronic publications. The materials may have been
delivered personally or through mass mailings
Educational meetings Healthcare providers who have participated in conferences, lec-
tures, workshops or traineeships
Local consensus processes Inclusion of participating providers in discussion to ensure that
they agreed that the chosen clinical problem was important and
the approach to managing the problem was appropriate
Educational outreach visits Use of a trained person who met with providers in their prac-
tice settings to give information with the intent of changing the
provider’s practice. The information given may have included
feedback on the performance of the provider(s)
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Table 1. Classification of relevant interventions from EPOC taxonomy (Continued)
Local opinion leaders Use of providers nominated by their colleagues as ‘educationally
influential’. The investigatorsmust have explicitly stated that their
colleagues identified the opinion leaders
Patient-mediated New clinical information (not previously available) collected di-
rectly frompatients and given to the provider e.g. depression scores
from an instrument
Audit and feedback Any summary of clinical performance of health care over a speci-
fied period of time. The summary may also have included recom-
mendations for clinical action. The information may have been
obtained frommedical records, computerised databases, or obser-
vations from patients
Reminders Patient or encounter specific information, provided verbally, on
paper or on a computer screen, which is designed or intended to
prompt a health professional to recall information. This would
usually be encountered through their general education; in the
medical records or through interactions with peers, and so remind
them to perform or avoid some action to aid individual patient
care. Computer aided decision support and drugs dosage are
included
Marketing Use of personal interviewing, group discussion (‘focus groups’)
, or a survey of targeted providers to identify barriers to change
and subsequent design of an intervention that addresses identified
barriers
Mass media (i) Varied use of communication that reached great numbers of
people including television, radio, newspapers, posters, leaflets,
and booklets, alone or in conjunction with other interventions;
(ii) Targeted at the population level
Other Patient-directed (education and reminders to see their primary
care physician)
Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional)
Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional) Table 2. Intervention
Intervention methods 1,2 No. of Studies Studies 3
Distribution of educational materials 27 Becker 2008; Bessette 2011; Bishop 2006; Boyd 2002; Broadhurst
2007; Chassany 2006; Ciaschini 2010; Cranney 2008; Dey 2004;
Eccles 2001; Engers 2005; Feldstein 2006; French 2013; Hazard
1997;Hollingworth 2002; Kerry 2000; Leslie 2012;Majumdar 2008;
Rahme 2005; Robling 2002; Rosemann 2007; Roux 2013; Rozental
2008; Schectman 2003; Solomon 2007a; Stross 1985; Watson 2008
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Table 2. Intervention types used in each study (N.B. All interventions evaluated were professional) (Continued)
Educational meetings 10 Becker 2008; Chassany 2006; Engers 2005; French 2013; Gormley
2003; Huas 2006; Rahme 2005; Rosemann 2007; Schectman 2003,
Watson 2008
Local consensus processes 0
Educational outreach visits 6 Becker 2008; Broadhurst 2007; Dey 2004; Robling 2002; Schectman
2003; Solomon 2007a
Local opinion leaders 3 Majumdar 2008; Stross 1985; Schectman 2003
Patient-mediated 6 Boyd 2002; Ciaschini 2010; Cranney 2008; Huas 2006; Roux 2013;
Rozental 2008
Audit and feedback 4 Eccles 2001; Kerry 2000; Robling 2002; Schectman 2003
Reminders 11 Bishop 2006; Ciaschini 2010; Cranney 2008; Eccles 2001; Feldstein
2006;Hazard 1997; Lafata 2007; Leslie 2012;Majumdar 2008; Roux
2013; Rozental 2008
Marketing 0
Mass media 0
Patient-directed4 12 Becker 2008; Bessette 2011; Bishop 2006; Leslie 2012; Ciaschini
2010; Cranney 2008; Feldstein 2006; Lafata 2007; Majumdar 2008;
Rosemann 2007; Roux 2013; Solomon 2007a
1. Category of intervention as classified by the EPOC taxonomy EPOC 2007 [9]
2. See Table 1 for definition of each intervention
3. Some studies used more than one intervention type and these are listed against their corresponding category
4. Patient-directed interventions targeted patients and included patient education and reminders to see their primary-care physician.
These were included in the review only if they were a component of a professional intervention targeting primary-care physicians
1. Category of inter
2. See Table 1 for
3. Some studies used
4. Patient-directed
These were included
Table 3. Intervention combinations compared to a no-intervention control group
Table 3. Intervention combinations compared to a no-intervention control group Table 3. Intervention
Intervention combinations No. of comparisons Study ID
Single component interventions:
Distribution of educational materials 1 Rahme 2005
Patient-directed 3 Lafata 2007; Leslie 2012; Solomon 2007a
Educational meetings, workshops 1 Rahme 2005
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Table 3. Intervention combinations compared to a no-intervention control group (Continued)
Multifaceted interventions: Two inter-
vention components
Distribution of educational material +
reminders
4 Bishop 2006; Feldstein 2006; Hazard 1997; Leslie 2012
Distribution of educational material +
educational outreach visits
4 Broadhurst 2007; Chassany 2006; Dey 2004; Solomon 2007a
Distribution of educational material +
educational meeting/workshop
6 Chassany 2006; Engers 2005; French 2013; Rahme 2005;
Rosemann 2007; Watson 2008
Distribution of educational material +
local opinion leaders
1 Stross 1985
Distribution of educational material +
audit/feedback
1 Kerry 2000
Patient-mediated + educational meet-
ing/workshop
1 Huas 2006
Patient-directed +reminder 1 Lafata 2007
Patient-directed + educational material 1 Bessette 2011
Multifaceted interventions: Three inter-
vention components
Patient-directed + educational material
+ reminder
3 Bishop 2006; Feldstein 2006, Leslie 2012
Patient-directed + educational material
+ educational meeting/workshop
1 Rosemann 2007
Patient-directed + educational material
+ educational outreach visit
1 Solomon 2007a
Multifaceted interventions: Four inter-
vention components
Patient-directed + distribution of educa-
tional material + reminder + local opin-
ion leaders
1 Majumdar 2008
Patient-mediated + distribution of edu-
cational material + reminders + patient-
directed (education and reminders)
3 Ciaschini 2010; Cranney 2008; Roux 2013
99Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Intervention combinations compared to a no-intervention control group (Continued)
Multifaceted interventions: Five inter-
vention components
Distribution of educational material +
educationalmeetings/workshops + audit
+ educational outreach visit + local opin-
ion leaders
1 Schectman 2003
Table 4. Intervention combinations compared to a different intervention
Table 4. Intervention combinations compared to a different intervention Table 4. Intervention
Intervention combinations No. of comparisons Study ID
Single component interventions:
Educational meetings/workshops vs dis-
tribution of educational material
1 Rahme 2005
Educational meetings/workshops vs a
different educational meeting/workshop
1 Gormley 2003
Multifaceted interventions: Two inter-
vention components
Distribution of educational material +
patient-mediated vs the same interven-
tion but less intensive
1 Boyd 2002
Distribution of educational material +
educational outreach visit vs distribu-
tion of educational material
1 Robling 2002
Distribution of educational material +
audit vs distribution of educational ma-
terial
2 Robling 2002; Eccles 2001
Distribution of educational material +
audit vs distribution of educational ma-
terial + reminder
1 Eccles 2001
Distribution of educational material +
outreach vs distribution of educational
material + audit
1 Robling 2002
Distribution of educational material +
educational outreach visit vs patient-di-
rected
1 Solomon 2007a
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Table 4. Intervention combinations compared to a different intervention (Continued)
Distribution of educational material +
patient-directed vs the same (more in-
tensive)
1 Bessette 2011
Patient-directed + reminder vs patient-
directed
1 Lafata 2007
Distribution of educational material +
reminder vs distribution of educational
material
1 Eccles 2001
Distribution of educational material +
reminder vs patient-mediated
1 Rozental 2008
Distribution of educational material +
educational meeting/workshop vs edu-
cational meeting/workshop
1 Rahme 2005
Distribution of educational material +
educational meeting/workshop vs distri-
bution of educational material
1 Rahme 2005
Multifaceted interventions: Three inter-
vention components
Distribution of educational material +
reminders + patient-directed vs distribu-
tion of educational material + reminders
2 Bishop 2006; Feldstein 2006
Distribution of educational material +
reminder + patient-directed vs patient-
directed
1 Leslie 2012
Distribution of educational material +
audit + reminders vs distribution of ed-
ucational material
1 Eccles 2001
Distribution of educational material +
audit + reminders vs distribution of ed-
ucational material + audit
1 Eccles 2001
Distribution of educational material +
audit + reminders vs distribution of ed-
ucational material + reminders
Eccles 2001
Distribution of educational material +
audit + outreach vs distribution of edu-
cational material + outreach
1 Robling 2002
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Table 4. Intervention combinations compared to a different intervention (Continued)
Distribution of educational material +
audit + outreach vs distribution of edu-
cational material + audit
1 Robling 2002
Distribution of educational material +
audit + outreach vs distribution of edu-
cational material
1 Robling 2002
Distribution of educational material +
educational meetings/workshops + edu-
cational outreach visits vs distribution of
educational material
1 Becker 2008
Distribution of educational material +
educational outreach visit + patient-di-
rected vs patient-directed
1 Solomon 2007a
Distribution of educational material +
educational outreach visit + patient-di-
rected vs distribution of educational ma-
terial + educational outreach visit
1 Solomon 2007a
Distribution of educational material +
educational meeting/workshop + pa-
tient-directed vs distribution of educa-
tional material + educational meeting/
workshop
1 Rosemann 2007
Multifaceted interventions: Four inter-
vention components
Distribution of educational material +
educational meetings/workshops + ed-
ucational outreach visits + patient-di-
rected vs distribution of educational ma-
terial
1 Becker 2008
Distribution of educational material +
educational meetings/workshops +edu-
cational outreach visits + patient di-
rected vs distribution of educational ma-
terial + educational meetings/workshops
+ educational outreach visits
1 Becker 2008
Patient-mediated + distribution of edu-
cationmaterial + reminders + patient-di-
rected (education and reminders) vs pa-
tient-mediated + distribution of educa-
tion material + reminders + patient-di-
1 Roux 2013
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Table 4. Intervention combinations compared to a different intervention (Continued)
rected (education and reminders)
Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data
(Study)
Interven-
tion
Int pre (%)
1
C pre (%)2 Int post (%)
3
C post (%)4 ARD 5 Risk
difference 6
(Pvalueif reportedbyauthors)
Relative %
change post 7
Risk ratio 8
(Bessette
2011)∗
Patient ed-
ucation and
reminder to
see
their physi-
cian (patient
directed)
, education
of physician
via the pa-
tient (distri-
bu-
tion of edu-
cational ma-
terial)
- - 14.72% 11.96% - 2.8% 23% 1.2
(Bessette
2011)∗
Patient edu-
ca-
tion (includ-
ing video on
osteo-
porosis) and
reminder to
see
their physi-
cian, educa-
tion
of physician
via the pa-
tient (distri-
bu-
tion of edu-
cational ma-
terial)
- - 15.81% 11.96% - 3.9% 32% 1.3
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Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data (Continued)
(Cranney
2008)**
Patient-spe-
cific mailed
letter to pri-
mary are
physi-
cian (includ-
ing guide-
lines) and
patient ed-
ucation and
reminder
- - 64/125
(51%)
36/145
(25%)
- 26.4%
(P< 0.0001)
106% 2.1
(Feldstein
2006)
Patient-spe-
cific Elec-
tronic Med-
ical Record
(EMR)
reminders to
primary-
care
provider in-
forming
them of pa-
tient in-
creased risk
and
guidelines.
Sent twice
- - 40/101 (39.
6%)
2/103 (1.
9%)
- 37.7%
(P< 0.01)
1940% 20.4
(Feldstein
2006)
EMR re-
minder plus
patient-di-
rected inter-
vention: ed-
ucation and
reminder
- - 36/110 (32.
7%)
2/103 (1.
9%)
- 30.8%
(P< 0.01)
1585% 16.9
(Lafata
2007)**
Patient-
directed: 2
mailings
(edu-
- - 720/3367
(21.4%)
313/2901
(10.8%)
- 10.6%
(P< 0.001)
98% 2
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Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data (Continued)
cational and
reminders)
(Lafata
2007)**
Physician
prompt:
Elec-
tronic Med-
ical Record
(EMR)
reminder to
physi-
cian and bi-
weekly mail-
ing
plus patient-
directed: 2
mailings
(edu-
cational and
reminders)
- - 1181/4086
(28.9%)
313/2901
(10.8%)
- 18.1%
(P< 0.001)
168% 2.7
(Leslie
2012)
Physician re-
minder plus
educational
material
224/1363
(16.4%)
58/1480 (3.
9%)
- 12.5% 319% 4.2
(Leslie
2012)
Physician re-
minder plus
educa-
tional mate-
rial plus pa-
tient-di-
rected inter-
vention (re-
minder
to see their
physician)
- - 258/1421
(18.2%)
58/1480 (3.
9%)
- 14.2% 363% 4.6
(Majumdar
2008)
Patient edu-
ca-
tion, physi-
cian patient-
- - 71/137 (51.
8%)
24/135 (17.
8%)
- 34%
(P< 0.001)
192% 2.9
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Table 5. Osteoporosis studies: intervention versus no intervention (control), outcome: BMD, dichotomous data (Continued)
specific
reminders
by mail/fax,
physician
guidelines
endorsed by
opinion
leaders
(Solomon
2007a)**
Patient
directed (3
mailed
letters edu-
cational)
- - 249/3274
(7.6%)
224/3268
(6.9%)
- 0.8%
(NS)
11% 1.1
(Solomon
2007a)**
Physi-
cian educa-
tion follow-
ing an aca-
demic-
detailing ap-
proach
- - 183/3574
(5.1%)
224/3268
(6.9%)
- -1.7%
(NS)
-25% 0.7
(Solomon
2007b)**
Com-
bination of
both physi-
cian and pa-
tient educa-
tion
- - 223/3339
(6.7%)
224/3268
(6.9%)
- -0.2%
(NS)
-3% 1
1. Intervention group pre-intervention proportion
2. Control group pre-intervention proportion
3. Intervention group post-intervention proportion
4. Control group post-intervention proportion
5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a
positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int post (%) minus C post (%). This is considered to be “small”
if≤ 5%, “modest” if > 5% and≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been adjusted
so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int post (%) divided by C post (%)
BMD: bone mineral density; C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant
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* In the study by Bessette 2011, the outcomes reported above include the participants with a diagnosis following the intervention. The
women were considered “diagnosed” if they received a BMD test, if they were informed by their physician that they were suffering
from osteoporosis and/or if they were initiated on osteoporosis medication. Therefore, the above percentages do not necessarily mean
that the women received a BMD test.
** The data reported above for the studies by Cranney 2008, Lafata 2007 and Solomon 2007b does not account for clustering. We did
not have access to sufficient information to adjust the data for clustering.
Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data
(Study)
Interven-
tion
Int pre (%)
1
C pre (%)2 Int post (%)
3
C post (%)4 ARD 5 Risk
difference 6
(Pvalueif reportedbyauthors)
Relative %
change post 7
Risk ratio 8
(Bessette
2011)
Patient edu-
ca-
tion (patient
directed),
education of
physi-
cian via the
patient (for
group of pa-
tients with-
out diagno-
sis or treat-
ment at ran-
domisation)
- - 11.79% 7.78% - 4% 52% 1.5
(Bessette
2011)
Patient ed-
ucation (in-
cluding
video on os-
teoporosis),
education of
physi-
cian via the
patient (for
group of pa-
tients with-
out diagno-
sis or treat-
ment at ran-
domisation)
- - 10.64% 7.78% - 2.9% 37% 1.4
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
(Bessette
2011)
Patient edu-
ca-
tion (patient
directed),
education of
physi-
cian via the
patient (for
group of pa-
tients with-
out treat-
ment at ran-
domisation)
- - 13.49% 10.31% - 3.2% 31% 1.3
(Bessette
2011)
Patient ed-
ucation (in-
cluding
video on os-
teoporosis),
education of
physi-
cian via the
patient (for
group of pa-
tients with-
out treat-
ment at ran-
domisation)
- - 12.71% 10.31% - 2.4% 23% 1.2
(Bessette
2011)
Patient edu-
cation, edu-
cation
of physician
via the pa-
tient where
the patient
did pass
the informa-
tion on
to the physi-
cian (for
group of pa-
tients with-
- - 15% 10% - 5% 50% 1.5
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
out treat-
ment at ran-
domisation)
(Ciaschini
2010)
Patient-
specific evi-
dence-based
recommen-
dations tar-
geted to im-
prove osteo-
poro-
sis treatment
to both the
patients and
their pri-
mary-care
providers
- - 29/52 (55.
8%)
16/60 (26.
7%)
- 29.1% 109% 2.1
(Cranney
2008)*
Patient-spe-
cific mailed
letter to pri-
mary are
physi-
cian (includ-
ing guide-
lines) and
patient ed-
ucation and
reminder
- - 35/125
(28%)
15/145 (10.
3%)
- 17.7%
(P=0.0002)
171% 2.7
(Feldstein
2006)
Patient-spe-
cific Elec-
tronic Med-
ical Record
(EMR)
reminders to
primary-
care
provider in-
forming
them of pa-
tient in-
- - 28/101 (27.
7%)
5/103 (5%) - 22.9%
(P< 0.01)
471% 5.7
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
creased risk
and
guidelines.
Sent twice
(Feldstein
2006)
EMR re-
minder plus
patient-di-
rected inter-
vention: ed-
ucation and
reminder
- - 22/110 (20.
2%)
5/103 (5%) - 15.1%
(P< 0.01)
312% 4.1
(Lafata
2007)*
Patient-
directed: x2
mailings
(edu-
cational and
reminders)
- - 11/128 (8.
6%)
3/51 (5.9%) - 2.7% 46% 1.5
(Lafata
2007)*
Physician
prompt:
Elec-
tronic Med-
ical Record
(EMR)
reminder to
physi-
cian and bi-
weekly mail-
ing
plus Patient-
directed: 2
mailings
(edu-
cational and
reminders)
- - 15/162 (9.
3%)
3/51 (5.9%) - 3.4% 57% 1.6
(Leslie
2012)
Physician re-
minder plus
educational
material
- - 200/1363
(14.7%)
157/1480
(10.6%)
- 4.1% 38% 1.4
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
(Leslie
2012)
Physician re-
minder plus
educa-
tional mate-
rial plus pa-
tient-di-
rected inter-
vention (re-
minder
to see their
physician)
- - 234/1421
(16.5%)
157/1480
(10.6%)
- 5.9% 55% 1.6
(Majumdar
2008)
Patient edu-
ca-
tion, physi-
cian patient-
specific
reminders
by mail/fax,
physician
guidelines
endorsed by
opinion
leaders
- - 30/137 (21.
9%)
10/135 (7.
4%)
- 14.5%
(P<0.001)
196% 3
(Roux
2013)
Ver-
bal and writ-
ten informa-
tion on os-
teoporosis to
pa-
tient and let-
ter with spe-
cific man-
agement
plan sent to
their treat-
ing physi-
cian. Patient
reminders at
6 and
12 months.
82/275 (29.
8%)
45/199 (22.
6%)
151/275
(54.9%)
71/199 (35.
7%)
12% 19.2%
(P< 0.005)
54% 1.5
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
Reminder to
physician if
patient un-
treated at 6
months
(Roux
2013)
Ver-
bal and writ-
ten informa-
tion on os-
teoporosis to
pa-
tient and let-
ter with spe-
cific man-
agement
plan sent to
their treat-
ing physi-
cian. Blood
tests and
BMD test
ordered for
patient and
results sent
to the physi-
cian. Patient
reminders at
4,8 and 12
months and
physician re-
minders at 4
and 8
months
if patient re-
mained un-
treated
65/251 (25.
9%)
45/199 (22.
6%)
156/251
(62.2%)
71/199 (35.
7%)
23.2% 26.5%
(P< 0.005)
74% 1.7
(Solomon
2007a)*
Patient
directed (x3
mailed
letters edu-
cational)
- - 208/3274
(6.4%)
231/3268
(7.1%)
- -0.7% -10% 0.9
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Table 6. Osteoporosis studies, intervention versus no intervention (control), outcome:osteoporosis medication, dichotomous
data (Continued)
(Solomon
2007a)*
Physi-
cian educa-
tion follow-
ing
an academic
detailing ap-
proach
- - 197/3574
(5.5%)
231/3268
(7.1%)
- -1.6% -22% 0.8
(Solomon
2007a)*
Com-
bination of
both physi-
cian and pa-
tient educa-
tion
- - 236/3339
(7.1%)
231/3268
(7.1%)
- 0 0 1
1. Intervention group pre-intervention proportion
2. Control group pre-intervention proportion
3. Intervention group post-intervention proportion
4. Control group post-intervention proportion
5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a
positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int post (%) minus C post (%). This is considered to be “small”
if≤ 5%, “modest” if > 5% and≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been adjusted
so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int post (%) divided by C post (%)
BMD: bone mineral density; C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant
* The data reported above for the studies by Cranney 2008, Lafata 2007 and Solomon 2007b does not account for clustering. We did
not have access to sufficient information to adjust the data for clustering.
Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data
(Study)
Interven-
tions
Int 1 pre
(%) 1
Int 2 pre
(%)2
Int 1 post
(%)3
Int 2 post
(%)4
ARD 5 Risk
difference6
(Pvalueif reportedbyauthors)
Relative %
change post 7
Risk ratio 8
(Bessette
2011)*
Patient edu-
cation, edu-
cation
of physician
14.72% 15.81% -1.1% -7% 0.9
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Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data (Continued)
via the pa-
tient,
reminder to
fam-
ily physician
versus Pa-
tient educa-
tion (includ-
ing video on
osteo-
porosis), ed-
ucation
of physician
via the pa-
tient,
reminder to
family
physician
(Boyd 2002)
Patient-spe-
cific letter to
primary care
physician
contain-
ing informa-
tion on re-
sults
and recom-
menda-
tions: stan-
dard versus
extended
letter
- - 25/83 (30.
1%)
29/78 (37.
2%)
- -7.1% -19% 0.8
(Feldstein
2007)
Patient-spe-
cific Elec-
tronic Med-
ical Record
(EMR)
reminders to
primary-
care
provider in-
forming
them of pa-
tient in-
- - 40/101 (39.
6%)
36/110
(32.7%)
- 6.9% 21% 1.2
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Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data (Continued)
creased risk
and
guidelines
(sent twice)
versus EMR
plus patient-
di-
rected inter-
vention (ed-
ucation and
reminder)
(Lafata
2007)**
Patient-
directed:
2 mailings
(educa-
tional and
reminders)
versus
physician
prompt:
Electronic
Medical
Record
(EMR)
reminder
to physi-
cian and
biweekly
mailing plus
patient-
directed:
2 mailings
(educa-
tional and
reminders)
- - 720/3367
(21.4%)
1181/4086
(28.9%)
- -7.5% -26% 0.7
(Leslie
2012)
Physician re-
minder plus
edu-
cational ma-
terial versus
physician re-
minder plus
educa-
tional mate-
- - 224/1363
(16.4%)
258/1421
(18.2%)
- -1.7%
(NS)
-9% 0.9
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Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data (Continued)
rial plus pa-
tient-di-
rected inter-
vention (re-
minder
to see their
physician)
(Rozental
2008)
Patient-spe-
cific letter to
primary-
care physi-
cian out-
lining guide-
lines versus
orthopaedic
sur-
geon order-
ing BMD
and for-
warding re-
sults to pri-
mary-care
physician
7/23 (30.
4%)
25/27(92.
6%)
- -62.2% -67% 0.3
(Solomon
2007a)**
Patient-
directed (3
mailed let-
ters educa-
tional) ver-
sus physi-
cian educa-
tion follow-
ing an aca-
demic-
detailing ap-
proach
- - 249/3274
(7.6%)
183/3574
(5.1%)
- 2.5% 49% 1.5
(Solomon
2007a)**
Patient-
directed (3
mailed
letters edu-
cational)
- - 249/3274
(7.6%)
223/3339
(6.7%)
- 0.9% 14% 1.1
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Table 7. Osteoporosis studies intervention versus another intervention, outcome: BMD, dichotomous data (Continued)
versus com-
bination of
both physi-
cian and pa-
tient educa-
tion
(Solomon
2007a)**
Physi-
cian educa-
tion follow-
ing an aca-
demic-
detailing ap-
proach
versus com-
bination of
both physi-
cian and pa-
tient educa-
tion
- - 183/3574
(5.1%)
223/3339
(6.7%)
- -1.6% -23% 0.8
1. Intervention 1 group pre-intervention proportion
2. Intervention 2 group pre-intervention proportion
3. Intervention 1 group post-intervention proportion
4. Intervention 2 group post-intervention proportion
5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted
so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be
“small” if ≤ 5%, “modest” if > 5% and ≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome.
7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a
positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)
BMD: bone mineral density; Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant
* In the study by Bessette 2011, the outcomes reported above include the participants with a diagnosis following the intervention. The
women were considered “diagnosed” if they received a BMD test, if they were informed by their physician that they were suffering
from osteoporosis and/or if they were initiated on osteoporosis medication. Therefore, the above percentages do not necessarily mean
that the women received a BMD test.
**The data reported above for the studies by Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access
to sufficient information to adjust the data for clustering.
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Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Study)
Interven-
tions
Int 1 pre
(%) 1
Int 2 pre
(%)2
Int 1 post
(%)3
Int 2 post
(%)4
ARD 5 Risk
difference 6
(Pvalueif reportedbyauthors)
Relative %
change post 7
Risk ratio 8
(Bessette
2011)
Patient
education,
education
of physician
via the
patient,
reminder
to family
physician
(for group
of patients
without
diagnosis or
treatment at
randomisa-
tion) versus
Patient
education
(including
video on os-
teoporosis)
, education
of physician
via the
patient,
reminder
to family
physician
(for group
of patients
without di-
agnosis and
treatment at
randomisa-
tion)
- - 11.79% 10.64% - 1.2% 11% 1.1
(Bessette
2011)
Patient
education,
education
of physician
- - 13.49% 12.71% - 0.8% 6% 1.1
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Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Continued)
via the
patient,
reminder
to family
physician
(for group
of patients
without
diagnosis or
treatment at
randomisa-
tion) versus
Patient
education
(including
video on os-
teoporosis)
, education
of physician
via the
patient,
reminder
to family
physician
(for group
of patients
without
treatment at
randomisa-
tion)
(Boyd 2002)
Patient-spe-
cific letter to
primary care
physician
contain-
ing informa-
tion on re-
sults
and recom-
menda-
tions: stan-
dard versus
extended
letter
- - 11/104 (10.
6%)
14/93 (15.
1%)
- -4.5% -30% 0.7
(Feldstein
2007)
- - 28/101 (27.
7%)
22/110
(20%)
- 7.7% 39% 1.4
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Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Continued)
Patient spe-
cific Elec-
tronic Med-
ical Record
(EMR)
reminders to
primary care
provider in-
forming
them of pa-
tient in-
creased risk
and
guidelines
(sent twice)
versus EMR
plus patient-
di-
rected inter-
vention (ed-
ucation and
reminder)
(Lafata
2007)*
Patient-
directed:
2 mailings
(educa-
tional and
reminders)
versus
physician
prompt:
Electronic
Medical
Record
(EMR)
reminder
to physi-
cian and
biweekly
mailing plus
patient-
directed:
2 mailings
(educa-
tional and
reminders)
- - 11/128 (8.
6%)
15/162 (9.
3%)
- -0.7% -7% 0.9
120Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Continued)
(Leslie
2012)
Physician re-
minder plus
edu-
cational ma-
terial versus
physician re-
minder plus
educa-
tional mate-
rial plus pa-
tient-di-
rected inter-
vention (re-
minder
to see their
physician)
- - 200/1363
(14.7%)
234/1421
(16.5%)
- -1.8%
(NS)
-11% 0.9
(Roux
2013)
Verbal and
written
informa-
tion on
osteoporosis
to patient
and letter
with specific
manage-
ment plan
sent to their
treating
physician.
Patient
reminders
at 6 and
12 months.
Reminder
to physician
if patient
untreated at
6 months
versus
verbal and
written
informa-
tion on
82/275 (29.
8%)
65/251 (25.
9%)
151/275
(54.9%)
156/251
(62.2%)
-11.2% -7.2%
(P<0.001)
-12% 0.9
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Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Continued)
osteoporosis
to patient
and letter
with specific
manage-
ment plan
sent to their
treating
physician.
Blood tests
and BMD
test ordered
for patient
and results
sent to the
physician.
Patient
reminders at
4,8 and 12
months and
physician
reminders
at 4 and
8 months
if patient
remained
untreated
(Rozental
2008)
Patient spe-
cific letter to
primary care
physician
out-
lining guide-
lines versus
orthopaedic
sur-
geon order-
ing BMD
and for-
warding re-
sults to pri-
mary-care
physician
6/23 (26.
1%)
20/27(74.
1%)
- -48% -65% 0.4
(Solomon
2007a)*
- - 208/3274
(6.4%)
197/3574
(5.5%)
- 0.8% 15% 1.2
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Table 8. Osteoporosis studies, intervention versus another intervention, outcome: osteoporosis medication, dichotomous data
(Continued)
Patient
directed (x3
mailed let-
ters educa-
tional) ver-
sus physi-
cian educa-
tion follow-
ing
an academic
detailing ap-
proach
(Solomon
2007a)*
Patient
directed (x3
mailed
letters edu-
cational)
versus com-
bination of
both physi-
cian and pa-
tient educa-
tion
- - 208/3274
(6.4%)
236/3339
(7.1%)
- -0.7% -10% 0.9
(Solomon
2007a)*
Physi-
cian educa-
tion follow-
ing
an academic
detailing ap-
proach
versus com-
bination of
both physi-
cian and pa-
tient educa-
tion
- - 197/3574
(5.5%)
236/3339
(7.1%)
- -1.6% -22% 0.8
1. Intervention 1 group pre-intervention proportion
2. Intervention 2 group pre-intervention proportion
3. Intervention 1 group post-intervention proportion
4. Intervention 2 group post-intervention proportion
5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted
so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
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6. Risk Difference (RD) is the absolute % change post-intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be
“small” if ≤ 5%, “modest” if > 5% and ≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome.
7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a
positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)
BMD: bone mineral density; Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: Adjusted risk difference;NS: not significant
* The data reported above for the studies by Lafata 2007 and Solomon 2007b does not account for clustering. We did not have access
to sufficient information to adjust the data for clustering.
Table 9. Low back pain studies, intervention versus control, dichotomous data
(Study)
Interven-
tion
Outcome Int pre
(%) 1
C pre (%)
2
Int post
(%)3
C post
(%)4
ARD 5 Risk differ-
ence 6
(Pvalueif reportedbyauthors)
Relative %
change
post 7
Risk ratio 8
(Bishop
2006)
Physician
education
(guide-
lines) and
3 patient-
specific re-
minder let-
ters
Education
and reas-
surance ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 10% (16/
162)
7% (10/
149)
3.2% 47% 1.5
Exercise
ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 38% (62/
162)
43% (64/
149)
-4.7% -11% 0.9
Appropri-
ate medi-
cation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 85% (138/
162)
77% (115/
149)
8%
(P=0.14)
10% 1.1
Spinal ma-
nip-
ulation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 2.5% (4/
162)
6% (9/
149)
-3.6% -59% 0.4
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
Guideline-
discordant
physician
recom-
mended
treatment
0 - 4 weeks
post-onset
- - 10% (16/
162)
17% (25/
149)
6.9%
(P=0.05)
41% 0.6
Super-
vised exer-
cise pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
post-
onset)
- - 19% (29/
154)
14% (21/
149)
4.7%
(P=0.11)
34% 1.3
Return to
work (rec-
om-
mended
treatment
5
- 12 weeks
post-
onset)
- - 24% (37/
154)
17% (25/
149)
7.2%
(P=0.18)
43% 1.4
Refer
to interdis-
ciplinary
pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
post-
onset)
- - 4% (6/
154)
2% (3/
149)
1.9% 94% 1.9
Physio-
therapy > 4
weeks
(guideline-
discor-
- - 41% (63/
154)
43% (64/
149)
2% 5% 1
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
dant)
Contin-
ued use of
spinal ma-
nipu-
lation ther-
apy (guide-
line-dis-
cordant)
- - -(no data
available)
33% (49/
149)
-
(P=0.04)
-
(Bishop
2006)
Physician
education,
reminders
and also
patient ed-
uca-
tion and 3
reminders
Education
and reas-
surance ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 6% (9/
151)
7% (10/
149)
-0.8% -11% 0.9
Exercise
ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 53% (80/
151)
43% (64/
149)
10%
(P=0.05)
23% 1.2
Appropri-
ate medi-
cation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 81% (122/
151)
77% (115/
149)
3.6%
(P=0.08)
5% 1
Spinal ma-
nip-
ulation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 5% (8/
151)
6% (9/
149)
-0.7% -12% 0.9
Guideline-
discordant
physician
recom-
mended
treatment
0 - 4 weeks
- - 18% (27/
151)
17% (25/
149)
-1.1% -7% 1.1
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
post-onset
Super-
vised exer-
cise pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
post-
onset)
- - 18% (26/
145)
14% (21/
149)
3.8%
(P=0.07)
27% 1.3
Return to
work (rec-
om-
mended
treatment
5
- 12 weeks
post-
onset)
- - 23% (33/
145)
17% (25/
149)
6%
(P=0.14)
36% 1.4
Refer
to interdis-
ciplinary
pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
post-
onset)
- - 0 2% (3/
149)
-2% -100% 0
Physio-
therapy > 4
weeks
(guideline-
discor-
dant)
- - 42% (61/
145)
43% (64/
149)
0.9% 2% 1
Contin-
ued use of
spinal ma-
nipu-
lation ther-
- - 3% (4/
145)
33% (49/
149)
30.1%
(P=0.05)
92% 0.1
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
apy (guide-
line-dis-
cordant)
(Dey
2004)*
Inter-
vention
(aimed at
general
practi-
tioners):
guidelines
discussion
(educa-
tional
compo-
nent),
patient in-
formation
leaflets,
access to
fast-track
physio-
therapy
and triage
services for
patients
with
persistent
symptoms
(organi-
sational
compo-
nent)
versus
usual care
(control)*
X-ray
referrals
15.1%
(43/284)
13.7%
(42/308)
-1.4%
(P=0.62)
-10% 1.1
Sickness
certificates
17.9 %
(34/190)
19.2%
(40/206)
1.3%
(P=0.74)
7% 0.9
Prescrip-
tions for
opioids or
muscle re-
laxants
18.6%
(84/452)
18.7%
(92/491)
0.1
(P=0.99)
1 1
Refer-
rals to sec-
ondary
care
3.4% (33/
962)
2.3% (24/
1044)
-1.1%
(P=0.12)
-49% 1.5
Referrals
to physio-
therapy or
educa-
tional pro-
gramme
- - 26.3%
(44/167)
13.8%
(25/181)
- -12.6%
(P=0.01)
-91% 1.9
(Engers
2005)**
Inter-
vention
(aimed at
general
practi-
tioners):
guidelines
on low
Referral to
a therapist
- - 22.9%
(75/328)
27.4%
(79/288)
- 4.6% 17% 0.8
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
back pain,
2-hour
workshop,
2 scientific
articles,
guidelines
on low
back pain
for occu-
pational
physicians,
tool for
patient
education
and man-
agement-
decision
tool. Con-
trol group:
usual care
Prescrip-
tion of
pain medi-
cation on a
time-con-
tingent ba-
sis
- - 70% (139/
328)
69% (130/
288)
- 2.8% 6% 0.9
Handed
patient in-
formation
leaflet
- - 36.9%
(121/328)
38.2%
(110/288)
- -1.3% -3% 1
Advised
patient to
stay active
- - 95.1%
(312/328)
89.2%
(257/288)
- 5.9% 7% 1.1
Advised
patient to
gradually
increase
activity
- - 78% (256/
328)
65.3%
(188/288)
- 12.8% 20% 1.2
Advised
patient
which ac-
tivities to
increase at
what mo-
ment
- - 18% (58/
328)
9% (26/
288)
- 8.7% 96% 2
(French
2013)***
Inter-
vention
(aimed at
general
practition-
ers): Inter-
active, ed-
ucational
workshops
plus ed-
ucational
material
Number of
x-ray
requests
out of to-
tal number
of patients
seen
- - 0.83%
(67/8,085)
1.02%
(80/7,826)
0.2%
(P=0.2)
19% 0.8
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
dissemi-
nated (via
DVDs);
Control
group:
usual
care**
Number of
CT
requests
out of to-
tal number
of patients
seen
- - 0.
61% (64/
10,419)
0.
66% (66/
10,085)
- 0.0%
(P=0.6)
7% 0.9
(Hazard
1997)
Interven-
tion
(aimed at
physicians)
: notifi-
cation that
patient was
at a high
risk of dis-
ability and
guidelines
on man-
agement.
Con-
trol group:
usual care
3-month
work ab-
sence rates
- - 28.6% (8/
28)
24% (6/
25)
- -4.6%
(NS)
-19% 1.2
(
Schectman
2003)
Inter-
vention
(aimed at
physicians)
: guideline
on low
back pain,
90-minute
educa-
tional
session on
Lum-
bosacral X-
ray
total utili-
sation (%
of patients
based
on episode
of care)
31% 21% 19% 18% 9% -1% -6% 1.1
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
guideline
imple-
mentation
delivered
by local
opinion
leaders
and audit
report
summaris-
ing per-
formance
against the
guideline
plus out-
reach visit.
Control
group:
usual
care plus/
minus
patient
education
(pamphlet
and video)
Lum-
bosacral X-
ray
not consis-
tent with
guideline
14.5% 8.2% 8.1% 8.6% 6.8% 0.5% 6% 0.9
Lum-
bosacral
CT/MRI
total utili-
sation (%
of patients
based
on episode
of care)
7.6% 5.6% 5.6% 7.1% 3.5% 1.5% 21% 0.8
Lum-
bosacral
CT/MRI
not consis-
tent with
guideline
5.7% 3.5% 3.5% 5.4% 4.1% 1.9% 35% 0.6
Physi-
cal therapy
referral to-
tal util-
isation (%
of patients
based
on episode
of care)
12% 13% 10% 13% 2% 3% 23% 0.8
Physi-
cal therapy
referral not
consistent
10% 10.9% 9.2% 12% 1.9% 2.8% 23% 0.8
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Table 9. Low back pain studies, intervention versus control, dichotomous data (Continued)
with
guideline
Specialty
referral to-
tal util-
isation (%
of patients
based
on episode
of care)
12% 5.9% 8.6% 7.1% 4.6% -1.5% -21% 1.2
Specialty
referral not
consistent
with
guideline
9.5% 4% 7.1% 5.6% 4% -1.5% -27% 1.3
1. Intervention group pre-intervention proportion
2. Control group pre-intervention proportion
3. Intervention group post-intervention proportion
4. Control group post-intervention proportion
5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a
positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int post (%) minus C post (%). This is considered to be “small”
if≤ 5%, “modest” if > 5% and≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been adjusted
so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int post (%) divided by C post (%)
C: control group; Int: intervention group; ARD: adjusted risk difference; NS: not significant
CT/MRI: computed tomography/magnetic resonance imaging
* Dey 2004 reported the Intercluster Correlation (ICC) for the results (mean cluster size=95.1) and this was used to calculate the above
effective sample sizes according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.
** The data reported above for the study by Engers 2005 does not account for clustering.We did not have access to sufficient information
to adjust the data for clustering.
***French 2013 reported Intercluster Correlation (ICC for x-rays 0.004 and for CTs 0.003, mean cluster size=2,154) and this was used
to calculate the above effective sample sizes according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a
Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data
(Study)
Interven-
tion 1 ver-
sus inter-
vention 2
Outcome Int 1 pre
(%) 1
Int 2 pre
(%)2
Int 1 post
(%)3
Int 2 post
(%)4
ARD 5 Risk differ-
ence 6
(Pvalueif reportedbyauthors)
Relative %
change
post 7
Risk ratio 8
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Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data (Continued)
(Bishop
2006)
Physician
education
(guide-
lines) and
3 patient-
specific re-
minder let-
ters versus
physician
education,
reminders
and also
patient ed-
uca-
tion and 3
reminders
Education
and reas-
surance ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 10% (16/
162)
6% (9/
151)
- 3.9%
(NS)
66% 1.7
Exercise
ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 38% (62/
162)
53% (80/
151)
- -14.7%
(P=0.0083)
-28% 0.7
Appropri-
ate medi-
cation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 85% (138/
162)
81% (122/
151)
- 4.4%
(NS)
5% 1.1
Spinal ma-
nip-
ulation ac-
cording to
guideline 0
- 4 weeks
post-onset
- - 2.5% (4/
162)
5% (13/
151)
- -6.1%
(P=0.018)
-71% 0.3
Guideline-
discordant
physician-
recom-
mended
treatment
0 - 4 weeks
post-onset
- - 10% (16/
162)
18% (27/
151)
- 8%
(P=0.04)
45% 0.6
Super-
vised exer-
cise pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
- - 19% (29/
154)
18% (26/
145)
- 0.9%
(NS)
5% 1.1
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Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data (Continued)
post-
onset)
Return to
work (rec-
om-
mended
treatment
5
- 12 weeks
post-
onset)
- - 24% (37/
154)
23% (33/
145)
- 1.3%
(NS)
6% 1.1
Refer
to interdis-
ciplinary
pro-
gramme
(recom-
mended
treatment
5
- 12 weeks
post-
onset)
- - 4% (6/
154)
0 - 3.9%
(P=0.02)
- -
Physio-
therapy > 4
weeks
(guideline-
discor-
dant)
- - 41% (63/
154)
42% (61/
145)
- 1.2%
(NS)
3% 1
Contin-
ued use of
spinal ma-
nipu-
lation ther-
apy (guide-
line-dis-
cordant)
- - - (no data
available)
3% (4/
145)
- - - -
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs
Lumbar
spine ra-
diographs
concor-
dant with
guidelines
- - 35.4%
(64/181)
43.6%
(120/275)
- -8.3% -19% 0.8
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Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data (Continued)
6 months
be-
fore and 6
months af-
ter the in-
tervention
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
(Eccles
2001)*
Reminder
mes-
sages on ra-
diograph
reports
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
Lumbar
spine ra-
diographs
concor-
dant with
guidelines
- - 41.2%
(35/85)
43.6%
(120/275)
- -2.5% -6% 0.9
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs 6
months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion plus
reminder
messages
on ra-
diograph
reports
Lumbar
spine ra-
diographs
concor-
dant with
guidelines
- - 36% (89/
247)
43.6%
(120/275)
- -7.6% -17% 0.8
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Table 10. Low back pain studies, intervention 1 versus intervention 2, dichotomous data (Continued)
versus
guideline
dissemina-
tion
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs 6
months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion versus
reminder
messages
on radio-
graph re-
ports plus
guideline
dissemina-
tion
Lumbar
spine ra-
diographs
concor-
dant with
guidelines
- - 35.4%
(64/181)
41.2%
(35/85)
- -5.8% -14% 0.9
1. Intervention 1 group pre-intervention proportion
2. Intervention 2 group pre-intervention proportion
3. Intervention 1 group post-intervention proportion
4. Intervention 2 group post-intervention proportion
5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted
so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be
“small” if ≤ 5%, “modest” if > 5% and ≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome.
7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a
positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)
Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: Adjusted risk difference; NS: not significant
*The data reported above for the study by Eccles 2001 does not account for clustering. We did not have access to sufficient information
to adjust the data for clustering.
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data
(Study)
Interven-
tion 1 ver-
sus Inter-
vention 2
Outcome Int 1 pre
mean
(SD)1
Int 2 pre
mean
(SD)2
Int 1
post mean
(SD)3
Int 2
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Functional
capacity
measured
by
Hannover
Functional
Ability
Question-
naire at 6
months
- - 72.9 70.3 2.7 4% - 0.1
(P=0.12)
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Functional
capacity
measured
by
Hannover
Functional
Ability
Question-
naire at 6
months
- - 73.9 70.3 3.6 5% - 0.2
(P=0.032)
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
Days
in pain at 6
months
- - 63.3 80.8 17.4 22% - 0.2
(P=0.002)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Days
in pain at 6
months
- - 62.9 80.8 17.9 22% - 0.2
(P=0.001)
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Overall ac-
tivity at 6
months
- - 36.5 33.5 3 9% - 0.1
(P=0.203)
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
Overall ac-
tivity at 6
months
- - 36.3 33.5 2.8 8% - 0.1
(P=0.230)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Days of
sick
leave at 6
months
- - 13 14.3 1.3 9% - 0
(P=0.569)
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Days of
sick
leave at 6
months
- - 13 14.3 1.3 9% - 0
(P=0.584)
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
Quality of
life at 6
months
- - 66.6 66.8 -0.3 0% - 0
(P=0.847)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Quality of
life at 6
months
- - 67.5 66.8 0.7 1% -- 0
(P=0.602)
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Functional
capacity
measured
by
Hannover
Functional
Ability
Question-
naire at 12
months
- - 73 71.6 1.4 2% - 0.1
(P=0.446)
(Becker
2008*)
Physician
education
(as above)
Functional
capacity
measured
by
Hannover
- - 74.6 71.6 3.1 4% - 0.1
(P=0.088)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Functional
Ability
Question-
naire at 12
months
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Days in
pain at 12
months
- - 58.5 71.3 12.8 18% - 0.2
(P=0.018)
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Days in
pain at 12
months
- - 61.6 71.3 9.8 14% - 0.1
(P=0.067)
(Becker
2008*)
Physician
education:
Guideline
Overall ac-
tivity at 12
months
- - 46.4 42.9 3.5 8% - 0.1
(P=0.202)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Overall ac-
tivity at 12
months
- - 45.4 42.9 2.5 6% - 0.1
(P=0.396)
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Days of
sick
leave at 12
months
- - 6.2 9.3 3.1 34% - 0.1
(P=0.256)
(Becker
2008*)
Physician
Days of
sick
leave at 12
- - 6.5 9.3 2.8 30% - 0.1
(P=0.320)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
months
(Becker
2008*)
Physician
education:
Guideline
(in 4 ver-
sions
includ-
ing patient
leaflet),
3 seminars
and aca-
demic de-
tailing ver-
sus guide-
line dis-
semination
Quality of
life at 12
months
- - 68.5 67.7 0.8 1% - 0
(P=0.535)
(Becker
2008*)
Physician
education
(as above)
plus prac-
tice nurse
train-
ing in mo-
tivational
coun-
selling ver-
sus guide-
line dis-
semination
Quality of
life at 12
months
- - 70.4 67.7 2.7 4% - 0.1
(P=0.036)
(Becker
2008*)
Physician
Functional
capacity
measured
- - 72.9 73.9 -1 -1% - 0
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
by
Hannover
Functional
Ability
Question-
naire at 6
months
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
Days
in pain at 6
months
- - 63.3 62.9 -0.4 -1% - 0
(NR)
(Becker
2008*)
Physician
education:
Overall ac-
tivity at 6
months
- - 36.5 36.3 0.2 0% - 0
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
Days of
sick
leave at 6
months
- - 13 13.1 0.1 0% - 0
(NR)
(Becker
2008*)
Physician
education:
Guideline
Quality of
life at 6
months
- - 66.6 67.5 -0.9 -1% - 0
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
Functional
capacity
measured
by
Hannover
Functional
Ability
Question-
naire at 12
months
- - 73 74.6 -1.7 -2% - -0.1
(NR)
(Becker
2008*)
Physician
education:
Guideline
(in 4
Days in
pain at 12
months
- - 58.5 61.6 3.1 5% - 0
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
Overall ac-
tivity at 12
months
- - 46.4 45.4 1 2% - 0
(NR)
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
Days of
sick
leave at 12
months
- - 6.2 6.458 0.3 5% - 0
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
(Becker
2008*)
Physician
education:
Guideline
(in 4
versions
including
patient
leaflet), 3
seminars
and aca-
demic de-
tailing vs
Physician
education
plus prac-
tice nurse
training
in moti-
vational
coun-
selling
Quality of
life at 12
months
- - 68.5 70.4 -1.9 -3% - -0.1
(NR)
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs
6 months
Number of
lumbar
spine ra-
diographs
per 1000
patients
7.24 (4.8) 7.53 (4.1) 5.97 (4.2) 6.80 (4.3) 0.83 12% 8% 0.2
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
be-
fore and 6
months af-
ter the in-
tervention
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
(Eccles
2001)*
Reminder
mes-
sages on ra-
diograph
reports
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
Number of
lumbar
spine ra-
diographs
per 1000
patients
7.31 (5.2) 7.53 (4.1) 5.14 (3.7) 6.80 (4.3) 1.66 24% 21% 0.4
(P=0.05)
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs 6
months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion plus
reminder
messages
on ra-
diograph
reports
versus
Number of
lumbar
spine ra-
diographs
per 1000
patients
8.30 (5.1) 7.53 (4.1) 5.23 (3.7) 6.80 (4.3) 1.57 23% 34% 0.4
(NR)
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Table 11. Low back pain studies intervention 1 versus intervention 2, continuous data (Continued)
guideline
dissemina-
tion
(Eccles
2001)*
Feedback
on number
of spinal
radio-
graphs 6
months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion versus
reminder
messages
on radio-
graph re-
ports plus
guideline
dissemina-
tion
Number of
lumbar
spine ra-
diographs
per 1000
patients
7.24 (4.8) 7.31 (5.2) 5.97 (4.2) 5.14 (3.7) -0.83 -16% -18% -0.2
(NR)
1. Intervention 1 group pre-intervention mean (standard deviation)
2. Intervention 2 group pre-intervention mean (standard deviation)
3. Intervention 1 group post-intervention mean (standard deviation)
4. Intervention 2 group postintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int1 post mean - Int2 post mean)/Int2 post mean. The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
7. Adjusted relative percentage change= (Int1 post mean-Int2 post mean)-(Int1 pre mean - Int2 pre mean)/Int2 post mean. The
direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.
8. SMD=Standardised Mean Difference=(Int1 post mean-Int2 post mean)/SD pooled. The direction of effect has been adjusted so that
a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
9. P value reported by study authors
Int 1: intervention 1 group; Int 2: Intervention 2 group; NR: not reported; SD: standard deviation
*The data reported above for Becker 2008 and Eccles 2001 was adjusted for clustering by the authors
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Table 12. Low back pain, interrupted time series studies, imaging outcomes
Study Interven-
tion
Outcome Mean pre
(SD)
Mean post
(SD)
Mean post
minus
mean pre
Relative%
change
pre to post
SMD pre
to post
Mean
change
in level (p
value)
Mean
change
in slope (p
value)
Holling-
worth
2002
Educa-
tional ma-
terial
Back x-rays
ordered
1133 (50) 1208.7
(111.5)
-75.7 -6.7 -1.51 -121.5 (P =
0.167)
6.8 (P = 0.
776)
Table 13. Osteoarthritis studies: Intervention versus control (continuous data)
(Study)
Interven-
tion
Outcome Int
pre mean
(SD)1
C
pre mean
(SD)2
Int
post mean
(SD)3
C
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Chassany
2006)*
GP train-
ing on rela-
tionships
and com-
munica-
tion,
pain evalu-
ation, pre-
scription
and nego-
tiation of a
pa-
tient con-
tract deliv-
ered in a 4-
hour inter-
active ses-
sion plus 8
reminders
on recom-
menda-
tions
Pain relief
(SPID)
- - 315.6
(289.5)
264.7
(242.9)
50.9 19% 19% 0.2
(P< 0.0001)
Intensity
of pain in
motion on
VAS
63.7 (13.
8)
62.8 (13.
5)
-29 (23.1) -24.8 (21.
1)
4.2 17% -21% 0.2
(P=0.01)
Lequesne
Index
9.2 (2.9) 9.8 (3.2) -2.5 (2.5) -2.0 (2.4) 0.5 25% 5% 0.2
(P< 0.0001)
WOMAC
index pain
9.3 (3.0) 9.6 (2.8) -2.9 (3.4) -2.2 (2.9) 0.7 32% -18% 0.2
(P< 0.0001)
WOMAC
index stiff-
ness
4.1 (1.4) 4.0 (1.4) -1.2 (1.6) -0.8 (1.4) 0.4 50% -62% 0.3
(P=0.0004)
WOMAC
in-
dex phys-
ical func-
tion
31.2 (10.
9)
32.8 (9.5) -8.7 (10.7) -6.1 (8.8) 2.6 43% -16% 0.3
(P< 0.0001)
WOMAC
in-
dex global
score
44.6 (14.
4)
46.4 (12.
5)
-12.9 (14.
8)
-9.2 (12.2) 3.7 40% -21% 0.3
(P< 0.0001)
Ac-
etaminophen
consump-
tion
- - 3400
(800)
2900
(900)
-500 -17% -17% -0.6
(P< 0.0001)
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Table 13. Osteoarthritis studies: Intervention versus control (continuous data) (Continued)
(
Rosemann
2007)*
Interven-
tion
(aimed at
GPs): 2 in-
teractive 8-
hour meet-
ings focus-
ing
on arthritis
self man-
agement,
guideline
dissemi-
nation and
patient in-
formation
material
versus con-
trol (usual
care)
Quality of
life
(AIMS2-
SF scores)
Lower
body
2.67 (1.
88)
2.65 (1.
85)
2.48 2.62 -0.14 -5% -6% -0.1
(P=0.349)
Quality of
life
(AIMS2-
SF
scores)Up-
per body
1.47 (2.
25)
1.33 (2.
09)
1.43 1.34 0.09 7% -4% 0.1
P=0.694)
Quality of
life
(AIMS2-
SF scores)
Symptom
4.87 (2.
13)
4.81 (2.
18)
4.51 4.72 -0.21 -4% -6% -0.2
(P=0.119)
Quality of
life
(AIMS2-
SF scores)
Affect
2.89 (1.
35)
2.88 (1.
33)
2.92 2.83 0.09 3% 3% 0.1
(P=0.610)
Quality of
life
(AIMS2-
SF scores)
Social
4.52 (1.
88)
4.69 (1.
80)
4.43 4.62 -0.19 -4% 0% -0.3
P=0.776
GP
contacts
4.56 (6.
13)
4.82 (6.
00)
4.44 4.6 0.16 3% -2% 0.1
(P=0.339)
Refer-
rals to or-
thopaedics
1.58 (3.
43)
1.76 (3.
52)
1.49 1.75 0.26 15% 5% 0.8
(P=0.153)
Radio-
graphs
0.82 (3.
12)
0.79 (2.
78)
0.75 0.85 0.1 12% 15% 0.2
(P=0.05)
Non-med-
ical practi-
tioners
0.11 (3.
01)
0.36 (3.
28)
0.09 0.32 0.23 72% -6% 0.6
(P=0.687)
Physio-
therapy
4.70 (9.
10)
5.81 (11.
10)
4.63 5.77 1.14 20% 1% 2
(P=0.242)
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Table 13. Osteoarthritis studies: Intervention versus control (continuous data) (Continued)
Acupunc-
ture
0.83 (3.
45)
0.97 (3.
80)
0.8 0.97 0.17 18% 3% 0.2
(P=0.821)
(
Rosemann
2007)*
Interven-
tion
(aimed
at GPs) as
above plus
patient
case man-
agement
via tele-
phone by
prac-
tice nurses
versus con-
trol (usual
care)
Quality of
life
(AIMS2-
SF scores)
Lower
body
3.01 (2.
11)
2.65 (1.
85)
2.61 2.62 -0.01 0% -14% 0
(P=0.049)
Quality of
life
(AIMS2-
SF
scores)Up-
per body
1.68 (2.
44)
1.33 (2.
09)
1.62 1.34 0.28 21% -5% 0.2
(P=0.621)
Quality of
life
(AIMS2-
SF scores)
Symptom
5.02 (2.
29)
4.81 (2.
18)
4.42 4.72 -0.3 -6% -11% -0.2
(P=0.048)
Quality of
life
(AIMS2-
SF scores)
Affect
3.04 (1.
39)
2.88 (1.
33)
2.98 2.83 0.15 5% 0% 0.2
(P=0.691)
Quality of
life
(AIMS2-
SF scores)
Social
4.79 (1.
80)
4.69 (1.
80)
4.736 4.62 0.116 3% 0% 0.1
(P< 0.001)
GP
contacts
5.01 (5.
78)
4.82 (6.
00)
4.9 4.6 -0.3 -7% -2% -0.2
(P=0.823)
Refer-
rals to or-
thopaedics
1.76 (3.
52)
1.76 (3.
52)
1.52 1.75 0.23 13% 13% 0.2
(P=0.044)
Radio-
graphs
0.80 (3.
01)
0.79 (2.
78)
0.71 0.85 0.14 16% 18% 0.4
(P=0.031)
Non-med-
ical practi-
tioners
0.50 (4.
20)
0.36 (3.
28)
0.47 0.32 -0.15 -47% -3% -0.4
(P=0.225)
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Table 13. Osteoarthritis studies: Intervention versus control (continuous data) (Continued)
Physio-
therapy
5.22 (10.
03)
5.81 (11.
10)
5.08 5.77 0.69 12% 2% 1.3
(P=0.129)
Acupunc-
ture
0.77 (3.
99)
0.97 (3.
80)
0.72 1.09 0.37 34% 16% 0.4
(P=0.769)
(Stross
1985)**
Interven-
tion: Edu-
cationally-
influen-
tial physi-
cians (EIs)
led educa-
tion of pri-
mary-
care physi-
cians: self-
study pro-
gramme
including
textbook,
audio-
visual ma-
terials and
recent arti-
cles on os-
teoarthritis
versus con-
trol (usual
care)
Length of
stay forOA
patients
8.8 8.4 8.4 8.6 0.2 2% 7% NR
Length of
stay for to-
tal
hip arthro-
plasty
(THA) pa-
tients
17.2 16.6 15.2 16.0 0.8 5% 9% NR
1. Intervention group pre-intervention mean (standard deviation)
2. Control group pre-intervention mean (standard deviation)
3. Intervention group post-intervention mean (standard deviation)
4. Control group pos-tintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int post mean - Control post mean)/Control post mean
7. Adjusted relative percentage change= (Int post mean-Control post mean)-(Int pre mean - Control pre mean)/Control post mean.
The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.
8. SMD=Standardised Mean Difference=(Int post mean-Control post mean)/SD pooled. The direction of effect has been adjusted so
that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
9. P value reported by study authors
AIMS2-SF: Arthritis Impact Measurement Scales Short Form
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index
* There are potential unit of analysis errors in the reported results as the study did not account for clustering and did not provide
sufficient data to allow an approximate analysis according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.
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**The study did not report standard deviations and therefore we were unable to calculate the SMD. There are potential unit of analysis
errors in the reported results as the study did not account for clustering and did not provide sufficient data to allow an approximate
analysis according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.
Table 14. Osteoarthritis studies: intervention versus control (dichotomous data)
(Study)
Interven-
tion
Outcome Int pre
(%) 1
C pre (%)
2
Int post
(%)3
C post
(%)4
ARD 5 Risk differ-
ence 6
(PV alueif reportedbyauthors)
Relative %
change
post 7
Risk ratio 8
(Rahme
2005)*
Interven-
tion
(aimed at
GPs): 90-
minute
workshop
on man-
agement of
os-
teoarthritis
versus con-
trol group
(usual
care)
Number of
ad-
equate pre-
scription,
accord-
ing to the
guidelines
51% (273/
536)
47% (675/
1437)
56% (251/
450)
49% (593/
1209)
3% 7% 14% 1.1
(Rahme
2005)*
Interven-
tion
(aimed at
GPs): de-
cision tree
on
treatment
choices for
os-
teoarthri-
tis patients
versus con-
trol (usual
care)
Number of
ad-
equate pre-
scription,
accord-
ing to the
guidelines
51% (799/
1569)
47% (675/
1437)
54% (712/
1317)
49% (593/
1209)
1% 5% 10% 1.1
(Rahme
2005)*
Interven-
tion
(aimed at
GPs): 90-
Number of
ad-
equate pre-
scription,
accord-
58%
(1022/
1776)
47% (675/
1437)
62%
(1008/
1634)
49% (593/
1209)
2% 13% 26% 1.3
155Professional interventions for general practitioners on the management of musculoskeletal conditions (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 14. Osteoarthritis studies: intervention versus control (dichotomous data) (Continued)
minute
workshop
and deci-
sion tree as
above
versus con-
trol (usual
care)
ing to the
guidelines
(
Rosemann
2007)*
Interven-
tion
(aimed at
GPs): 2 in-
teractive 8-
hour meet-
ings focus-
ing
on arthritis
self man-
agement,
guideline
dissemi-
nation and
patient in-
formation
material
versus con-
trol (usual
care)
Paraceta-
mol pre-
scriptions
8.9% (31/
345)
6.6% (22/
332)
16.4% 5.3% 8.7% 11.1%
(<0.001)
209% 3.1
Opioids 5.8% (20/
345)
6.9% (23/
332)
10.1% 7.9% 3.4% 2.2%
(NS)
28% 1.3
NSAID 40% (138/
345)
41.9%
(139/332)
44.3% 44.2% 2.0% 0.1%
(NS)
23% 1.0
Homeo-
pathics
6.1% (21/
345)
8.1% (27/
332)
7.7% 9.8% -0.1% -2.2%
(NS)
-22% 0.8
(
Rosemann
2007)*
Interven-
tion
(aimed
at GPs) as
above plus
patient
case man-
agement
via tele-
phone by
prac-
tice nurses
versus con-
Paraceta-
mol pre-
scriptions
7.3% (25/
345)
6.6% (22/
332)
14.1% 5.3% 8.2% 8.8%
(<0.01)
166% 2.7
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Table 14. Osteoarthritis studies: intervention versus control (dichotomous data) (Continued)
trol (usual
care)
Opioids 7.3% (25/
345)
6.9% (23/
332)
16.0% 7.9% 7.8% 8.1%
(< 0.01)
102% 2.0
NSAID 43.3%
(149/345)
41.9%
(139/332)
49.7% 44.2% 4.3% 5.6%
(0.019)
13% 1.1
Homeo-
pathics
6.7% (23/
345)
8.1% (27/
332)
9.6% 9.8% 1.2% -0.2%
(NS)
-2% 1.0
(Stross
1985)*
Interven-
tion: Edu-
cationally-
influen-
tial physi-
cians (EIs)
led educa-
tion of pri-
mary-
care physi-
cians: self-
study pro-
gramme
including
textbook,
audio-
visual ma-
terials and
recent arti-
cles on os-
teoarthritis
versus con-
trol (usual
care)
Man-
agement of
OA pa-
tients with
aspirin
39% (9/
23)
50% (9/
18)
20% (6/
30)
28% (5/
18)
3% -8% -28% 0.7
Man-
agement of
OA pa-
tients with
NSAIDs
83% (19/
23)
78% (14/
18)
87% (26/
30)
94% (17/
18)
-13% -8% -8% 0.9
Man-
agement of
OA pa-
tients with
systemic
corticos-
teroids
13% (3/
23)
17% (3/
18)
3% (1/30) 22% (4/
18)
15% 19%
(< 0.05)
85% 0.2
Man-
agement of
OA pa-
tients with
intra-artic-
ular corti-
costeroids
17% (4/
23)
11% (2/
18)
40% (12/
30)
11% (2/
18)
23% 29%
(<0.05)
260% 3.6
Man-
agement of
OA
patients
with physi-
cal therapy
87% (20/
23)
83% (15/
18)
93% (28/
30)
83% (15/
18)
6% 10% 12% 1.1
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Table 14. Osteoarthritis studies: intervention versus control (dichotomous data) (Continued)
Referral
of OA pa-
tients
39% (9/
23)
39% (7/
18)
30% (9/
30)
33% (6/
18)
-4% 3% 10% 0.9
Pre-
op physical
therapy of
THA
patients
56% (10/
18)
46% (12/
26)
97% (35/
36)
40% (12/
30)
48% 57%
(< 0.05)
143% 2.4
Post-op
narcotics
of THA
patients
72% (13/
18)
77% (20/
26)
89% (32/
36)
93% (28/
30)
0% 4% 5% 1.0
Post-
op physical
therapy of
THA
patients
100% (18/
18)
100% (26/
26)
100% (36/
36)
100% (30/
30)
0% 0% 0% 1.0
Post-
op compli-
cations of
THA
patients
11% (2/
18)
15% (4/
26)
6% (2/36) 13% (4/
30)
4% 8% 58% 0.4
1. Intervention group pre-intervention proportion
2. Control group pre-intervention proportion
3. Intervention group post-intervention proportion
4. Control group post-intervention proportion
5. ARD = [Int post (%) minus C post (%)] minus [Int pre (%) minus C pre (%)]. The direction of effect has been adjusted so that a
positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int post (%) minus C post (%). This is considered to be “small”
if≤ 5%, “modest” if > 5% and≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been adjusted
so that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
7. Relative % change post = absolute % change post divided by C post (%). The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int post (%) divided by C post (%)
C: control group; Int: intervention group; ARD: Adjusted risk difference; NS: not significant
NSAID: non-steroidal anti-inflammatory drug, THA: total hip arthroplasty
* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.
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Table 15. Osteoarthritis studies: intervention 1 versus intervention 2, dichotomous data
(Study)
Interven-
tion 1 ver-
sus inter-
vention 2
Outcome Int 1 pre
(%) 1
Int 2 pre
(%)2
Int 1 post
(%)3
Int 2 post
(%)4
ARD 5 Risk differ-
ence 6
(Pvalueif reportedbyauthors)
Relative %
change
post 7
Risk ratio 8
(Rahme
2005)*
Interven-
tion 1
(aimed at
GPs): 90-
minute
workshop
on man-
agement
of os-
teoarthritis
versus In-
tervention
2 (aimed
at GPs)
: decision
tree on
treatment
choices
for os-
teoarthritis
patients
Number of
ad-
equate pre-
scription,
accord-
ing to the
guidelines
51% (273/
536)
51% (799/
1569)
56% (251/
450)
54% (712/
1317)
1.7% 1.7% 3% 1
(Rahme
2005)*
Interven-
tion 1
(aimed at
GPs): 90-
minute
workshop
on man-
agement
of os-
teoarthritis
versus In-
tervention
2 (aimed
at GPs):
90-minute
workshop
and deci-
Number of
ad-
equate pre-
scription,
accord-
ing to the
guidelines
51% (273/
536)
58%
(1022/
1776)
56% (251/
450)
62%
(1008/
1634)
0.7% -5.9% -10% 0.9
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Table 15. Osteoarthritis studies: intervention 1 versus intervention 2, dichotomous data (Continued)
sion tree
(Rahme
2005)*
Inter-
vention 1
(aimed
at GPs):de-
cision tree
on
treatment
choices for
os-
teoarthri-
tis patients
versus In-
tervention
2 (aimed at
GPs): 90-
minute
workshop
and deci-
sion tree
Number of
ad-
equate pre-
scription,
accord-
ing to the
guidelines
51% (799/
1569)
58%
(1022/
1776)
54% (712/
1317)
62%
(1008/
1634)
-1% -7.6% -12% 0.9
(
Rosemann
2007)*
Inter-
vention
(aimed at
GPs): 2
interactive
8-hour
meetings
focusing
on arthritis
self man-
agement,
guideline
dissemina-
tion and
patient in-
formation
material
versus In-
tervention
(aimed
at GPs)
as above
plus pa-
Paraceta-
mol pre-
scriptions
8.9% (31/
345)
7.3% (25/
345)
16.4% 14.1% 0.5% 2.3% 16% 1.2
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Table 15. Osteoarthritis studies: intervention 1 versus intervention 2, dichotomous data (Continued)
tient case
manage-
ment via
telephone
by practice
nurses Opioids 5.8% (20/
345)
7.3% (25/
345)
10.1% 16.0% -4.5% -5.9% -37% 1.2
NSAID 40% (138/
345)
43.3%
(149/345)
44.3% 49.7% -2.2% -5.4% -11% 1.2
Homeo-
pathics
6.1% (21/
345)
6.7% (23/
345)
7.7% 9.6% -1.4% -1.9% -20% 1.2
1. Intervention 1 group pre-intervention proportion
2. Intervention 2 group pre-intervention proportion
3. Intervention 1 group post-intervention proportion
4. Intervention 2 group post-intervention proportion
5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted
so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Risk Difference (RD) is the absolute % change post-intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be
“small” if ≤ 5%, “modest” if > 5% and ≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome.
7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a
positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)
Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant, NSAID: non-steroidal
anti-inflammatory drug
* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.
Table 16. Osteoarthritis studies: intervention 1 versus intervention 2 continuous data
(Study)
Interven-
tion 1 ver-
sus Inter-
vention 2
Outcome Int 1 pre
mean
(SD)1
Int 2 pre
mean
(SD)2
Int 1
post mean
(SD)3
Int 2
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(
Rosemann
2007)*
Inter-
vention
(aimed at
GPs): 2
interactive
8-hour
meetings
Quality of
life
(AIMS2-
SF scores)
Lower
body
2.67 (1.
88)
3.01 (2.
11)
2.48 (1.1) 2.61 (1.4) -0.13 -5% 0% -0.1
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Table 16. Osteoarthritis studies: intervention 1 versus intervention 2 continuous data (Continued)
focusing
on arthritis
self man-
agement,
guideline
dissemina-
tion and
patient in-
formation
material
versus In-
tervention
(aimed
at GPs)
as above
plus pa-
tient case
manage-
ment via
telephone
by practice
nurses
Quality of
life
(AIMS2-
SF
scores)Up-
per body
1.47 (2.
25)
1.68 (2.
44)
1.43 (1.5) 1.62 (1.3) -0.19 -12% -6% -0.1
Quality of
life
(AIMS2-
SF scores)
Symptom
4.87 (2.
13)
5.02 (2.
29)
4.51 (1.0) 4.42 (1.8) 0.09 2% 12% 0.1
Quality of
life
(AIMS2-
SF scores)
Affect
2.89 (1.
35)
3.04 (1.
39)
2.92 (0.8) 2.98 (0.9) -0.06 -2% -1% -0.1
Quality of
life
(AIMS2-
SF scores)
Social
4.52 (1.
88)
4.79 (1.
80)
4.43 (0.6) 4.736 (1.
2)
-0.31 -6% -25% -0.3
GP
contacts
4.56 (6.
13)
5.01 (5.
78)
4.44 (1.7) 4.9 (1.6) 0.46 9% 37% 0.3
Refer-
rals to or-
thopaedics
1.58 (3.
43)
1.76 (3.
52)
1.49 (0.4) 1.52 (1.3) 0.03 2% -9% 0.0
Radio-
graphs
0.82 (3.
12)
0.80 (3.
01)
0.75 (0.6) 0.71 (0.4) -0.04 -6% -1% -0.1
Non-med-
ical practi-
tioners
0.11 (3.
01)
0.50 (4.
20)
0.09 (0.4) 0.47 (0.4) 0.38 81% -45% 0.9
Physio-
therapy
4.70 (9.
10)
5.22 (10.
03)
4.63 (0.6) 5.08 (0.6) 0.45 9% 35% 0.7
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Table 16. Osteoarthritis studies: intervention 1 versus intervention 2 continuous data (Continued)
Acupunc-
ture
0.83 (3.
45)
0.77 (3.
99)
0.8 (1.3) 0.72 (1.3) -0.08 -11% 0% -0.1
1. Intervention 1 group pre-intervention mean (standard deviation)
2. Intervention 2 group pre-intervention mean (standard deviation)
3. Intervention 1 group post-intervention mean (standard deviation)
4. Intervention 2 group postintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int1 post mean - Int2 post mean)/Int2 post mean. The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
7. Adjusted relative percentage change= (Int1 post mean-Int2 post mean)-(Int1 pre mean - Int2 pre mean)/Int2 post mean. The
direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.
8. SMD=Standardised Mean Difference=(Int1 post mean-Int2 post mean)/SD pooled. The direction of effect has been adjusted so that
a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
9. P value reported by study authors
AIMS2-SF: Arthritis Impact Measurement Scales Short Form
* There are unit of analysis errors in the reported results because the available data did not account for the effect of clustering.
Table 17. Shoulder studies: intervention versus control, continuous data
(Study)
Interven-
tion
Outcome Int
pre mean
(SD)1
C
pre mean
(SD)2
Int
post mean
(SD)3
C
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Watson
2008)
Interven-
tion: 60-
minute
lecture on
shoul-
der disor-
ders, hand-
outs, train-
ing in in-
jection
techniques
versus con-
trol group
(usual
care)
British
Shoulder
Disabil-
ity Ques-
tionnaire
(BSDQ)
12.22 (4.
21)
13.11 (4.
43)
8.51 (0.
60)
9.46 (0.
82)
0.95 10% 1% 0.2
(P=0.36)
Short form
36
item (SF-
36) Health
37.78 (8.
69)
35.96 (8.
93)
40.55 (0.
60)
40.80 (0.
90)
-0.25 -1% -5% 0.0
(P=0.82)
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Table 17. Shoulder studies: intervention versus control, continuous data (Continued)
Sur-
vey - physi-
cal compo-
nent score
Short form
36
item (SF-
36) Health
Sur-
vey - men-
tal compo-
nent score
45.42 (13.
33)
44.64 (13.
09)
46.81 (0.
93)
45.64 (1.
28)
1.17 3% 1% 0.1
(P=0.47)
1. Intervention group pre-intervention mean (standard deviation)
2. Control group pre-intervention mean (standard deviation)
3. Intervention group post-intervention mean (standard deviation)
4. Control group pos-tintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int post mean - Control post mean)/Control post mean
7. Adjusted relative percentage change= (Int post mean-Control post mean)-(Int pre mean - Control pre mean)/Control post mean.
The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.
8. SMD=Standardised Mean Difference=(Int post mean-Control post mean)/SD pooled. The direction of effect has been adjusted so
that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
9. P value reported by study authors
Table 18. Shoulder studies: intervention 1 versus intervention 2, continuous data
(Study)
Interven-
tion 1 ver-
sus Inter-
vention 2
Outcome Int 1 pre
mean
(SD)1
Int 2 pre
mean
(SD)2
Int 1
post mean
(SD)3
Int 2
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Gormley
2003*)
Shoulder
injection
training on
man-
nequins
ver-
sus shoul-
der injec-
tion
training on
man-
Shoul-
der injec-
tions per-
formed by
gen-
eral practi-
tioner
3.5 3.4 4.5 7.8 -3.3 -42% -44% (P=0.02)
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Table 18. Shoulder studies: intervention 1 versus intervention 2, continuous data (Continued)
nequins
and real
patients
Referrals
to shoulder
injection
clinics
2.3 2.0 1.5 0.6 -0.9 -150% -100% (P=0.36)
Referrals
to physio-
therapy
5.9 5.6 4.7 3.2 -1.5 -47% -38% (P=0.20)
1. Intervention 1 group pre-intervention mean (standard deviation)
2. Intervention 2 group pre-intervention mean (standard deviation)
3. Intervention 1 group post-intervention mean (standard deviation)
4. Intervention 2 group postintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int1 post mean - Int2 post mean)/Int2 post mean. The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
7. Adjusted relative percentage change= (Int1 post mean-Int2 post mean)-(Int1 pre mean - Int2 pre mean)/Int2 post mean. The
direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.
8. SMD=Standardised Mean Difference=(Int1 post mean-Int2 post mean)/SD pooled. The direction of effect has been adjusted so that
a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
9. P value reported by study authors
* The study does not report SD and therefore we were not able to calculate the SMD
Table 19. Other musculoskeletal conditions studies: Intervention versus control, continuous data
(Study)
Interven-
tion
Outcome Int
pre mean
(SD)1
C
pre mean
(SD)2
Int
post mean
(SD)3
C
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Huas
2006)
Training of
gen-
eral practi-
tioners on
the use of
2 validated
assessment
instru-
ments for
pain versus
con-
Pain relief
a week af-
ter
last consul-
tation with
gen-
eral practi-
tioner
41.1 (4.6) 50.7 (4.8) -9.6 -19% -2
(P=0.0004)
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Table 19. Other musculoskeletal conditions studies: Intervention versus control, continuous data (Continued)
trol group
(usual
care)
Pain relief
a week af-
ter
last consul-
tation with
gen-
eral practi-
tioner not
including
patients on
Level 3
analgesics
40.8 (4.0) 50.7 (4.2) -9.9 -20% -2.4
(P=0.0001)
Level
1 analgesic
treatment
(as defined
by WHO
classifi-
cation sys-
tem)
34.7 (10.
6)
42.9 (18.
4)
29.6 (9.9) 34.2 (12.
4)
-4.6 -13% 11% -0.3
(P=0.38)
Level
2 analgesic
treatment
(as defined
by WHO
classifi-
cation sys-
tem)
42.2 (5.9) 44.1 (19.
6)
35.4 (6.3) 47.7 (8.8) -12.3 -26% -22% -0.9
(P=0.003)
Level
3 analgesic
treatment
(as defined
by WHO
classifi-
cation sys-
tem)
7.5 (5.6) 2.5 (2.1) 7.2 (4.7) 1.8 (2.5) 5.4 300% 22% 1.2
(P=0.007)
Co-anal-
gesics (an-
tidepres-
sants, anxi-
olytics,
46.0 (7.6) 38.7 (7.5) 38.4 (11.
4)
33.0 (15.
1)
5.4 16% -6% 0.7
(P=0.38)
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Table 19. Other musculoskeletal conditions studies: Intervention versus control, continuous data (Continued)
anti-
epileptics)
Other
drugs
(non-psy-
chotropic
muscle re-
laxants)
21.6 (7.1) 27.3 (13.
5)
19.0 (5.3) 22.9 (11.
5)
-3.9 -17% 8% -0.4
(P=0.34)
Non-
medicinal
treatment
(physio-
ther-
apy, home-
opathy,
acupunc-
ture, com-
pres-
sion ban-
dages, etc)
44.3 (10.
2)
44.9 (11.
1)
33.8 (11.
8)
39.3 (12.
5)
-5.5 -14% -12% -0.5
(P=0.30)
1. Intervention group pre-intervention mean (standard deviation)
2. Control group pre-intervention mean (standard deviation)
3. Intervention group post-intervention mean (standard deviation)
4. Control group pos-tintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int post mean - Control post mean)/Control post mean
7. Adjusted relative percentage change= (Int post mean-Control post mean)-(Int pre mean - Control pre mean)/Control post mean.
The direction of effect has been adjusted so that a positive result represents a beneficial intervention outcome.
8. SMD=Standardised Mean Difference=(Int post mean-Control post mean)/SD pooled. The direction of effect has been adjusted so
that a positive result represents a beneficial intervention outcome, according to Grimshaw 2004.
9. P value reported by study authors
Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data
(Study)
Interven-
tion 1 ver-
sus inter-
vention 2
Outcome Int 1 pre
(%) 1
Int 2 pre
(%)2
Int 1 post
(%)3
Int 2 post
(%)4
ARD 5 Risk differ-
ence 6
(Pvalueif reportedbyauthors)
Relative %
change
post 7
Risk ratio 8
(Robling
2002)*
Guidelines
and semi-
Con-
cordant re-
quests
- - 79% (23/
29)
79% (32/
41)
- 0% 0% 1
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Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data (Continued)
nar versus
guideline
dissem-
ination by
post*
(Robling
2002)*
Guidelines
and feed-
back versus
guideline
dissem-
ination by
post*
Con-
cordant re-
quests
- - 67% (21/
32)
79% (32/
41)
- -12.1% -15% 0.8
(Robling
2002)*
Guide-
lines, semi-
nar
and feed-
back versus
guideline
dissem-
ination by
post*
Con-
cordant re-
quests
- - 71% (27/
37)
79% (32/
41)
- -7.6% -10% 0.9
(Robling
2002)*
Guidelines
and semi-
nar versus
guidelines
and feed-
back*
Con-
cordant re-
quests
- - 79% (23/
29
67% (21/
32)
- 12.1% 18% 1.2
(Robling
2002)*
Guidelines
and semi-
nar ver-
sus guide-
lines, semi-
nar and
feedback*
Con-
cordant re-
quests
- - 79% (23/
29)
71% (27/
37)
- 7.6% 11% 1.1
(Robling
2002)*
Con-
cordant re-
- - 67% (21/
32)
71% (27/
37)
- -4.5% -6% 0.9
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Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data (Continued)
Guidelines
and feed-
back versus
guide-
lines, semi-
nar and
feedback*
quests
(Eccles
2001)**
Feedback
on number
of knee ra-
diographs
6 months
be-
fore and 6
months af-
ter the in-
tervention
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
Knee ra-
diographs
concor-
dant with
guidelines
- - 22% (52/
240)
25% (83/
328)
- -3.6% -14% 0.9
(Eccles
2001)**
Reminder
mes-
sages on ra-
diograph
reports
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
Knee ra-
diographs
concor-
dant with
guidelines
- - 31% (26/
85)
25% (83/
328)
- 5.3% 21% 1.2
(Eccles
2001)**
Feedback
on number
of knee ra-
diographs
6 months
Knee ra-
diographs
concor-
dant with
guidelines
- - 28% (70/
252)
25% (83/
328)
- 2.5% 10% 1.1
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Table 20. Other musculoskeletal studies: Intervention versus a different intervention, dichotomous data (Continued)
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion plus
reminder
messages
on ra-
diograph
reports
versus
guideline
dissemina-
tion
(Eccles
2001)**
Feedback
on number
of knee ra-
diographs
6 months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion versus
reminder
messages
on radio-
graph re-
ports plus
guideline
dissemina-
tion
Knee ra-
diographs
concor-
dant with
guidelines
- - 22% (52/
240)
31% (26/
85)
- -8.9% -29% 0.7
1. Intervention 1 group pre-intervention proportion
2. Intervention 2 group pre-intervention proportion
3. Intervention 1 group post-intervention proportion
4. Intervention 2 group post-intervention proportion
5. ARD = [Int 1 post (%) minus Int 2 post (%)] minus [Int 1 pre (%) minus Int 2 pre (%)]. The direction of effect has been adjusted
so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
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6. Risk Difference (RD) is the absolute % change post-intervention = Int 1 post (%) minus Int 2 post (%). This is considered to be
“small” if ≤ 5%, “modest” if > 5% and ≤10%,“moderate” if > 10% but ≤ 20%, and “large” if > 20%.The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome.
7. Relative % change post = absolute % change post divided by Int 2 post (%). The direction of effect has been adjusted so that a
positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
8. Risk ratio (RR) = Int 1 post (%) divided by Int 2 post (%)
Int 1: intervention 1 group; Int 2: Intervention 2 group; ARD: adjusted risk difference; NS: not significant
*The results have been re-calculated taking into account the reported Intercluster Correlation (ICC=0.0269) and average cluster size
12.5 according to chapter 16.3.4 of the Cochrane Handbook, Higgins 2011a.
** The data reported above for the study by Eccles 2001 does not account for clustering.We did not have access to sufficient information
to adjust the data for clustering.
Table 21. Other musculoskeletal studies: Intervention versus a different intervention, continuous data
(Study)
Interven-
tion 1 ver-
sus Inter-
vention 2
Outcome Int 1 pre
mean
(SD)1
Int 2 pre
mean
(SD)2
Int 1
post mean
(SD)3
Int 2
post mean
(SD)4
MD 5 Relative %
change 6
Adjusted
relative %
change7
SMD8
(P value)9
(Eccles
2001)*
Feedback
on number
of knee ra-
diographs
6 months
be-
fore and 6
months af-
ter the in-
tervention
plus guide-
line
dissemi-
nation ver-
sus guide-
line dis-
semination
Number of
knee radio-
graphs per
1000
patients
7.03 (5.1) 6.67 (3.9) 6.32 (4.0) 7.02 (3.6) 0.7 10% 15% 0.2
(NR)
(Eccles
2001)*
Reminder
mes-
sages on ra-
diograph
reports
plus guide-
line
dissemi-
nation ver-
Number of
knee radio-
graphs per
1000
patients
7.18 (5.0) 6.67 (3.9) 5.22 (3.6) 7.02 (3.6) 1.8 26% 33% 0.5
(P< 0.05)
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Table 21. Other musculoskeletal studies: Intervention versus a different intervention, continuous data (Continued)
sus guide-
line dis-
semination
(Eccles
2001)*
Feedback
on number
of knee ra-
diographs
6 months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion plus
reminder
messages
on ra-
diograph
reports
versus
guideline
dissemina-
tion
Number of
knee radio-
graphs per
1000
patients
9.34 (6.1) 6.67 (3.9) 5.21 (3.7) 7.02 (3.6) 1.8 26% 64% 0.5
(NR)
(Eccles
2001)*
Feedback
on number
of knee ra-
diographs
6 months
before and
6 months
after the
interven-
tion plus
guideline
dissemina-
tion versus
reminder
messages
on radio-
graph re-
ports plus
guideline
Number of
knee radio-
graphs per
1000
patients
7.03 (5.1) 7.18 (5.0) 6.32 (4.0) 5.22 (3.6) -1.1 -21% -24% -0.3
(NR)
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Table 21. Other musculoskeletal studies: Intervention versus a different intervention, continuous data (Continued)
dissemina-
tion
1. Intervention 1 group pre-intervention mean (standard deviation)
2. Intervention 2 group pre-intervention mean (standard deviation)
3. Intervention 1 group post-intervention mean (standard deviation)
4. Intervention 2 group postintervention mean (standard deviation)
5. Mean Difference (MD)=Difference between post-intervention means. The direction of effect has been adjusted so that a positive
result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
6. Relative percentage change post-intervention = (Int1 post mean - Int2 post mean)/Int2 post mean. The direction of effect has been
adjusted so that a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
7. Adjusted relative percentage change= (Int1 post mean-Int2 post mean)-(Int1 pre mean - Int2 pre mean)/Int2 post mean. The
direction of effect has been adjusted so that a positive result represents a beneficial intervention 1 outcome.
8. SMD=Standardised Mean Difference=(Int1 post mean-Int2 post mean)/SD pooled. The direction of effect has been adjusted so that
a positive result represents a beneficial intervention 1 outcome, according to Grimshaw 2004.
9. P value reported by study authors
*The above data reported above for Eccles 2001 was adjusted for clustering by the authors
Table 22. Summary of median absolute effect sizes (risk difference) of dichotomous outcomes for interventions aiming to
increase or decrease a clinical behaviour
Table 23: Summary of median absolute effect sizes (risk difference) of dichotomous outcomes for interventions aiming to
increase or decrease a clinical behaviour
Table 23: Summar
mous outcomes
haviour
Study characteristic: be-
haviour targeted
Number of comparisons
(n studies)
Median absolute effect
size
Interquartile range Range
In-
crease an existing clin-
ical behaviour accord-
ing to guidelines
68 (14) 5% 0.6% to 12.6% -7.8% to 57.2%
Decrease an existing
clinical behaviour ac-
cording to guidelines
26 (7) 1.1% -1.1% to 3% -12.6% to 30.1%
Table 23. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or
decrease a clinical behaviour (including only comparisons from Low Back Pain studies)
Table 24: Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or
decrease a clinical behaviour (including only comparisons from Low Back Pain studies)
Table 24: Summar
outcomes for inter
(including only
Study characteristic: be-
haviour targeted
Number of comparisons
(n studies)
Median absolute effect
size
Interquartile range Range
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Table 23. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or
decrease a clinical behaviour (including only comparisons from Low Back Pain studies) (Continued)
In-
crease an existing clin-
ical behaviour accord-
ing to guidelines
18 (2) 3.7% -0.8% to 6.9% -4.7% to 12.8%
Decrease an existing
clinical behaviour ac-
cording to guidelines
23 (6) 0.5% -1.1% to 2.4% -12.6% to 30.1%
Table 24. Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or
decrease a clinical behaviour (including only comparisons from Osteoarthritis studies)
Table 25: Summary of median effect sizes (risk difference) of dichotomous outcomes for interventions aiming to increase or
decrease a clinical behaviour (including only comparisons from Osteoarthritis studies)
Table 25: Summar
outcomes for inter
(including only
Study characteristic: be-
haviour targeted
Number of comparisons
(n studies)
Median absolute effect
size
Interquartile range Range
In-
crease an existing clin-
ical behaviour accord-
ing to guidelines
18 (3) 6.3% -0.2% to 10% -7.8% to 57.2%
Decrease an existing
clinical behaviour ac-
cording to guidelines
3 (1) 7.8% 6.1% to 13.4% 4.4% to 18.9%
A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE OVID
Search date: October 24, 2013
1 exp musculoskeletal diseases/ or rheumatology/ or exp orthopedics/ or orthopedic procedures/ (857643)
2 (musculoskeletal or arthriti$ or orthop?edic? or osteo$ or polymyalg$ or periarthrit$).ti. (249636)
3 (arthritis or back pain or chondrocalcinosis or dermatomyositis or dupuytren? contracture or fibromyal$ or Fibrositis or Fibrositides
or gout or hyperostos$ or low$ back or lupus or osteitis or osteoarthrit$ or osteoarthrop$ or osteochondr$ or Osteonecros$ or
osteoporos$ or periarthriti$ or polymyalgia? or raynaud disease? or rheumatism or rheumatic disease? or sciatica or scleroderma$ or
Spondylarthrit$).ti,ab. (352214)
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4 (((cartiledge or connective tissue? or joint? or ligament? or muscula$ or myofascial or neck or soft tissue? or spine or spinal) adj2
(damage? or disease? or disorder? or injury or injuries or pain? or strain?)) and (care or treatment)).ti. (2884)
5 ((caplan? or felty’s or Sjogren’s or still’s or wissler’s) adj (disease? or syndrome?)).ti,ab. (11736)
6 ((elbow or hand? or knee or knees or leg or muscle or muscular$ or orthop?edic? or shoulder? or wrist?) adj2 (care or treatment? or
injury or injuries or pain? or strain?)).ti,ab. (38503)
7 (athletic? adj2 (strain? or injury or injuries)).ti. (451)
8 Dermatomyositis/ or Dupuytren’s Contracture/ or Lupus Erythematosus, Cutaneous/ or Lupus Erythematosus, Systemic/ or exp
back pain/ or neck pain/ or sciatica/ or exp Raynaud Disease/ or exp Scleroderma, Systemic/ or exp arm injuries/ or athletic injuries/
or exp back injuries/ or exp dislocations/ or exp fractures bone/ or fractures cartilage/ or exp hand injuries/ or exp hip injuries/ or exp
leg injuries/ or multiple trauma/ or exp neck injuries/ or soft tissue injuries/ or exp spinal cord injuries/ or exp spinal injuries/ or exp
“sprains and strains”/ or exp tendon injuries/ or exp musculoskeletal system/ (1447111)
9 or/1-8 [MSK Rev] (2072899)
10 general practice/ or physicians, primary care/ [Terms added August 2012] (4535)
11 family practice/ or physicians, family/ or primary health care/ (122879)
12 ((family or general) adj2 (doctor? or medicine or medical practitioner? or medical practice? or practice? or practitioner? or physi-
cian$)).ti,ab. [Increased adj Aug 2012] (101849)
13 (primary adj2 (care or health care or healthcare or medical care or patient care)).ti,ab. (89077)
14 or/10-13 [Primary Care Rev ML] (217520)
15 (randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or ran-
domly.ab. or trial.ti. (930250)
16 exp animals/ not humans.sh. (4051829)
17 15 not 16 [Cochrane RCT Filter 6.4.d Sens/Precision Maximizing] (859939)
18 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational
or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$
or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or
multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy
or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or
tailor$ or target$ or team$ or usual care)).ab. (165998)
19 (pre-intervention? or preintervention? or “pre intervention?” or post-intervention? or postintervention? or “post intervention?”).ti,ab.
[added 2.4] (10262)
20 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing
or doctor?).ti,hw. (720981)
21 demonstration project?.ti,ab. (1984)
22 (pre-post or “pre test$” or pretest$ or posttest$ or “post test$” or (pre adj5 post)).ti,ab. (65680)
23 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (610)
24 trial.ti. or ((study adj3 aim?) or “our study”).ab. (632839)
25 (before adj10 (after or during)).ti,ab. (362830)
26 (“quasi-experiment$” or quasiexperiment$ or “quasi random$” or quasirandom$ or “quasi control$” or quasicontrol$ or ((quasi$
or experimental) adj3 (method$ or study or trial or design$))).ti,ab,hw. [ML] (104437)
27 (“time series” adj2 interrupt$).ti,ab,hw. [ML] (1184)
28 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or
hour? or day? or “more than”)).ab. (9391)
29 pilot.ti. (39876)
30 Pilot projects/ [ML] (84019)
31 (clinical trial or controlled clinical trial or multicenter study).pt. [ML] (649874)
32 (multicentre or multicenter or multi-centre or multi-center).ti. (29829)
33 random$.ti,ab. or controlled.ti. (779263)
34 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not
(controlled clinical trial or randomized controlled trial).pt. [ML] (412256)
35 “comment on”.cm. or review.ti,pt. or randomized controlled trial.pt. [ML] (2959592)
36 review.ti. [EM] (255522)
37 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (1368734)
38 exp animals/ not humans.sh. [ML] (4051829)
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39 (animal$ not human$).sh,hw. [EM] (3956028)
40 *experimental design/ or *pilot study/ or quasi experimental study/ [EM] (24261)
41 (“quasi-experiment$” or quasiexperiment$ or “quasi random$” or quasirandom$ or “quasi control$” or quasicontrol$ or ((quasi$
or experimental) adj3 (method$ or study or trial or design$))).ti,ab. [EM] (104437)
42 (“time series” adj2 interrupt$).ti,ab. [EM] (1184)
43 (or/18-29,32-34) or experimental design/ or between groups design/ or quantitative methods/ or quasi experimental methods/
[PsycInfo] (2839256)
44 exp animals/ or animal?.ti,id,hw. [PsycInfo] (17706941)
45 (or/18-34) not (or/35,37-38) [EPOC Methods Filter 2.4 Medline] (2151565)
46 (or/18-25,28-29,32-33,40-42) not (or/36,39) [EPOCMethods Filter 2.4 EMBASE] (2199704)
47 43 not (or/36-37,44) [EPOC Methods Filter 2.4 PsycInfo] (339055)
48 9 and 14 [MSK & PC] (11460)
49 9 and 14 and 17 [MSK & PC & RCT FILTER] (1584)
50 (9 and 14 and 45) not 49 [MSK & PC & EPOC FILTER 2.4] (2810)
51 (201208$ or 201209$ or 201210$ or 201211$ or 201212$ or 2013$).ed,ep,yr. (1796601)
52 49 and 51 [rct] (167)
53 remove duplicates from 52 [RCT to export Oct 24-2013] (129)
54 50 and 51 [EPOC] (292)
55 remove duplicates from 54 [EPOC to export Oct 2013]
EMBASE OVID
Embase Classic+Embase <1947 to 2013 October 23>
1 exp *musculoskeletal disease/ or rheumatology/ or *orthopedics/ or *orthopedic surgery/ (1190591)
2 (arthrit$ or back pain or fibromyalg$ or gout or low$ back or musculoskeletal or orthop?edic? or lupus or osteitis or osteoarthrit$ or
osteoarthrop$ or osteochondr$ or Osteonecros$ or osteoporos$ or periarthriti$ or polymyalgia? or rheumatism or rheumatic disease?
or sciatica or scleroderma$ or Spondylarthrit$).ti. (311875)
3 ((arthritis or back pain or chondrocalcinosis or dermatomyositis or dupuytren? contracture or fibromyal$ or Fibrositis or Fibrositides or
gout or hyperostos$ or low$ back or lupus or osteitis or osteoarthrit$ or osteoarthrop$ or osteochondr$ or Osteonecros$ or osteoporos$
or periarthriti$ or polymyalgia? or raynaud disease? or rheumatism or rheumatic disease? or sciatica or scleroderma$ or Spondylarthrit$)
adj3 (care or treatment?)).ab. (24640)
4 (((cartiledge or connective tissue? or joint? or ligament? or muscula$ or myofascial or neck or soft tissue? or spine or spinal) adj2
(damage? or disease? or disorder? or injury or injuries or pain? or strain?)) and (care or treatment)).ti. (3734)
5 ((caplan? or felty’s or Sjogren’s or still’s or wissler’s) adj (disease? or syndrome?)).ti,ab. (15557)
6 ((elbow or hand? or knee or knees or leg or muscle or muscular$ or orthop?edic? or shoulder? or sprain$ or wrist?) adj4 (care or
treatment)).ti,ab. (32341)
7 (athletic? adj2 (strain? or injury or injuries)).ti. (491)
8 (bone adj2 (fracture? or fractured)).ti. (2759)
9 ((bone? or cartiledge or connective tissue? or joint? or ligament? or muscula$ or myofascial or neck or soft tissue? or spine or spinal)
adj2 (damage? or disease? or disorder? or injury or injuries or pain? or strain?)).ti. (49287)
10 *dermatomyositis/ or *Dupuytren contracture/ or *skin lupus erythematosus/ or *systemic lupus erythematosus/ or exp *backache/
or exp *leg pain/ or exp *musculoskeletal pain/ or *neck pain/ or *ischialgia/ or *Raynaud phenomenon/ or *scleroderma/ or exp *ARM
INJURY/ or exp *TENDON INJURY/ or exp *SOFT TISSUE INJURY/ or exp *NECK INJURY/ or exp *HAND INJURY/ or exp
*LEG INJURY/ or exp *SPINE INJURY/ or exp *SPINAL CORD INJURY/ or exp *HIP INJURY/ or *sport injury/ or *dislocation/
or exp *fracture/ or exp *sprain/ or muscle strain/ or exp *tendon injury/ (367353)
11 or/1-10 [MSK conditions] (1404842)
12 *general practitioner/ (15844)
13 *general practice/ (39859)
14 exp *primary health care/ (40728)
15 ((family or general) adj2 (doctor? or medical practitioner? or medical practice? or practice? or practitioner? or physician$)).ti,ab.
(117580)
16 (primary adj2 (care or health care or healthcare or medical care or patient care)).ti,ab. (104088)
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17 or/12-16 [Primary care] (231098)
18 controlled clinical trial/ or controlled study/ or randomized controlled trial/ [EM] (4244044)
19 (book or conference paper or editorial or letter or review).pt. not randomized controlled trial/ [Per BMJ Clinical Evidence filter]
(4034696)
20 (random sampl$ or random digit$ or random effect$ or random survey or random regression).ti,ab. not randomized controlled
trial/ [Per BMJ Clinical Evidence filter] (54247)
21 (animal$ not human$).sh,hw. (3913735)
22 18 not (or/19-21) [Trial filter per BMJ CLinical Evidence] (2801374)
23 intervention?.ti. or (intervention? adj6 (clinician? or collaborat$ or community or complex or DESIGN$ or doctor? or educational
or family doctor? or family physician? or family practitioner? or financial or GP or general practice? or hospital? or impact? or improv$
or individuali?e? or individuali?ing or interdisciplin$ or multicomponent or multi-component or multidisciplin$ or multi-disciplin$ or
multifacet$ or multi-facet$ or multimodal$ or multi-modal$ or personali?e? or personali?ing or pharmacies or pharmacist? or pharmacy
or physician? or practitioner? or prescrib$ or prescription? or primary care or professional$ or provider? or regulatory or regulatory or
tailor$ or target$ or team$ or usual care)).ab. (201463)
24 (pre-intervention? or preintervention? or “pre intervention?” or post-intervention? or postintervention? or “post intervention?”).ti,ab.
[added 2.4] (12626)
25 (hospital$ or patient?).hw. and (study or studies or care or health$ or practitioner? or provider? or physician? or nurse? or nursing
or doctor?).ti,hw. (1623934)
26 demonstration project?.ti,ab. (2357)
27 (pre-post or “pre test$” or pretest$ or posttest$ or “post test$” or (pre adj5 post)).ti,ab. (93420)
28 (pre-workshop or post-workshop or (before adj3 workshop) or (after adj3 workshop)).ti,ab. (809)
29 trial.ti. or ((study adj3 aim?) or “our study”).ab. (838686)
30 (before adj10 (after or during)).ti,ab. (474031)
31 deleted line; no impact on strategy
32 deleted line; no impact on strategy
33 (time points adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or eleven or twelve or month$ or
hour? or day? or “more than”)).ab. (11728)
34 pilot.ti. (49794)
35 deleted line; no impact on strategy
36 deleted line; no impact on strategy
37 (multicentre or multicenter or multi-centre or multi-center).ti. (39211)
38 random$.ti,ab. or controlled.ti. (932656)
39 (control adj3 (area or cohort? or compare? or condition or design or group? or intervention? or participant? or study)).ab. not
(controlled clinical trial or randomized controlled trial).pt. [ML] (615626)
40 deleted line; no impact on strategy
41 review.ti. [EM] (312835)
42 (rat or rats or cow or cows or chicken? or horse or horses or mice or mouse or bovine or animal?).ti. (1654258)
43deleted line; no impact on strategy
44 (animal$ not human$).sh,hw. [EM] (3913735)
45 *experimental design/ or *pilot study/ or quasi experimental study/ [EM] (6990)
46 (“quasi-experiment$” or quasiexperiment$ or “quasi random$” or quasirandom$ or “quasi control$” or quasicontrol$ or ((quasi$
or experimental) adj3 (method$ or study or trial or design$))).ti,ab. [EM] (128680)
47 (“time series” adj2 interrupt$).ti,ab. [EM] (1124)
48-50 deleted lines; no impact on strategy
51 (or/23-30,33-34,37-38,45-47) not (or/41,44) [EPOCMethods Filter 2.4 EMBASE] (3323291)
52 48 not (or/41-42,49) [EPOC Methods Filter 2.4 PsycInfo] (715574)
53 11 and 17 [MSK & Primary Care] (10572)
54 11 and 17 and 22 [MSK & PC & RCT] (2143)
55 (11 and 17 and 51) not 54 [MSK & PC & EPOC Filter] (3595)
Cochrane Library via OVID EBM Collection
Search date: October 2013
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EBM Reviews - Cochrane Database of Systematic Reviews <2005 to September 2013>, EBM Reviews - ACP Journal Club <1991 to
October 2013>, EBM Reviews - Database of Abstracts of Reviews of Effects <3rd Quarter 2013>, EBM Reviews - Cochrane Central
Register of Controlled Trials <September 2013>, EBM Reviews - Cochrane Methodology Register <3rd Quarter 2012>, EBM Reviews
- Health Technology Assessment <3rd Quarter 2013>, EBM Reviews - NHS Economic Evaluation Database <3rd Quarter 2013>
1 exp musculoskeletal diseases/ or rheumatology/ or exp orthopedics/ or orthopedic procedures/ (20864)
2 (musculoskeletal or arthrit$ or orthop?edic? or osteo$ or polymyalg$ or periarthrit$).ti. (13266)
3 (arthritis or back pain or chondrocalcinosis or dermatomyositis or dupuytren? contracture or fibromyal$ or Fibrositis or Fibrositides
or gout or hyperostos$ or low$ back or lupus or osteitis or osteoarthrit$ or osteoarthrop$ or osteochondr$ or Osteonecros$ or
osteoporos$ or periarthriti$ or polymyalgia? or raynaud disease? or rheumatism or rheumatic disease? or sciatica or scleroderma$ or
Spondylarthrit$).ti,ab. (19487)
4 (((cartiledge or connective tissue? or joint? or ligament? or muscula$ or myofascial or neck or soft tissue? or spine or spinal) adj2
(damage? or disease? or disorder? or injury or injuries or pain? or strain?)) and (care or treatment)).ti. (472)
5 ((caplan? or felty’s or Sjogren’s or still’s or wissler’s) adj (disease? or syndrome?)).ti,ab. (247)
6 ((elbow or hand? or knee or knees or leg or muscle or muscular$ or orthop?edic? or shoulder? or wrist?) adj2 (care or treatment? or
injury or injuries or pain? or strain?)).ti,ab. (5343)
7 (athletic? adj2 (strain? or injury or injuries)).ti. (14)
8 Dermatomyositis/ or Dupuytren’s Contracture/ or Lupus Erythematosus, Cutaneous/ or Lupus Erythematosus, Systemic/ or exp
back pain/ or neck pain/ or sciatica/ or exp Raynaud Disease/ or exp Scleroderma, Systemic/ or exp arm injuries/ or athletic injuries/
or exp back injuries/ or exp dislocations/ or exp fractures bone/ or fractures cartilage/ or exp hand injuries/ or exp hip injuries/ or exp
leg injuries/ or multiple trauma/ or exp neck injuries/ or soft tissue injuries/ or exp spinal cord injuries/ or exp spinal injuries/ or exp
“sprains and strains”/ or exp tendon injuries/ or exp musculoskeletal system/ (28264)
9 or/1-8 [MSK Rev] (53389
10 general practice/ or physicians, primary care/ [Terms added August 2012] (145)
11 family practice/ or physicians, family/ or primary health care/ (4521)
12 ((family or general) adj2 (doctor? or medicine or medical practitioner? or medical practice? or practice? or practitioner? or physi-
cian$)).ti,ab. [Increased adj Aug 2012] (6968)
13 (primary adj2 (care or health care or healthcare or medical care or patient care)).ti,ab. (7493)
14 or/10-13 [Primary Care Rev ML] (13418)
15 9 and 14 (1090)
16 limit 15 to yr=“2012 - 2014” [Limit not valid in DARE; records were retained] (68)
17 from 16 keep 1-3 [CDSR] (3)
18 from 16 keep 4-7 [ACP] (4)
19 from 16 keep 8-9 [DARE] (2)
20 from 16 keep 10-53 [Central] (44)
21 from 16 keep 45-53 [HTA] (9)
22 from 16 keep 63-68 [EED] (6)
Cochrane Library, Issue 2, 2010 [Wiley]
Search Date: 2010-08-23 15:34:51.33
#1MeSH descriptor Musculoskeletal Diseases explode all trees
#2MeSH descriptor Rheumatology, this term only
#3MeSH descriptor Orthopedics explode all trees
#4MeSH descriptor Orthopedic Procedures, this term only
#5(musculoskeletal or arthritis or osteoarthritis):ab
#6(arthrit*):ti
#7((bone near/2 fracture*) or (bone near/2 fractured)):ti
#8(Chondrocalcinosis or dermatomyositis or dupuytren* contracture or fibromyalgia* or Fibrositis or Fibrositides or gout or hyperostos*
or lupus orMusculoskeletal or orthopedic* or orthopaedic* or osteitis or osteoarthrit* or osteoarthrop* or osteochondr* or Osteonecros*
or osteoporos* or periarthriti* or polymyalgia* or raynaud disease* or rheumati* or sciatica or scleroderma* or Spondylarthrit* or
sprain*):ti
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#9((caplan* or felty’s or Sjogren’s or still’s or wissler’s) near/ disease*):ti
#10((caplan* or felty’s or Sjogren’s or still’s or wissler’s) near/ syndrome*):ti
#11((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 strain*):ti
#12((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 damage*):ti
#13((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 disease*):ti
#14((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 disorder*):ti
#15((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 injury):ti
#16((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 pain*):ti
#17((bone* or cartiledge or connective tissue* or joint* or ligament* or muscula* or myofascial or neck or soft tissue* or spine or spinal)
near/2 injuries):ti
#18((elbow) near/2 (injury or injuries or pain* or strain*)):ti
#19((shoulder) near/2 (injury or injuries or pain* or strain*)):ti
#20((hand*) near/2 (injury or injuries or pain* or strain*)):ti
#21(knee near/2 (injury or injuries or pain* or strain*)):ti
#22(athletic* near/2 (strain* or injury or injuries)):ti
#23MeSH descriptor Dermatomyositis, this term only
#24MeSH descriptor Dupuytren Contracture, this term only
#25MeSH descriptor Lupus Erythematosus, Cutaneous, this term only
#26MeSH descriptor Lupus Erythematosus, Systemic explode all trees
#27MeSH descriptor Back Pain explode all trees
#28MeSH descriptor Sciatica, this term only
#29MeSH descriptor Raynaud Disease, this term only
#30MeSH descriptor Scleroderma, Systemic explode all trees
#31MeSH descriptor Arm Injuries explode all trees
#32MeSH descriptor Neck Pain explode all trees
#33MeSH descriptor Athletic Injuries, this term only
#34MeSH descriptor Back Injuries explode all trees
#35MeSH descriptor Dislocations explode all trees
#36MeSH descriptor Fractures, Bone explode all trees
#37MeSH descriptor Fractures, Cartilage, this term only
#38MeSH descriptor Hand Injuries explode all trees
#39MeSH descriptor Hip Injuries explode all trees
#40MeSH descriptor Leg Injuries explode all trees
#41MeSH descriptor Multiple Trauma, this term only
#42MeSH descriptor Neck Injuries explode all trees
#43MeSH descriptor Soft Tissue Injuries, this term only
#44MeSH descriptor Spinal Cord Injuries explode all trees
#45MeSH descriptor Sprains and Strains explode all trees
#46MeSH descriptor Tendon Injuries explode all trees
#47MeSH descriptor Musculoskeletal System explode all trees
#48(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR
#32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR
#47)
#49MeSH descriptor Family Practice, this term only
#50MeSH descriptor Physicians, Family, this term only
#51MeSH descriptor Primary Health Care, this term only
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#52(general near/ (doctor* or medicine or medical practitioner* or medical practice* or practice* or practitioner* or physician*)):ti,ab
#53(family near/ (doctor* or medicine or medical practitioner* or medical practice* or practice* or practitioner* or physician*)):ti,ab
#54(primary near/2 (care or health care or healthcare or medical care or patient care)):ti,ab
#55(#49 OR #50 OR #51 OR #52 OR #53 OR #54)
#56intervention*:ti
#57(intervention* near/6 (clinician* or collaborat* or community or complex or doctor* or educational or family doctor* or family
physician* or family practitioner* or financial or GP or general practice* or hospital* or impact* or improv* or individuali*e* or
individuali*ing or interdisciplin* or multicomponent or multi-component or
multidisciplin* or multi-disciplin* or multifacet* or multi-facet* or multimodal* or multi-modal* or personali*e* or personali*ing or
pharmacies or pharmacist* or pharmacy or
physician* or practitioner* or prescrib* or prescription* or primary care or professional* or provider* or regulatory or regulatory or
tailor* or target* or team* or usual care)):ab
#58((evidence near/4 intervention) or (evidence-based near/4 intervention) or (evidence-driven)):ti,ab
#59“practice-based”:ti,ab
#60(improv* near/3 (decision* or implement* or health care or healthcare or initiative* or management or multifacet* or multi-facet* or
multi-component or practi*e* or practitioner* or prescrib* or prescription* or professional* or program* or programme* or provider*)):
ti
#61(improv* near/2 (patient-care or family practice or ((family or general) near/2 (practi*e or practitioner* or doctor*)) or primary
care)):ab
#62recommended practice*:ti,ab
#63((information or evidence) near/2 uptake):ti,ab
#64(knowledge near/2 (application or broke* or creation or diffus* or disseminat* or exchang* or implement* or management or
mobili* or translat* or transfer* or uptake or utili*)):ti,ab
#65(evidence* near/2 (exchang* or translat* or transfer*)):ti,ab
#66(KT near/2 (application or broke* or diffus* or disseminat* or decision* or exchang* or implement* or intervent* or mobili* or
plan* or policy or policies or strateg* or translat* or transfer* or uptake or utili*)):ti,ab
#67((computer-tailored or individuali*ing or individuali*ed or personali*e* or personali*ing or tailor*) near/2 (feedback or intervention*
or information or plan*)):ti,ab
#68((conventional or evidence-based or pattern or regular or routine or standard or traditional or usual) near/2 (care or healthcare or
patient care or practice)):ti,ab #69(collaborative* or interdisciplin* or inter-disciplin* or multidisciplin* or multi- disciplin* or team*
or team-based or skill- mix):ti
#70(skill* near/2 (mix or mixes)):ti,ab
#71((collaborative) near/2 (care or patient care or healthcare)):ab
#72((multidisciplinary) near/2 (care or patient care or healthcare)):ab
#73((interdisciplinary) near/2 (care or patient care or healthcare)):ab
#74(doctor-driven or doctor-led or GP-LED or nurse-led or nurse-driven or pharmacist-led or pharmacist-driven or physician-led or
physician- driven):ti,ab
#75physician directed:ti,ab
#76(leaflet* or pamphlet* or “written information”):ti
#77((leaflet*) near/5 (intervention* or care or healthcare or physician* or practitioner* or provider*)):ab
#78((pamphlet*) near/5 (intervention* or care or healthcare or physician* or practitioner* or provider*)):ab
#79((“written information”) near/5 (intervention* or care or healthcare or physician* or practitioner* or provider*)):ab
#80((academic detailing or e-detailing) or (opinion* near/2 leader*)):ti,ab
#81(“audit and feedback”):ti,ab
#82((physician* or doctor* or practitioner* or nurse* or provider*) near/ feedback):ti,ab
#83(clinician* near/2 (prompt or prompts or prompting)):ti,ab or (physician* near/2 (prompt or prompts or prompting)):ti,ab or
(remind* near/2 (prompt or prompts or prompting)):ti,ab
#84(reminder* near/2 (clinician* or physician* or practitioner* or nurse* or doctor* or provider*)):ti,ab
#85MeSH descriptor Reminder Systems, this term only
#86((doctor* or nurse* or pharmacist* or physician* or practitioner*) near/2 behavio*r*):ti,ab
#87(nurse* near/4 substitut*):ti,ab
#88(practice pattern*):ti,ab or ((change* or changing) near/2 practice):ti,ab
#89MeSH descriptor Physician’s Practice Patterns, this term only
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#90(nurse-practitioner* or physician* assistant*):ti
#91((doctor* or pharmacist* or physician*) near/2 role*):ab
#92MeSH descriptor Referral and Consultation, this term only
#93(Referral* and (primary care or specialist* or general practitioner* or change* or changing or improv* or impact or effect* or reduce*
or reducing or increase* or increasing or optimi* or optimal or quality or healthcare or patient care or intensive care or emergency or
chronic or management or administration)):ti,ab
#94(Referral* and (primary care or specialist* or general practitioner* or optimi*e* or optimal)):ti or (Referral* near/3 (primary care
or specialist* or general practitioner* or optimi*e* or optimal)):ab
#95((nurse* or physician* or pharmacist* or provider*) near/2 initiative*):ti,ab
#96(virtual reality or VR Training or VR simulat* or (simulat* near/2 skill*)):ti,ab
#97(blog* or wiki* or PDA or “palm pilot* ” or blackberr* or Twitter or tweet or tweeting or facebook or social networking or social
marketing or youtube):ti,ab or blogging or (health 20 or healthcare 20 or health care 20 or web 20):ti,ab
#98(guideline adherence or (guideline* near/3 (adherence or compliance or concordance or implement* or UPTAKE))):ti,ab
#99((individuali* near/2 (care or healthcare or medical care)) or (integrated near/2 (care or healthcare or medical care)) or (patient-
centred or patient-centered or patient-control*)):ti,ab
#100quality improvement:ti,ab
#101(Patient satisfaction or algorithm*):ti,ab
#102MeSH descriptor Education, Pharmacy, Continuing, this term only
#103MeSH descriptor Education, Medical, Continuing, this term only
#104MeSH descriptor Education, Nursing, Continuing, this term only
#105MeSH descriptor Education, Professional, this term only
#106(continuing near/2 education near/3 (physician* or nurse* or nursing or practitioner* or doctor* or family physician* or general
practitioner* or family doctor* or primary care or primary healthcare)):ab
#107(continuing near/3 education):ti
#108((continuing or “on the job” or “off the job” or postgrad* or post-grad* or resident* or intern* or internship* or workplace) near/
2 training):ti,ab
#109(((continuing or “on the job” or “off the job” or postgrad* or post-grad* or resident* or intern* or internship* or workplace) near/
2 education*) or (skill* near/ (education or training))):ti,ab
#110(#56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67 OR #68 OR #69 OR #
70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR #78 OR #79 OR #80 OR #81 OR #82 OR #83 OR #84 OR #
85 OR #86 OR #87 OR #88 OR #89 OR #90 OR #91 OR #92 OR #93 OR #94 OR #95 OR #96 OR #97 OR #98 OR #99 OR #
100 OR #101 OR #102 OR #103 OR #104 OR #105 OR #106 OR #107 OR #108 OR #109)
#111(#48 AND #55)
#112(#48 AND #55 AND #110)
#113(#111 OR #112)
CINAHL, EbscoHost 1980-
Search dates: August 24, 2010 AND november 20, 2013
Date: 20100101-20131231 NOVEMBER 20, 2013 288
S52 S51 or S50 [All Results] AUGUST 24, 2010 608
S51 S49 and S46 (Results with EPOC 1.7 Filter) 485
S50 S49 and S45 (Results with RCT filter) 302
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(Continued)
S49 S47 and S48 and S17 (S17= primary Care terms) 1681
S48 S18 or S19 or S20 or S21 or S22 or S23 (Education/Collab-
oration Intervention terms)
76261
S47 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or
S11 or S12 or S13 or S14 or S15 or S16 (MSK terms)
404871
S46 S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32
or S34 or S35 or S36 or S37 or S38 (EPOC Filter 1.7)
187032
S45 S39 or S40 or S41 or S42 or S43 or S44 (RCT filter) 126098
S44 TI ( “control* N1 clinical” or “control* N1 group*” or “con-
trol*N1 trial*” or “control*N1 study” or “control*N1 studies”
or “control* N1 design*” or “control* N1 method*” ) or AB
( “control* N1 clinical” or “control* N1 group*” or “control*
N1 trial*” or “control* N1 study” or “control* N1 studies” or
“control* N1 design*” or “control* N1 method*” )
57555
S43 TI controlled or AB controlled 44233
S42 TI random* or AB random* 77414
S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical
study” or “clinical studies” )
11229
S40 (MM “Clinical Trials+”) 6045
S39 TI ( (multicent* n2 design*) or (multicent* n2 study) or (mul-
ticent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi-
cent* n2 design*) or (multicent* n2 study) or (multicent* n2
studies) or (multicent* n2 trial*) )
5282
S38 TI pilot 7878
S37 (MH “Pilot Studies”) 20827
S36 AB “before-and-after” 12207
S35 AB time series 1089
S34 TI time series 141
S33 AB ( before* n7 during or before n3 after ) or AU ( before* n7
during or before n3 after )
19048
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(Continued)
S32 TI ( (time point*) or (period* n4 interrupted) or (period*
n4 multiple) or (period* n4 time) or (period* n4 various) or
(period* n4 varying) or (period* n4 week*) or (period* n4
month*) or (period* n4 year*) ) or AB ( (time point*) or (pe-
riod* n4 interrupted) or (period* n4 multiple) or (period* n4
time) or (period* n4 various) or (period* n4 varying) or (pe-
riod* n4 week*) or (period* n4 month*) or (period* n4 year*)
)
34841
S31 TI ( ( quasi-experiment* or quasiexperiment* or quasi-ran-
dom* or quasirandom* or quasi control* or quasicontrol* or
“quasi* W3 method*” or “quasi* W3 study” or “quasi* W3
studies” or “quasi* W3 trial” or “quasi* W3 design*” or “ex-
perimental W3 method*” or “experimental W3 study” or “ex-
perimental W3 studies” or “experimental W3 trial” or “exper-
imental W3 design*” ) ) or AB ( ( quasi-experiment* or quasi-
experiment* or quasi-random* or quasirandom* or quasi con-
trol* or quasicontrol* or “quasi* W3 method*” or “quasi* W3
study” or “quasi* W3 studies” or “quasi* W3 trial” or “quasi*
W3 design*” or “experimental W3method*” or “experimental
W3 study” or “experimental W3 studies” or “experimental W3
trial” or “experimental W3 design*” ) )
8591
S30 TI pre w7 post or AB pre w7 post 6142
S29 MH “Multiple Time Series” or MH “Time Series” 922
S28 TI ( (comparative N2 study) or (comparative N2 studies) or
“evaluation study” or “evaluation studies” ) or AB ( (compar-
ative N2 study) or (comparative N2 studies) or “evaluation
study” or “evaluation studies” )
5677
S27 MH Experimental Studies or Community Trials or Commu-
nity Trials or Pretest-Posttest Design + or Quasi-Experimental
Studies + Pilot Studies or Policy Studies + Multicenter Studies
24708
S26 TI ( “pre test*” or pretest* or posttest* or “post test*” ) or AB
( “pre test*” or pretest* or posttest* or “post test*” )
5942
S25 TI ( intervention* or multiintervention* or multi-interven-
tion* or postintervention* or post-intervention* or preinter-
vention* or pre-intervention* ) or AB ( intervention* or mul-
tiintervention* or multi-intervention* or postintervention* or
post-intervention* or preintervention* or pre-intervention* )
105013
S24 (MH “Quasi-Experimental Studies”) 4258
S23 (MH “Professional Development”) 10105
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(Continued)
S22 (MH “Practice Patterns”) OR (MH “Prescribing Patterns”) 3110
S21 AB ( (multifacet* or multi-facet* or multimodal* or multi-
modal* or multidisciplin* or interdisciplin* or collaborat* or
shared or team-based or team or skill-mix or inter-disciplin*
or multi-disciplin*) ) and AB ( (care or practice or decsion* or
refer* or consult*) )
32079
S20 (MH “Education, Medical, Continuing”) OR (MH “Educa-
tion, Nursing, Continuing”)
10047
S19 (MH “Multidisciplinary Care Team”) 15543
S18 (MH “Referral and Consultation”) OR (MH “Group Prac-
tice”)
12699
S17 (MH “Family Practice”) OR (MH “Physicians, Family”) OR
(MH “Primary Health Care”)ORAB (“primary care” or “fam-
ily physician*” or “family doctor*” or “primary health”)
41203
S16 TI (caplan* or felty’s or Sjogren’s or still’s or wissler’s)N disease* 266964
S15 TI (Chondrocalcinosis or dermatomyositis or dupuytren* con-
tracture or fibromyalgia* or Fibrositis or Fibrositides or gout
or hyperostos* or lupus or Musculoskeletal or orthopedic* or
orthopaedic* or osteitis or osteoarthrit* or osteoarthrop* or
osteochondr* or Osteonecros* or osteoporos* or periarthriti*
or polymyalgia* or raynaud disease* or rheumati* or sciatica
or scleroderma* or Spondylarthrit* or sprain*)
19656
S14 (MH “Dermatomyositis”) OR (MH “Musculoskeletal Sys-
tem+”)
64039
S13 (MH “Back Pain+”) OR (MH “Neck Pain”) 13141
S12 (MH “Sciatica”) 443
S11 (MH “Tendon Injuries+”) OR (MH “Soft Tissue Injuries”)
OR (MH “Spinal Cord Injuries+”) OR (MH “Dislocations+”)
14157
S10 (MH “Multiple Trauma”) 1104
S9 (MH “Dupuytren’s Contracture”) OR (MH “Scleroderma,
Systemic+”)
1057
S8 (MH “Raynaud’s Disease”) 299
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(Continued)
S7 (MH “Back Injuries+”) OR (MH “Arm Injuries+”) OR (MH
“Athletic Injuries+”) OR (MH “Fractures+”) OR (MH “Hand
Injuries+”) OR (MH “Leg Injuries+”) OR (MH “Neck In-
juries+”) OR (MH “Sprains and Strains+”)
38128
S6 (MH “Arthritis+”) 19407
S5 (MH “Orthopedic Care”) OR (MH “Orthopedic Surgery”) 5307
S4 (MH “Orthopedics”) 4192
S3 (MH “Rheumatology”) 676
S2 (MH “Lupus Erythematosus, Systemic+”) 2417
S1 (MH “Musculoskeletal Diseases+”) 72861
C O N T R I B U T I O N S O F A U T H O R S
VTB, DM and MU conceived and designed the review. VTB and NM screened search results and DM and MU acted as arbitrators
when disagreement arose. VTB and NM extracted data from included studies. VTB led the interpretation and write up of the results
of the review, and DM, MU and OW provided detailed comments and guidance on different aspects of the review.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Michelle Fiander, Trials Search Co-ordinator (TSC) for the EPOC Group, reviewed the search strategy in 2008, and recommended
changes in order to broaden the scope of the review and identify all relevant studies. These revised strategies were based on the 2008
strategy and finalised in consultation with the authors.
We revised the wording of the primary outcomes so that this is more consistent with the EPOC guidance on reporting outcomes in
EPOC reviews (EPOC 2013d).
We modified some of the planned methods documented in the protocol in response to piloting and advances in the methods for
systematic reviews. As noted in the main text of the review, we modified the search strategy, we changed the methods of assessment of
risk of bias, and changed some of the methods of data analysis.
In the protocol we mentioned that “We will pool the results of studies in this review if at least two studies are homogeneous regarding the
participants, interventions and outcomes. Because of the expected diversity of the interventions and outcomes, it may not be possible to pool the
results.” We explored the possibility of grouping the studies by intervention type and pooling the results to assess their effect. However,
this was not always clinically appropriate because not all intervention outcomes were applicable to all musculoskeletal conditions (for
example, BMD testing was only applicable in osteoporosis). We concluded that clinically, the main source of heterogeneity amongst
studies was the musculoskeletal condition studied, as this often determined the type of intervention and measured outcomes. Therefore,
and in accordance with the protocol, we presented a narrative summary after grouping the studies by condition, and we included in a
meta-analysis only those studies which were sufficiently similar in terms of intervention and outcomes.
We further divided the osteoporosis studies which were sufficiently similar to allow their results to be combined, into those where
the intervention targeted just physicians versus those where both physicians and patients were targeted. This allowed an assessment of
the effect of adding a patient-directed component to interventions targeting a physician in order to establish whether the combined
intervention results in improved outcomes.
We used risk differences and risk ratios to express the effect sizes for dichotomous outcomes, in accordance with the protocol. For
the expression of the meta-analysis results, we decided to use risk ratios because reporting relative effect measures is, on average, more
consistent, in accordance with the Cochrane Handbook (Deeks 2011). However, we also conducted a sensitivity analysis in order to
investigate whether the choice of the summary statistic was critical to the conclusions of the meta-analysis.
We planned to do a sensitivity analysis in order to re-examine our inclusion criteria with regards to the study design, as mentioned in
the protocol. However, in view of the fact that all studies in the meta-analysis were RCTs, we could not undertake a sensitivity analysis
after removing the NRCTs, as planned in the protocol where we mentioned that we would conduct further “analyses based upon study
design (RCT versus other)”.
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We did a subgroup analysis to assess the intended direction of the intervention’s effect on the targeted behavioural change (i.e. whether
increasing or decreasing an existing behaviour resulted in different effects).
Two additional authors (Olwyn Westwood and Noman Mohamed) joined the review for this update.
The surname of the corresponding author is changed to “Tzortziou Brown”.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bone Density; Back Pain [diagnosis; therapy]; Bone Density Conservation Agents [therapeutic use]; Controlled Before-After Studies;
General Practitioners [∗education]; Guideline Adherence; Interrupted Time Series Analysis; Musculoskeletal Diseases [∗diagnosis;
∗therapy]; Osteoarthritis [diagnosis; therapy]; Osteoporosis [diagnosis; therapy]; Randomized Controlled Trials as Topic; Reminder
Systems; Shoulder Pain [diagnosis; therapy]
MeSH check words
Humans
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